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Abstract 
 Merrilactone A (1) and the epimeric anislactones A (2) and B (3) are 
sesquiterpene natural products that were first isolated from the dried pericarps of 
Illicium merrillianum (Fukuyama in 2000)  and Illicium anisatum (Kouno in 1990), 
respectively. Merrilactone A (1) was identified as a potent nonpeptidal neurotrophic 
factor that strongly promotes neurite outgrowth in the culture of foetal rat cortical 
neurons and is a potential small molecule lead for the treatment of 
neurodegenerative disorders. Merrilactone A (1) together with 2 and 3, are highly 
complex cage-like structures that have established themselves as challenging and 
attractive targets in natural product synthesis. 
 
Presented in this research is a regiodivergent approach to both sets of natural 
products via the first known application of the defining transformation, an 
intramolecular tandem cyano-aldol cyclisation. We demonstrated an efficient route 
to the cyano-aldol product 303, which acted as the common intermediate to either 
natural product by orthogonal lactonisation sequences. This culminated in the 
successful synthesis of known intermediate 320, which represents the formal total 
synthesis of 1, and advanced tetracyclic intermediate 309, that is the full carbon 
skeleton of 2 and 3.  
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Abbreviations 
Ac  acetyl 
AD  Alzheimer's disease 
AIBN 2,2-azobis(isobutyronitrile) 
aq  aqueous 
ASA atmospheric solids analysis 
Bn  benzyl 
br  broad 
BTB  bis-(trifluoromethyl)benzyl 
Bu  butyl 
Bz  benzoyl 
calcd  calculated 
cat  catalytic  
COSY  correlation spectroscopy 
Cp  cyclopentadiene 
CSA  camphorsulfonic acid 
Cy  cyclohexyl 
d  doublet 
dba  dibenzylideneacetone 
DBB  di-tert-butylbiphenylide 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC N,N-dicyclohexylcarbodiimide 
DCB 2,6-dichlorobenzyl 
DCM  dichloromethane 
DDQ  2,3-dichloro-5,6-dicyanobenzoquinone 
DEPT  distortionless enhancement by polarisation transfer 
DIBALH  diisobutyl aluminium hydride 
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DIPEA  N,N-diisopropylethylamine 
DMAP  dimethylaminopyridine 
DMDO  dimethyldioxirane 
DME  dimethoxyethane 
DMF  dimethylformamide 
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hr hour(s) 
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IR  infrared 
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1   Introduction 
1.1   Illicium Sesquiterpenes: Origin, Structure and Biosynthesis 
Terpenes are the largest and most diverse class of natural products with over 
55,000 compounds isolated to date. The colossal structural diversity offered by this 
class of secondary metabolites ensures an extensive range of biological 
properties—ranging from anti-cancer and anti-malarial activities, to tumor promotion 
and ion-channel binding. Terpenes are ubiquitous in nature and are used to defend 
many species of plants, animals and microorganisms against predators, pathogens 
and competitors. Apart from being used as a deterrent, terpenes are used as a 
communication tool to alert others to the presence of food, mates and enemies.1 
Derived biosynthetically from, and classified by, the number of isopropene units 
used to construct them, they have a basic molecular formula of (C5)n otherwise 
known as the ‘isoprene rule’.2  Further rearrangement of the carbon skeleton and 
oxidation results in an almost endless amount of possible structures.  These 
different classes include hemiterpenes (C5), monoterpenes (C10), sesquiterpenes 
(C15), diterpenes (C20), sesterterpenes (C25), triterpenes (C30), tetraterpenes (C40) 
and polyterpenes  (> C40). Representative examples of compounds belonging to 
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Figure 1-1:   Representative examples of terpene natural products 
 
Sesquiterpenes or sesquiterpenoids exhibit a 15-carbon skeleton resulting from the 
combination of three isoprene units. This group of natural products cover an 
immense range of structural diversity (over 200 skeletal types), which includes 
acyclic, monocyclic, bicyclic, tricyclic, tetracyclic and pentacyclic compounds. A rich 
source of sesquiterpenes can be found in the characteristic star-shaped fruits of 
Illicium, a genus of flowering plants, evergreen shrubs and trees indigenous to 
tropical and subtropical regions of North America, Mexico, the West Indies and 
eastern Asia. An abundance of these species are found in the northern regions of 
Myanmar and China, with 24 species considered native to China.3,4  The fruits of 
Illicium are commonly known as ‘Star Anise’ and the Chinese star anise (Illicium 
verum) has a long history of use as a spice in cooking and as a herbal treatment for 
infant colic. In contrast, the fruits of Illicium anisatum are not consumed as they have 
been acknowledged for many centuries to contain toxic compounds, and it is well 
documented that they cause convulsions and serious neurological effects such as 
seizures, vomiting and jitteriness.  
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Numerous attempts to isolate the toxic ingredient of the Illicium anisatum plant were 
unsuccessful until 1952, when Lane isolated a pure toxic compound to which the 
name anisatin 7 was first proposed.5 The structure of anisatin was later fully 
established in 1968 by Yamada and co-workers as a structurally unique 
sesquiterpene.6 Anisatin is regarded as one of the most potent neurotoxins of plant 
origin (LD50 = 1 mg/kg, mice) and further neuropharmacological studies have 
revealed it to be a potent noncompetitive GABA antagonist.7,8 The isolation of 
anisatin generated intense chemical interest into the components of the Illicium 
species culminating in the isolation and structural determination of several 
biologically active sesquiterpenes 4–6 and 1 (Figure 1-2).4,9,10 
Figure 1-2:   Examples of sesquiterpenes isolated from the Illicium species 
 
Fukuyama and colleagues were responsible for the isolation of a large number 
Illicium sesquiterpene natural products 1–6 and demonstrated 1 and 5 to have 
potent neurite outgrowth activity in primary cultured rat cortical neurons.4,11 These 
sesquiterpenes have attracted much attention for the development of small molecule 
neurotrophic factors as a possible treatment of neurodegenerative disorders such as 
Alzheimer’s, Huntington’s or Parkinson’s disease.9 
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Even though the structures show great diversity in their fused-ring architectures, 
Fukuyama proposed that compounds 1-7 are biosynthetically related.12 As illustrated 
in Scheme 1-1, Fukuyama suggested that compound E is a common intermediate 
that is derived from A via intermediates B-D. Compound E, which is tied to structure 
4, undergoes cleavage of bond a to provide 5, 7 or 8  through F. Cleavage of bond b 
of E leads to bicyclic carbon skeleton H through G, leading to the biosynthesis of 1, 
2 and 3.  
Scheme 1-1:  Proposed biosynthetic route of sesquiterpenes from Illicium species 
Illicium sesquiterpenes, based on their carbon skeletons, have been classified into 
three groups: seco-prezizaane, anislactone and the very rare allo-cedrane types.13,14  
The majority of Illicium sesquiterpenes belong to the seco-prezizaane group, which 
is divided further into four sub-groups according to their carbon architecture:  
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anisatin 7, pseudoanisatin, majucin and  minwanensin types.4 Majucin 8, 
merrilactone A (1), anislactone B (3) and tashironin 9 are representative structures 
of the three main groups (Figure1-3). These occur exclusively in the Illicium species 
and are considered to be characteristic chemical markers of this species of plants. 
Many of these compounds have unique and complex carbon frameworks consisting 
of various fused-ring structures and dense stereochemical congestion.15 This, 
combined with the interesting neurotrophic behaviour of a number of these, has 
attracted the attention of daring synthetic organic chemists as noteworthy targets for 
total synthesis.  
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1.2   Merrilactone A, Anislactones A and B: Origin, Structure and 
Properties 
1.2.1   Merrilactone A 
Plants of the Illicium species have generated much 
chemical interest as they are a rich source of rare 
bioactive sesquiterpenes. The species Illicium 
merrillianum, abundant in parts of China and Myanmar, 
has alone had more than 36 structurally unique sesquiterpenes isolated from 
them.16 In the search of non-peptidic neurotrophic compounds by Fukuyama and co-
workers, merrilactone A (1)† was first isolated in 2000 from the methanol extract of 
the pericarps of Illicium merrillianum in an overall yield of 0.004% yield.11 Structural 
determination of merrilactone A was achieved using a combination of spectroscopic 
and X-ray data analysis with the absolute configuration confirmed by Mosher’s 
method. The structure confirmed merrilactone A to be an anislactone-type 
sesquiterpene with a pentacyclic caged structure, with two -lactones and a unique 
oxetane bridge, which at the time was the first known example of an anislactone-
type sesquiterpene containing an oxetane ring. The dense, highly oxygenated 
compact architecture also contains seven contiguous stereocentres of which five are 
fully substituted carbons and a cis-arrangement of two angular methyl groups at the 
CD ring junctions. This demanding steric congestion will challenge modern synthetic 
methodology and stereoselective C–C bond formation.  Biological assessment 
revealed intriguing neurotrophic activity, promoting neurite outgrowth in the primary 
cultures of foetal rat cortical neurons at concentrations of 0.1- 10 µM, confirming 
merrilactone A to be a possible lead compound for the development of novel 
                                               
†
 An inconsistency in the labelling of the five rings of merrilactone A (1) is evident in the literature. 
Several different systems of labelling are in use, however, all labelling employed within this document 
is based on the assignment shown here. 
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nonpeptidal neurotrophic factors as a treatment for neurodegenerative disorders.11 
This combination of structural complexity and intriguing biological activity has made 
this challenging synthetic target spark the attention of numerous research groups. 
This has culminated in a total of five total syntheses by the research groups of 
Danishefsky,17,18 Inoue and Hirama,19-21 Mehta,22 Frontier,23,24 and Greaney,25 in 
addition to several synthetic studies on subsections of the merrilactone A 
framework.26-29 
1.2.2   Anislactones A and B 
Anislactones A (2) and B (3)‡ were first isolated from 
the methanol extracts of dried pericarps of Illicium 
anisatum by Kouno and co-workers in 1989 and 
1990, respectively. They were both obtained in an 
overall yield of 0.0003% and their structures 
established by the use of NMR analysis combined with extensive spectroscopic and 
X-ray crystallographic methods.30-32  Interestingly, anislactone B was later isolated 
as the main component of the fruits of Illicium merrillianum in an overall yield of 
0.18% (over 600 times more abundant than in Illicium anisatum).15 At the time of 
their discovery, their unique carbon skeleton structures had never been found before 
in nature. This led to the creation of a new class of sesquiterpene, aptly named 
‘anislactone-type’.  
Anislactones A and B, are a pair of epimeric sesquiterpenes that have a 
remarkable and intricate structure with an unusual tetracyclic carbon skeleton with 
two γ-lactones and six stereocentres, of which five are contiguous fully substituted 
carbon centres. Unlike merrilactone A, anislactones A and B have received little 
                                               
‡
 All labelling of the four rings of anislactones A (2) and B (3) within this document are based on the 
assignment shown here. 
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interest from synthetic research groups largely because of their unknown biological 
activity with only a single total synthesis reported to date.25 Nevertheless, these 
structurally complex epimers are synthetically challenging, present an interesting 
platform to showcase new C–C bond forming methodologies and are attractive 
targets in natural product synthesis. 
1.3   Biological Activity: Neurotrophic Factors and Alzheimer’s Disease 
Neurotrophic factors (NTFs) are small proteins that have the ability to promote nerve 
cell survival and to maintain and/or enhance nerve cell function. NTFs regulate 
growth of neurons, associated metabolic functions such as protein synthesis, and 
the ability of the neuron to make neurotransmitters. This allows the neuron to 
communicate with other neurons or with other targets (e.g. skeletal muscle). 
Because of these actions, neurotrophic factors play a significant role in the 
maintenance of neuronal function throughout an individual's entire lifetime.  Neurons 
that fail to obtain the necessary NTFs die by a process called programmed                   
cell-death. Alterations in the levels of NTFs, due to age, genetic background or other 
factors might contribute to neuronal degradation processes. Based on this evidence, 
it has been postulated that a diminished endogenous neurotrophic support may lead 
to neuronal degeneration, characteristic of neurodegenerative diseases like 
Alzheimer’s, Parkinson’s and Huntington’s disease. Therefore, NTFs are attractive 
candidates as therapeutic agents for neurodegenerative disorders and acute injuries 
including trauma and stroke.33 
Alzheimer’s Disease (AD) is a common, insidiously progressive form of 
dementia that affects memory, thinking and behaviour. Dementia affects 825,000 
people in the UK with AD accounting for more than 50% of that number and 25 
million (or 45%) of the UK population has a close friend or family member affected 
by dementia. Dementia now costs the UK economy more than £23 billion a year— 
more than cancer and heart disease combined.34 AD is characterised by confusion, 
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irritability and aggression, mood swings, language breakdown, long-term memory 
loss and the general withdrawal of the sufferer as their senses gradually deteriorate. 
AD is an irreversible process and currently used treatments offer a small 
symptomatic benefit; no treatments to delay or halt the progression of the disease 
are, as of yet, available. As of 2011, more than 800 clinical trials in the US have 
been conducted for identification of a promising treatment for AD, but it is unknown if 
any of these will show promising results.35 Current research have proposed 
numerous hypotheses for the onset of AD, yet most present drug therapies are 
based upon the cholingenic hypothesis.36  
 The two main pathological markers in people affected by AD are: 
- Amyloid plaques. Plaques contain ß-amyloid (Aß) peptides which are made 
by a protein called amyloid precursor protein. These plaques are dense 
insoluble deposits and also contain cellular material outside and around 
neurons. The accumulation of Aß has been associated with neuronal 
damage and the weakening of synaptic connections important for memory 
formation. Until recently, it has been assumed that amyloid plaques were the 
primary cause of neuronal damage in AD. Recent developments have 
revealed soluble forms of ß-amyloid which are now thought to be the main 
culprits in neuronal damage.37-39 
- Neurofibrillary tangles. These are found inside neurons and are abnormal 
aggregates of a protein called tau. Tau-protein binds to microtubules and 
helps stabilise them preserving the transport of nutrients to the end of the 
axon, and maintaining the overall health of the neuron. In AD, tau undergoes 
abnormal chemical changes causing it to disengage from microtubules and   
self-aggregate to form neurofibrillary tangles. The microtubules disintegrate, 
and the neuron's transport system collapses.37 
 Introduction      
14 | P a g e  
 
 The use of acetylcholinesterase inhibitors as treatments for AD has been 
met with limited success and intracerebroventricular administration of NTFs to 
reverse neuronal atrophy are now becoming promising alternatives.  Infusion of 
nerve growth factor into aged rats and primates reduced the spatial recent memory 
deficits making this a possible treatment for AD.40 Common to all peptides is their 
inherent metabolic instability to oral administration and poor cell penetration 
properties, making the less convenient route of intravenous administration the only 
way of ensuring sufficient drug levels reach the brain. Small molecule non-peptide 
based neurotrophic agents are expected to be stable alternatives to NTFs, and thus 
are promising therapeutic agents. Exploration in the development and preparation of 
such agents will contribute to the understanding and eventual effective treatment of 
neurodegenerative diseases.41 
1.4   Previous Total Syntheses of Merrilactone A 
Merrilactone A has attracted considerable attention from research groups due to its 
conceivable use as a lead compound for the development of nonpeptidal small 
molecule drugs towards the treatment of neurodegenerative disorders. The highly 
complex pentacyclic carbon skeleton with a cage-like structure added to its 
attractiveness, establishing merrilactone A as a challenging target for total 
synthesis. 
1.4.1   Danishefsky’s total syntheses of Merrilactone A 
1.4.1.1  Racemic total synthesis  
In 2002, the Danishefsky group reported the first total synthesis of (±)-merrilactone 
A (1). This efficient racemic synthetic approach yielded merrilactone A in an overall 
yield of 10.7% over a very respectable 20 steps but still left room for improvement, 
as several transformations lacked regio- and stereoselective control.17 The planned 
retrosynthesis is outlined in Scheme 1-2. 
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Scheme 1-2:  Danishefsky’s retrosynthetic analysis of merrilactone A 
 
The oxetane linkage is installed in the last step via a known biomimetic homo-
Payne-type rearrangement of epoxy alcohol 10. The C1 oxygen functionality is 
introduced by epoxidation after isomerisation of exo-methylene 11,12 and the 
sterically crowded C9 quaternary centre would be installed via an ambitious radical 
cyclisation of 12. Tricycle 12 was in turn envisioned to be obtained via a two-fold 
oxidation of 13, which could arise from the iodolactonisation of γ,δ-unsaturated acid 
14. Substrate 14 was expected to be prepared by a Claisen rearrangement from 
allylic alcohol 15, which itself could be accessed by ring contraction of the 6-
membered ring in 16. Diels–Alder reaction of diene 17 and dienophile 18 was 
intended to establish the contiguous quaternary stereocentres at C5 and C6.9 
The synthesis opened with a Diels-Alder reaction between diene 19 and               
2,3-dimethylmaleic anhydride 20 furnishing adduct 21 in 74% yield. This simple, but 
powerful cycloaddition reaction under stereo- and regioselective control established 
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the stereochemistry of three stereocentres, installing both cis-methyl groups at 
newly formed quaternary centres C5 and C6 (Scheme 1-3).  
Scheme 1-3: Diels Alder reaction and regioselective C14 reduction 
 
a) 165 C, mesitylene, 74%; b) NaOMe, MeOH; c) ClCO2Me, THF, then NaBH4, MeOH, −35 C;            
d) aq. LiOH; e) LiBHEt3, THF, then TFA, DCM, 78% (four steps). 
Attempted reductions at the C14 carbon using conventional reducing agents led to 
complex mixtures and as a result, a laborious but high-yielding four-step sequence 
was employed, affording 22 in 78% yield from 21. An overall ring contraction was 
performed next, starting with ozonolysis of 22, followed by treatment with 
triphenylphosphine leading to the bis-aldehyde, which after aldol condensation and 
reduction of the αß-unsaturated aldehyde, afforded the newly formed five-
membered ring in 23 in high yield (Scheme 1-4). 
Scheme 1-4:  Johnson-ortho-ester reaction and Keck C-allylation 
 
a) O3, PPh3, DCM/MeOH; b) Bn2NH·TFA, PhH, 65 C, 94% (two steps); c) NaBH4, DCM, MeOH,             
−78 C, quant.; d) MeC(OEt)3, mesitylene, PivOH, 135 C, 92%; e) aq. LiOH, MeOH; f) I2, NaHCO3, 
THF, 59% 27 and 35% 26 (two steps); g) AllylSnBu3, AIBN, PhH, 75%. 
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Johnson-Claisen rearrangement of 23 resulted in the formation of diastereomeric 
mixture of esters 24/25 in a 1.8:1 ratio. After hydrolysis of the ester mixture and 
subsequent iodolactonisation of the resulting acids, two chromatographically 
separable iodolactones 26 and 27, were obtained, in 35% and 59% yield, 
respectively. Chain extension of 27 was accomplished by the Keck C-allylation 
method to give tricyclic intermediate 28.  
Synthesis of the key radical cyclisation substrate was achieved by a two-fold 
oxidation sequence. Selenylation of lactone 28 at C10 via an intermediate silyl 
ketene acetal was followed by bromoselenylation of the terminal vinyl group, 
resulting in the bis-selenide 29. Oxidation-induced deselenation afforded the desired 
30 in an overall yield of 77% from 28 over three steps. The decisive radical 
cyclization of vinyl bromide 30 delivered the desired tetracyclic core 31 whilst 
overcoming extreme steric congestion at the sp2 centre at C9. Isomerisation of the 
exo-olefin into the ring and simultaneous alcohol deprotection supplied ß-alcohol 32 
in 98% yield. Hydroxyl groups have often been used with peracids to direct  
epoxidation in a syn sense42 but in this specific situation, the congested nature of 
the β-face of the C1–C2 double bond was sufficient for the epoxidation to mainly 
occur from the α-face (α/β epoxide = 3.5:1). To complete the total synthesis, an acid 
induced homo-Payne rearrangement of the major isomer 10 installed the final 
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Scheme 1-5:  Final stages of the synthesis of merrilactone A including free radical 
cyclisation and homo-Payne rearrangement                                                                                               
 
a) LHMDS, TMSCl, PhSeCl; b) PhSeBr, MeCN; c) O3, DCM, 1-hexene, PhH, NEt3, reflux, 77% (three 
steps); d) Bu3SnH, AIBN, PhH, 90%; e) TsOH·H2O, PhH, reflux, 98%; f) mCPBA, DCM, 3.5:1 ratio                
of α /β epoxide, quant.; g) TsOH·H2O, DCM, 71% (two steps). 
This highly efficient synthesis of (±)-merrilactone A had set the bar high for future 
syntheses of the natural product. Even more impressive is the fact that this 
synthesis was completed only two years after the characterisation of the natural 
product, but even so, a number of selectivity issues have been left unresolved.   
1.4.1.2  Asymmetric formal synthesis  
In an effort to address the regio- and diastereoselectivity issues in his earlier 
racemic synthesis of merrilactone A, Danishefsky and co-workers reported in 2005, 
an improved formal, asymmetric synthesis to either enantiomer of the natural 
product.18 Stereocontrolled synthesis of key intermediate 27 was deemed to be a 
significant milestone in this new approach as the transformations from 27 to 
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merrilactone A were already proven to be concise and efficient.17  A re-work was 
required on the synthetic steps to enantiomerically pure 27, such as the 
regioselective C14 reduction to 22 that required a lengthy four step circumvention, 
or the marginally selective Claisen rearrangement, yielding a mixture of 
diastereomeric esters 24/25 in a less than optimal 1.8:1 ratio (Scheme 1-4). 
The synthesis opened with the endo-selective Diels-Alder reaction between 
diene 33 and cyclic anhydride 34, installing the C5 quaternary centre. Subsequently, 
methanolysis of the anhydride, esterification of the free acid, followed by a 
stereoselective methylation via lithiation installed the C6 quaternary centre and 
afforded meso-35 in 87% yield over two steps.  A stepwise LAH and Birch reduction 
of 35 yielded ketone 36, which after protection as the acetonide, Horner–Emmons 
olefination, Mg-promoted 1,4-reduction and removal of the acetonide supplied 
meso-diol 37 an overall yield of 48% over five steps (Scheme 1-6). 
Scheme 1-6:  Endo-Diels Alder and conversion into meso 1,4-diol compound 37                                                                                                           
  
a) 180 C, neat, then MeOH, reflux, PhH/MeOH, TMSCHN2. 92%; b) LDA, HMPA, MeI, THF, −78 C to 
RT, 95%; c) LiAlH4, THF, reflux; d) Na, NH3, THF/EtOH, 72% over 2 steps; e) 2,2-dimethoxypropane, 
acetone, TsOH; f) NaH, (EtO)2POCH2CO2Et, THF, 86% (two steps); g) Mg, MeOH, 77%. 
To achieve an enantioselective synthesis of merilactone A, a crucial asymmetric 
epoxide-ring-opening reaction was utilised.  DMDO epoxidation of meso-diol 37 led 
to exo-epoxide 38, the substrate for the asymmetric ring-opening reaction. 
Treatment of 38 with a catalytic amount of (S,S)-[CoIII(salen)]-OAc as described by 
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Jacobsen and colleagues, yielded enantioenriched 39 with 86% ee and 86% yield.43 
As expected, use of the R,R Jacobsen catalyst led to ent-39 allowing access to both 
enantiomers of merrilactone A.  PDC oxidation of diol 39 followed by esterification 
gave ketoester 40 in a 70% yield over two steps.  A Baeyer-Villiger oxidation 
converted 40 into bicyclic 41 in 88% yield (Scheme 1-7).  
Scheme 1-7:  Regio- and enantio-controlled chemical degradation pathway 
a) DMDO, DCM; b) (S,S)-[CoIII(salen)]-OAc, −78 C to −25 C, THF, 86% (two steps); c) PDC, DMF;           
d) K2CO3, MeI, acetone, reflux, 70% (two steps); e) MMPP, MeOH, 0 C to RT, 88%. 
Carboxylic acid 41 was then transformed over three steps into the secondary 
alcohol 42 with retention of stereochemistry via carboxy inversion in an overall yield 
of 58% (Scheme 1-8). A Lewis acid facilitated ring opening of the 
methoxytetrahydrofuran ring moiety 42 by trapping its masked aldehyde, which 
resulted in lactonisation and produced 43. The latter was then easily converted, via 
a two-step sequence, to diol 44. With the synthesis of key intermediate 27 almost 
within reach, diol 44 was exposed to the protocols of Grieco, resulting in a selective 
reaction at the primary alcohol to provide a transient selenide, which afforded the 
desired exo-methylene 45 after oxidative elimination. Hydrolysis of 45 resulted in a 
carboxylic acid that underwent iodolactonisation to afford advanced intermediate 27 
in a more efficient manner as compared to Danishefsky’s first generation synthesis 
with an overall yield of 6% over 21 steps.17  
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Scheme 1-8:   Completion of the synthesis of enantioenriched intermediate 27                                        
 
a) DCC, mCPBA, 0 C to RT, 83%; b) PhH, reflux; c) K2CO3, MeOH, 70% (two steps); d) BF3·OEt2, 
HS(CH2)3SH, DCM, 50%; e) PhI(OCOCF3)2, MeCN/H2O, 50%; f) NaBH4, MeOH, 0 C;                                 
g) o-NO2C6H4SeCN, Bu3P, THF, then 30% H2O2, 86% (two steps); h) TBSOTf, NEt3, DCM, 76%;                    
i) LiOH, H2O/MeOH, then I2, aq. NaHCO3/THF, 75%. 
Advanced enantioenriched key intermediate 27 could then be converted to 
merrilactone A in eight steps via the same methods originally reported by the group 
in their racemic synthesis.17 This revamped synthetic route addressed the selectivity 
issues highlighted by Danishefsky in his first generation synthesis and for the first 
time allowed access to either enantiomer of the natural product in 29 steps, 
concluding the first formal asymmetric synthesis of (-)-merrilactone A. 
1.4.2   Hirama’s total syntheses of Merrilactone A 
1.4.2.1  Racemic total synthesis 
In 2003, the Hirama group published the second total synthesis of merrilactone A.19 
In this racemic synthesis, a novel intramolecular aldol reaction of an eight-
membered diketone was employed to construct the bicyclic core of merrilactone A. 
This innovative strategy completed the racemic total synthesis in 27 steps with an 
overall yield of 1% (Scheme 1-9). 
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Scheme 1-9:  Hirama’s retrosynthesis of merrilactone A 
 
As previously demonstrated by Danishefsky, the homo-Payne rearrangement would 
once again be used to install the oxetane ring in the final step of the synthesis and 
give merrilactone A from precursor 10. Tetracyclic 10 would be prepared from              
exo-methylene 46 via standard manipulations, which itself is envisaged to be 
obtained from bromo acetal 47 by the way of an intramolecular radical cyclisation, 
establishing the stereochemistry of the C9 quaternary centre. Simple manipulations 
of bicyclic 48 including epoxidation and alkylation would provide the bromo acetal 
47, substrate for the key radical reaction. The cis-bicyclo[3.3.0]octane core of 48 
was expected to be accessible via a desymmetrisation of meso-diketone 49 by 
implementing a critical intramolecular aldol reaction. This single step would set the 
relative stereochemistries of three stereocentres, C4, C5 and C6. The substrate 49 
for this key transformation would be the product of a number of relatively 
straightforward functional group manipulations, a double allylation and a ring closing 
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metathesis and ring expansion sequence from cyclobutane 50. The two contiguous 
quaternary carbons at C5 and C6 would be introduced using a [2+2] cycloaddition 
reaction between trans-dichorloethylene 51 and cyclic anhydride 20.9 
In the forward synthesis, [2+2] photocyclisation between substrates 51 and 
20 stereospecifically installed the consecutive C5 and C6 stereocentres (Scheme 1-
10). Reductive dehalogenation of 50 and subsequent LAH reduction of the 
anhydride yielded meso-diol 52, which was protected with benzyl ethers, and then 
subjected to OsO4 induced dihydroxylation to afford 53 in a 44% yield over 5 steps. 
Swern oxidation of diol 53 and double-allylation of the resultant diketone 54 was 
accomplished in one-pot because of the strong tendency of diketone 54 toward 
hydration in the aqueous workup. The double cis-allylation of diketone 54 
approached mainly from the α-face yielding a mixture of isomers of 55.  Ring-closing 
metathesis of 55αα in the presence of Grubbs I catalyst effectively provided 
bicyclo[4.2.0]octane system 56αα as the major isomer, which was subsequently 
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Scheme 1-10:  Synthesis of meso-eight-membered diketone                                                                                   
  
a) benzophenone, acetone, hv; b) Zn dust, TMSCl, Ac2O, toluene, 85 C; c) LiAlH4, THF, 47% (three 




BuOH/H2O, 94%;  f) (COCl)2, DMSO, 
Et3N, DCM, −78 °C, then allylmagnesium bromide, −78 °C, 78% (55αα:55ββ:55αβ=15:2.6:1);                       
g) (PCy3)2Cl2Ru=CHPh, CH2Cl2, reflux, then Pb(OAc)4, RT, 95%. 
Next followed the highlight of the total synthesis, a base-mediated intramolecular 
aldol reaction of meso-diketone 57, which led to the selective formation of 
diastereomers 48 and 58, whilst setting the relative stereochemistries of C4, C5 and 
C6 (Scheme1-11). The selectivity of this reaction was dependent on the conditions 
employed with the most optimal selectivity achieved using LHMDS at -100 °C, 
yielding  a 3.1:1 ratio of desired diastereomer 48 over the undesired 58 in a 
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Scheme 1-11:  Desymmetrisation via intramolecular aldol reaction 
 
a) LHDMS, THF, −100 C, 48:58, d.r. ratio 3.1:1, 85%. 
Epoxidation of the desired bicyclic product 48 afforded the α-epoxide 59, which was 
subjected to a DBU-induced isomerisation and following IBX oxidation, an                      
α-bromoacetal was appended to furnish 47 in 38% yield over four steps and as a 4:1 
mixture of acetal diastereomers (Scheme 1-12). Radical cyclisation of the resultant 
diastereomeric mixture delivered 5-exo cyclised products 60ß and epimeric 60α in a 
71% yield and diastereomeric ratio of 3.5:1(ß:α). Undesired diastereomer 60α was 
easily converted to desired 60ß under acidic ethanol conditions in an 86% yield. 
Tricycle 60ß was then regioselectively transformed into exo-olefin 61 via a three-
step sequence of TMSOTf, Eschenmoser’s salt, followed by mCPBA induced 
elimination in an overall yield of 34%.  Triol 62 was synthesised from exo-methylene 
61 via a number of functional group conversions in which the order was critical for 
success. The subsequent enol ether of triol 62 was next hydrolysed and a 
simultaneous Fetizon oxidation of the C11 and C12 alcohols afforded tetracyclic 32 
with astonishing regio- and chemoselectivity. The known two-step sequence of 
highly selective epoxidation from the α-face and an acid-induced homo-Payne 
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Scheme 1-12:  End sequence of the total synthesis of merrilactone A  
 
a) mCPBA, DCM, 81%; b) DBU, DCM, −40 C , 81%; c) IBX, DMSO, 94%; d) BrCH2CHBr(OEt), 
PhNMe2, DCM, −78 C to RT, 62%; e) Bu3SnH, BEt3/O2, toluene, 57% 60ß, 16% 60α; f) CSA, EtOH, 




, DCM; i) mCBPA, DCM, 70% (three steps);       
j) TFA/H2O, 94%; k) MsCl, Et3N, THF, 50 °C, 77%; l) LiBH(s-Bu)3 (L-Selectride),THF, MS. 4Å, −78 °C 
then 2-Tf2N-5-chloropyridine, −78 °C, 99%; m) Pd(OAc)2, PPh3, NBu3, HCOOH, DMF, 40 C, 89%;       
n) DIBALH, DCM, −78 C, 88%; o) Na, NH3, THF/EtOH, −78 C, 100%; p) DOWEX 50WX2, THF/H2O; 
q) Ag2CO3 on celite, toluene, 130 C, 64% (two steps); r) DMDO, DCM, 96%; s) TsOH, DCM, 81%. 
In this racemic synthesis of merrilactone A, Hirama et al. showcased an elegant 
stereocontrolled desymmetrisation reaction to generate the bicyclic core of 
merrilactone A, and at the same time, setting the relative stereochemistry of three 
stereocentres in a single reaction. Nevertheless, there are a number of selectivity 
difficulties affecting the synthesis at several stages, but even so, the total racemic 
synthesis of merrilactone A was accomplished in 27 steps with an overall 1% yield. 
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1.4.2.2  Asymmetric total synthesis 
Building on their initial 2003 racemic synthesis, the Hirama group, reported in 2006 
an asymmetric version of their total synthesis of merrilactone A. Investigations 
revealed the possibilty of using a bulky protecting group to induce long range stereo-
controlling effects in the key intramolecular aldol reaction and in doing so, allowed 
access to the desired enantiomer out of the four possible isomers. This strategy 
required the use of an analogue of 57 (cf. Scheme 1-11), where both alcohols are 
differentially protected and consequently a new route was designed. The synthesis 
began with the reduction of 2,3-dimethylmaleic anhydride 20 followed by Wittig 
olefination and esterification to afford ester 63 in 68% yield over three steps 
(Scheme 1-13). Sharpless asymmetric dihydroxylation of 63 proceeded with 
excellent chemo- and enantioselective control and the resultant hydroxy-γ-lactone 
was protected as its pivaloate ester to give enantiomerically pure 64.                                   
A [2+2] photocycloaddition of 64 with cis-1,2-dichloroethylene and the ensuing                   
Zn-promoted eliminative dehalogenation furnished bicyclic 65.   In an effort to set-up 
the differential protecting group arrangement, 65 was reduced with LAH generating 
a 1,2-diol that was protected as its isopropylidene acetal 66 in 61% yield over two 
steps. The single primary alcohol is benzyl protected and acid-mediated cleavage of 
the acetonide provided monobenzyl-protected diol 67. A one-carbon atom truncation 
of 67 to liberate the C14 primary alcohol was achieved via a two-step sequence in a 
one-pot reaction of Pb(OAc)4-induced oxidative cleavage and DIBALH reduction. 
Next, followed a simple protection of the resulting primary alcohol as the bis-
(trifluoromethyl)benzyl (BTB) ether affording the differentially protected 68. A set of 
transformations previously demonstrated in the racemic synthesis (cf. Scheme 1-10) 
were used to convert from cyclobutene 68 to the intramolecular aldol substrate 69 in 
three steps.  
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BuOK, 0 C to RT, 87%; c) MeI, K2CO3, 
THF, 50 C, 92%; d) AD-mix-α 
t
BuOH/H2O, 0 C, 65%, >99% ee after recrystallisation; e) PivCl, 
pyridine, DMAP, DCM, 99%; f) cis-dichloroethylene, MeCN, -20 C, hv; g) Zn, Ac2O, toluene, 120 C;   
h) LiAlH4, Et2O, 75% (three steps); i) Me2C(OMe)2, TsOH, DCM, 81%; j) BnBr, NaH, THF/DMF;               
k) 3M HCl, THF, 91% for 2 steps; l) Pd(OAc)4, pyridine, DCM, −50 C then DIBALH, −78 C to −50 C, 




BuOH/H2O, 94% (two steps); 
o)SO3·pyr, DIPEA, DMSO, DCM, −15 C then allylmagnesium bromide, −78 C, ratio α/ß 2.7:1, 78%;                                
p) [(PCy3)2Cl2Ru=CHPh], TCM, reflux then Pb(OAc)4, 97%. 
The BTB protecting group developed by Hirama was used as a tool to enable              
site-selective deprotonation at C9 over C3 as a consequence of long-range steric 
interaction between the base and the trifluoromethyl substituents of the BTB group. 
The effect of the counter cation of the base was investigated revealing NaHMDS as 
the most selective. The desired bicyclo[3.3.0]octane 72 was furnished as the major 
enantiomer in 75% yield, with the remaining three possible diastereomers 
accounting for a further 22% yield (Scheme 1-14). This highly innovative 
diastereoselective transannular aldol reaction establishes the stereochemistry of 
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Scheme 1-14:  Asymmetric synthesis of the core bicyclo-[3.3.0]octane framework 
  
a) NaHMDS, THF, −100 C, 97% overall, 75% 72 
After reaching the milestone of enantiomer 72, a facile conversion to                         
(-)-merrilactone A was accomplished, by following a similar path to that previously 
established in the racemic synthesis (cf. Scheme 1-12).  In this synthesis, the issue 
of selectivity of the transannular aldol reaction from the previous racemic synthesis 
was resolved by the use of a novel bulky protecting group as a long-range stereo-
controlling element. This enabled access to key enantiomeric intermediate 72 under 
impressive regio- and stereoselective control. Enantiomer 72 was then converted to 
(-)-merrilactone A in a further 15 transformations, completing the total synthesis in a 
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1.4.2.3  Asymmetric total synthesis of ent-(+)-merrilactone A 
Building on their previous elegant asymmetric synthesis of (-)-merrilactone A,20 In 
2007, Hirama and co-workers published a second asymmetric route to the unnatural 
(+)-enantiomer of merrilactone A.21  In this synthesis, a strategy to replace the 
drawn-out sequence of differential protection of alcohols included the use of a chiral 
lithium amide base in the key transannular aldol reaction resulting in the selective 
deprotonation at C9 over C3. This allowed a more straightforward synthesis of the 
key aldol substrate as compared to the lengthy route in the asymmetric total 
synthesis of (-)-merrilactone A (cf. Scheme 1-13). 
The synthesis begins with a photochemical [2+2] reaction between                     
trans-dichloroethylene 51 and 2,3-dimethylmaleic anhydride 20, followed by                
Zn-induced dehalogenation and LAH reduction, yielding diol 52 in a 57% yield over 
three steps (Scheme 1-15). In contrast to the previous asymmetric synthesis, both 
alcohols are protected as their respective 2,6-dichlorobenzyl (DCB) ethers, the 
protecting group found to impart the greatest selectivity in the key aldol reaction.  A 
dihydroxylation furnished diol 73, which was further elaborated via a one-pot Swern 
oxidation and double Grignard addition of allylmagnesium bromide to give 
predominantly diastereomer 75αα over 75ββ in a 9:1 ratio. The cis-arrangement of 
allyl groups facilitated the ring-closing metathesis to produce intermediate                   
bicyclo-[4.2.0]octyl system 76αα, which was treated with Pb(OAc)4 in situ to yield 
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Scheme 1-15:  Synthesis of DCB protected meso-eight-membered diketone      
 
a) benzophenone, acetone, hv; b) Zn, TMSCl, Ac2O, toluene, 85 C; c) LiAlH4, THF, 57% (three steps); 




BuOH/H2O, 91% (two steps); f) (COCl)2, DMSO, 
NEt3, DCM, −78 C then allylmagnesium bromide, −78 C, 75αα/75ßß ratio 9:1, 80%;                                     
g) (PCy3)2Cl2Ru=CHPh, DCM, reflux, then Pb(OAc)4, 95%.  
To accomplish the enantioselective transformation of meso-aldol substrate 77 into 
pure enantiomer 78 a variety of chiral amide bases were screened under the 
desymmetrisation reaction conditions. It was discovered that amine base 79 
delivered the required selectivity over the other undesired enantio- and 
diastereomers, providing an enantioselective route to either enantiomer of 
merrilactone A. Exposure of 77 to chiral amine base 79 resulted in selective 
deprotonation at C9 over C3 providing lithium enolate 78 that underwent an 
intramolecular aldol reaction to afford enantioenriched 80 in 79% and 57% ee. A 
respectable 6:1 diastereomeric ratio was seen with a 4.7:1 enantiomeric ratio in 
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favour of the desired enantiomer 79. The enantiopurity of 80 could be increased to 
99% ee after a single recrystallization attempt in a 53% yield (Scheme 1-16). 
Scheme 1-16:  Enantioselective transannular aldol reaction using chiral base                                                  
 
a) 79, LiCl, THF, −78 C, 79%; b) recrystallisation, 1:1 EtOAc/hexane, 53%. 
Utilising a chiral base in the transannular aldol reaction negated the need of a 
differential alcohol protection strategy, resulting in a more straightforward synthesis 
to enantiopure key intermediate 80. This approach contained the added flexibility of 
accessing either enantiomer of merrilactone A by switching the chirality of the base. 
Enantiopure 80 was directed towards the total synthesis of ent-(+)-merrilactone A 
via conversions previously employed in both the racemic synthesis (cf. Scheme             
1-12) and asymmetric synthesis variants. The total synthesis of the unnatural 
enantiomer of merrilactone A was accomplished in 23 steps with an overall yield of 
1.3%. Investigations into the biological activity of the unnatural enantiomer 
unexpectedly revealed it to stimulate neurite outgrowth to a similar extent as the 
natural enantiomer. This represents one of the few instances where both 
enantiomers of a natural product or drug have similar levels of biological potency.21 
This final synthesis of merrilactone A by Hirama’s group completes their 
efforts in developing their novel desymmetrisation strategy in the key intramolecular 
aldol reaction for the synthesis of merrilactone A. The use of chiral bases or a 
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protecting group strategy to generate enantioselectivity in the intramolecular aldol 
reaction provides an approach to both enantiomers of the natural product.   
1.4.3   Mehta’s racemic total synthesis 
In 2005, Mehta and Singh published a novel synthetic route to the core of 
merrilactone A.26 This research laid the groundwork for their racemic total synthesis 
of merrilactone A, which was reported in 2006.22 Mehta’s retrosynthetic approach to 
merrilactone A is outlined in Scheme 1-17.  
Scheme 1-17:  Mehta and Singh’s retrosynthetic analysis of merrilactone A 
 
Analogous to previous syntheses of merrilactone A, the oxetane bridge would be 
installed by acid-induced homo-Payne rearrangement to provide racemic 
merrilactone A (1). Bis-lactone 32 was to be prepared from cyclobutene 81 by two   
γ-lactone syntheses, with one lactone originating from a hemi-acetal and the other 
through the ozonolysis of cyclobutene. Tetracycle 81 would be acquired from a [2+2] 
photocycloaddition reaction of tricycle 82, establishing the contiguous C5 and C6 
quaternary centres, and itself accessed through a crucial ring closing metathesis 
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reaction of diene 83. A deprotection and protection sequence would give rise to 
diene 83 from acetonide 84, identifying 1,4-dione 85 as a suitable starting point.9 
The synthetic sequence began with the elaboration of 1,4-dione 85 that 
included a double hydroxylmethylation, subsequent acetonide protection and Luche 
reduction, furnishing 86 in 77% yield over three steps (Scheme 1-18). Combination 
of allylation followed by re-oxidation afforded hydroxyenone 84, which itself was 
exposed to an acetonide deprotection-protection sequence. This sequence installed 
the four necessary side chains required for the on-coming RCM reaction and 
installation of the γ-lactone D ring. Thus, deprotection and re-protection of 84 under 
equilibrating conditions furnished a 1:1 mixture of 84 and 87, which 84 was simply 
recycled to furnish 87 in 85% yield over two steps. PDC oxidation of the primary 
alcohol, methylation and a further oxidation, followed by a Wittig methylenation 
yielded RCM substrate 83 in 36% yield over four steps. The cis-orientated allyl- and 
propenyl-side-chains of 83 on exposure to Grubbs’ first generation catalyst readily 
underwent the key ring closing metathesis reaction, affording tricycle 82 in a 
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Scheme 1-18:  Synthesis of RCM substrate and metathesis reaction           
  
a) DBU, 40% HCHO, THF, 0 C, 95%; b) acetone, MS, Amberlyst-15 then NaBH4, CeCl3, 0 C, 83% 
(two steps); c) CeCl3, allylmagnesium chloride, −78 C, then MnO2, DCM, 81%; d) 2M HCl, THF/H2O, 
90%; e) acetone, MS, amberlyst-15, 94%; f) PDC, DCM, then MeLi, Et2O, 62% (two steps); g) PDC, 
DCM then Ph3PCH3Br, 
t
BuOK, Et2O, 58% (two steps); h) Grubbs’ catalyst I, DCM, reflux, 76%. 
Photochemical [2+2] cycloaddition of trans-1,2-dichloroethylene and tricycle 82 
proceeded only with a moderate degree of β-facial selectivity, directed by the steric 
bulk of the acetonide methyl groups positioned on the a-face, to deliver a readily 
separable mixture of isomers, 88 and 89 in a 2:1 ratio, in a combined yield of 65% 
(Scheme 1-19). Eliminative dichlorination, DIBALH reduction, TBS protection of the 
resulting alcohol and acetonide deprotection, furnished the diol 90 in 54% yield over 
four steps. TPAP oxidation of 90, furnished an intermediate aldehyde, which was 
homologated via a Wittig methoxymethylenation to give an enol ether, followed by  
acid-mediated hydrolysis and subsequent PCC oxidation afforded γ-lactone 91 in 
four steps. Elaboration of the cyclobutene ring began with exposing 91 to ozone to 
yield a di-aldehyde intermediate, which was reduced in situ with sodium borohydride 
and oxidised to deliver bis-γ-lactone 92. The total synthesis was straightforwardly 
accomplished via well-known transformations that included TBS deprotection and an 
acid-induced homo-Payne rearrangement to complete the synthesis of                          
merrilactone A (1).  
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Scheme 1-19:  Final transformations from key tricyclic intermediate 82 to merrilactone A     
 
a) trans-dichloroethylene, hv, 88:89 (2:1), 65%; b) sodium naphthalenide, −60 C, 70%; c) DIBALH,        
−78 C, 95%; d) TBSOTf, NEt3, DCM, 86%; e) 2M HCl, THF/H2O, 95%; f) TPAP, DCM then 
Ph3PCH3OCH3, 
t
BuOK, THF, 54% (two steps); g) HClO4, DCM/THF; h) PCC, DCM, 62% (two steps);    
i) O3, MeOH, −78 C then NaBH4, MeOH, −78 C, 45%; j) PCC, DCM, 80%; k) TBAF, AcOH, THF, 
85%;   l) DMDO, 95%; m) TsOH, DCM, 80%.                                                                                                                                                                                                                                                                        
To conclude, Mehta and Singh have provided a route to racemic merrilactone A in 
27 steps with an overall yield of 0.4%. Examination of the synthetic route highlights 
the possibility of an asymmetric variant, but nevertheless, other areas of concern 
would initially have to be addressed, most notably the poor selectivity observed in 
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1.4.4   Frontier’s racemic total synthesis 
Frontier and co-workers have developed the Nazarov cyclization of polarised divinyl 
ketones in the hope of incorporating this methodology in the total synthesis of (±)-
merrilactone A.45-47 They successfully incorporated the Ir-catalysed Nazarov reaction 
of a silyloxyfuryl enone 93 in the presence of 1 mol % of 94 to assemble the 
oxabicyclo[3.3.0]octane skeleton 95 of merrilactone A.24 In this proposed strategy, 
they intended to simultaneously introduce the C4 and C5 quaternary centres 
through the implementation of the catalytic Nazarov cyclisation (Scheme1-20).  
Scheme 1-20:  Catalytic Nazarov key cyclisation reaction 
 
Frontier reported their total synthesis in 200723 and followed this with a full account 
of their efforts in 2008.24 Their retrosynthetic strategy first relied upon the well-known 
combination of epoxidation and homo-Payne rearrangement to convert 32 to 
merrilactone A (1) (Scheme 1-21). Tetracycle 32 is derived from exo-olefin 96 via 
acid-induced double bond isomerisation and a late-stage lactonisation, installing the 
γ-lactone D-ring. Subsequently, 96 would be generated by the means of a radical 
cyclisation approach from bicycle 97, which in turn, is accessed via the critical 
Nazarov cyclisation reaction of substrate 98. Examination of the Nazarov cyclisation 
substrate identified 99 as a precursor that could easily be prepared from the readily 
available aldehyde 100. 
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Scheme 1-21:  Frontier’s retrosynthetic analysis of merrilactone A 
 
The approach to the key Nazarov cyclisation substrate began with the 
organometallic 1,2-addition of lithiated ethyl propiolate to known aldehyde 100.  The 
ensuing diyne in the presence of a higher order stannyl cuprate underwent a 
lactonisation delivering a vinyltin compound and a subsequent tin bromide exchange 
delivered vinyl bromide 99. The key Nazarov substrate 98 was obtained by treating 
99 with triisopropylsilyl triflate followed by lithiated addition to α,β-unsaturated 
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Scheme 1-22:  Synthesis of key Nazarov cyclisation substrate                                                                                     
 
a) ethyl propiolate, 
n
BuLi, THF, −78 C, 88%; b) Bu3Sn(Bu)(CN)CuLi2, THF/MeOH, −78 C, 90%; c) 
Br2, DCM, 93%; d) NEt3, TIPSOTf, DCM, −78 C to 0 C, quant.; e) 
t
BuLi, Et2O, then 101, 82%. 
This sets the stage for the important Nazarov cyclisation, which was executed by 
exposing silyloxyfuran 98 to 2 mol% of dicationic iridium catalyst 94, yielding a 
single diastereomer of the bicycle 102. During this transformation, the desired 
stereochemistries at C4 and C5 are introduced in a stereospecific manner due to the 
conrotatory nature of the 4π electrocyclic pathway of the Nazarov cyclisation 
(Scheme1-23). 
Scheme 1-23:  Catalytic Nazarov cyclisation silyloxyfuran 98          
 
a) 94 (2 mol%), DCM, 87%. 
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Removal of the trimethylsilyl group of 102 afforded the substrate for the radical 
cyclisation reaction. Subsequent exposure to tributyl tinhydride, followed by TBAF 
global deprotection conditions, exo-methylene 103 was obtained in 65% yield over 
four steps. The late-stage installation of the γ-lactone D-ring followed a four-step 
sequence of converting the primary alcohol to a carbonate, intramolecular 
nucleophilic lactonisation and α-methylation, to deliver bis-lactone 104. The main 
carbon framework of merrilactone A is now complete with only a stereoselective 
carbonyl reduction at C7 required to access an intermediate that has previously 
been transformed by Danishefsky to merrilactone A. Unfortunately, the facial 
selectivity of the reduction was poor, yielding a mixture of 105a and 106b in a ratio 
of 1.2:1, respectively. The undesired isomer 106b was recycled via a Dess-Martin 
oxidation to fully convert all material to the desired isomer 105a. In accordance with 
previous total syntheses, the exo-olefin was isomerised under acidic conditions to 
give a known intermediate that in two steps via epoxidation and a homo-Payne 
rearrangement yielded racemic merrilactone A. 
Scheme 1-24:  Final stages of the synthesis of (±)-merrilactone A                                                                             
 
a) AgNO3, KCN, THF/EtOH/H2O, 83%; b) AIBN, Bu3SnH, PhH, reflux then TsOH, 91%; c) TBAF, THF, 
99%; d) pyridine, DMAP, ethylchloroformate, 95%; e) NaH, THF; f) TsOH, PhH, reflux, 90% (two 
steps); g) NaH, MeI, HMPA, THF, 97%; h) NaBH4, MeOH, d.r. 105a:106b (1.2:1), 93%; i) 106b, DMP, 
DCM, 98%; j) TsOH, PhH, reflux, 92%; k) mCPBA, DCM, l) TsOH, DCM, 68% (two steps). 
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In completing the total synthesis of merilactone A, Frontier demonstrated the 
utility of a novel iridium-catalysed Nazarov cyclisation in the construction of fused 
carbocycles and in natural product synthesis. Even more impressive, is the fact this 
was achieved in a remarkable 17 steps with a highly impressive overall yield of 19%, 
making this the most efficient synthesis of racemic merilactone A to date.  
1.4.5   Greaney’s syntheses of Merrilactone A and Anislactone A 
In 2005, the Greaney group reported a radically different approach to merrilactone 
A. In all previous syntheses of the natural product, the oxetane bridge was installed 
in the final step via an effective homo-Payne type rearrangement. The Greaney 
group instead proposed a [2+2] Paternò-Büchi photo-addition to facilitate the 
introduction of this key structural motif. The development of this approach proved 
ultimately unsuccessful, but did lay the foundation for a successful synthesis via 
alternative chemistry.28 As recently as 2010, the Greaney group published a formal 
racemic synthesis of merrilactone A and the first total synthesis of closely related 
anislactone A via a common intermediate.25 The defining transformation in their 
synthesis is a reductive epoxide cleavage-cyclisation that establishes the 
stereochemistry of the C9 quaternary stereocentre. 
The retrosynthetic approach highlights a strategy to access the core tricyclic 
structures of both anislactones A/B and merrilactone A via a selective lactonisation 
of common intermediate 106 (Scheme 1-25). Starting with merrilactone A (1), the 
central oxetane motif would be again constructed from the well-established 
procedures of homo-Payne rearrangement, selective epoxidation and isomerisation 
of the exo-alkene. A regioselective Fetizon oxidation was anticipated to install the                
γ-lactone D-ring of tricycle 107, a procedure adapted from Hirama’s total synthesis 
of merrilactone A.19 Common intermediate 106 would be directed to 107 or the 
tricyclic ABC core 108 of anislactone A via selective formation of the γ-lactone                 
A-ring. The total synthesis of anislactone A (2) was expected to proceed from 
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tricycle 108 via a series of oxidations and reductions including the aforementioned 
regioselective Fetizon oxidation.  An obvious milestone in this synthesis will be the 
preparation of common intermediate 106 that would be accessed from highly 
functionalised 109 via an ambitious reductive epoxide cleavage-cyclisation, installing 
the highly congested C9 stereocentre. Tertiary alcohol 109 was believed to be 
accessible through a stereoselective organometallic addition of ketone 110, which in 
turn could be prepared by a regioselective ring-expansion of a cyclobutane 
derivative 111. The latter was suggestive of a [2+2] photocycloaddition between 
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Scheme 1-25:  Retrosynthetic analysis of merrilactone A (1) and anislactones A/B (2/3) 
 
The synthesis began with [2+2] photocycloaddition of 4,5-dimethylmaleic anhydride 
20 and dimethylketene acetal 112, affording cyclobutane 113 with the requisite               
cis-methyl groups at newly formed quaternary centres C5 and C6 (Scheme 1-26). 
Subsequent LAH reduction, benzyl protection and ketal hydrolysis, produced 
cyclobutanone 111, the substrate for a regioselective ring expansion, in 87% yield 
over three steps. A Tiffeneau-Demjanov type reaction, using ethyl diazoacetate in 
the presence of BF3·Et2O, converted cyclobutanone 111 to the required 
cyclopentanone. With the C-ring now formed, transesterification of 114 with allyl 
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alcohol and C-alkylation of the formed ß-keto ester, furnished the substrate for a 
Tsuji-Trost decarboxylation-dehydrogenation reaction. Treatment with catalytic 
Pd(OAc)2 and PPh3 afforded cyclopentenone 115 in 70% over three steps. Oxidative 
cleavage of the terminal alkene followed immediately by a chemoselective ZnBH4 
reduction of the resultant aldehyde furnished cyclopentenone 116. The desired α-
epoxide was prepared via NaOCl treatment of enone 116 in excellent yield but only 
moderate diastereoselectivity, yielding a separable diastereomeric mixture of 
117α:118β in a 2.2:1 ratio. The unwanted ß-epoxide was recycled through reductive 
deoxygenation using [Cp2TiCl2] to improve the efficiency of the transformation.  
Scheme 1-26:  Synthesis of highly functionalised cyclopentenone C-ring 117α                                                                  
 
a) hv, pyrex, MeCN/acetone (9:1), 96%; b) LiAlH4, Et2O, 0 C, 97%; c) BnBr, TBAI, NaH, THF;             
d) H2SO4 (aq), MeCN, 90% (two steps); e) N2CHCO2Et, BF3·Et2O, DCM, 0 C, 88%; f) allyl alcohol, 
toluene, reflux, 93%; g) allyl bromide, K2CO3, acetone, 89%; h) Pd(OAc)2 (5 mol%), PPh3 (5 mol%), 
MeCN, reflux, 90%; i) OsO4 (2 mol%), NMO, acetone/H2O (4:1), 96%; j) NaIO4,THF/H2O (1:1);             
k) ZnBH4·pyridine, isopropyl alcohol, 0 C, 76% (two steps); l) NaOCl (aq), pyridine, 0 C, 90%, d.r. 
117α:118ß (2.2:1); m) [TiCp2Cl2] (2 equiv), Zn (6 equiv), THF, 70%. 
A TBS alcohol protection of 117α led to a diastereoselective organometallic addition 
of lithiated homopropargyl reagent 119 to an extremely hindered ketone affording a 
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single diastereomer, which after desilylation presented substrate 120 for the key 
reductive epoxide fragmentation/cyclisation reaction (Scheme 1-27). Treatment of 
120 with [TiCp2Cl2] and zinc resulted in reductive cleavage of the epoxide followed 
instantly by a 5-exo-dig cyclisation onto the pendant alkyne. In this transformation, 
the sterically challenged C9 stereocentre is installed resulting in BC bicycle 106, 
which contains the full carbon skeleton of both merrilactone and anislactone, 
enabling a regiodivergent approach to both natural products. 
Scheme 1-27:  Construction of BC core via a key reductive epoxide cleavage cyclisation                           
 
a) TBSCl, imidazole, DCM, 0 C, 98%; b) 119, 
t
BuLi, Et2O, −78 C, 94%; c) KOH, MeOH, 98%;            
d) [Cp2TiCl2], Zn, THF, 69%, 10% starting material recovered. 
The conversion to merrilactone A from common intermediate 106 started with TPAP 
oxidation, TBAF desilylation and oxidative lactonisation to afford tricyclic compound 
121 (Scheme 1-28). Careful treatment of 121 with a TsOH/AcOH mixture delivered 
the internal alkene in high yield. Application of Hirama’s two-step procedure of 
global debenzylation and regioselective Fetizon oxidation,20 provided tetracycle 32 
in 22% yield over three steps. Tetracycle 32 has been demonstrated in all previous 
syntheses to be easily directed towards merrilactone A, by the well-established two-
step protocol of epoxidation followed by acid-induced homo-Payne rearrangement. 
Thus, a formal synthesis of racemic merrilactone A was achieved in an overall yield 
of 2.4% over 22 steps (24 steps to the natural product).  
Anislactone A was too accessed from common intermediate 106 by installing 
the other regioisomeric lactone between C1 and C9, as compared to C4 and C9 in 
merrilactone A. Accordingly, TBAF-mediated desilylation and treatment with a 
catalytic amount of Al(OTf)3 resulted in tricycle 122. Once again, a global 
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debenzylation followed by regioselective Fetizon oxidation led to tetracycle 123. 
Subsequent oxidation at C11 of the cyclic ether resulted in simultaneous oxidation of 
the secondary alcohol to ketone. Reduction of the ketone yielded anislactone A and 
B in 95% yield, as a 5:1 mixture from which anislactone A (2) was isolated 
completing the synthesis. This represents the first total synthesis of anislactone A, 
which was completed in 22 steps with an overall yield of 5.7%. 
Scheme 1-28:  Final transformations to merrilactone A (1) and anislactone A (2)                                                             
 
a) TPAP (0.5 equiv), NMO, MS. 4Å, DCM, 82%; b) TBAF, THF; c) TPAP (0.1 equiv), NMO, M.S. 4Å, 
DCM, 90% (two steps); d) TsOH, AcOH/DCM (1:1), 30 C, 78% (5% starting material recovered);         
e) Na, liq NH3, THF/EtOH (5:1), −78 C; f) Ag2CO3 on celite, toluene, 130 C, 28% (two steps);             
g) TBAF, DCM/THF (5:1); h) Al(OTf)3 (5 mol%), DCM, 88% (two steps); i) H2, Pd/C, MeOH; j) Ag2CO3 
on celite, toluene, 130 C, 73% (two steps); k) RuCl3 (0.5 equiv), NaIO4, MeCN/CCl4/H2O (1:1:1), 73%; 
l) NaBH4, THF, 95% d.r. 5:1. 
In summary, Greaney and co-workers have presented an approach to both 
merrilactone A and anislactone A via a common route. At the heart of the synthesis 
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is the reductive epoxide cleavage-cyclisation reaction, which allows access to both 
natural products via a shared intermediate. 
1.5   Fukuyama’s Chemical Conversion of Anislactone B to Merrilactone A 
Fukuyama and colleagues previously reported in 2000 the isolation of merrilactone 
A from Illicium merrillianum11 and further studies in 2001 revealed additional 
anislactone-type sesquiterpene constituents including relatively large quantities of 
anislactone B.12 It was shown that merrilactone A could be synthesised from 
anislactone B in three relatively simple steps. The synthesis began with treating 
anislactone B (3) with trifluoroacetic acid under refluxing conditions that resulted in 
the formation of γ-lactone at C4 and dehydration of the C1 hydroxyl gave tetracycle 
32 in a 92% yield (Scheme 1-29). Next, a stereoselective epoxidation of 32 
furnished a separable mixture of the desired α-epoxide 10α and unwanted               
β-epoxide 10β in 64% and 4% yield, respectively. The peroxyacid attacked 
predominantly from the less hindered convex face of 32 giving rise to a highly 
stereoselective epoxidation. The oxetane ring was constructed in the last step by 
exposing 10α with p-toluenesulfonic acid, which resulted in a homo-Payne type 
rearrangement affording merrilactone A, in 78% yield. Common to all subsequent 
total syntheses of merrilactone A is this acid-induced homo-Payne rearrangement 
as a feasible method of installing the oxetane bridge in the final synthetic step of this 
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Scheme 1-29:  Chemical conversion of anislactone B (3) to merrilactone A (1)   
 
a) TFA, reflux, 90%; b) mCPBA, DCM, 10α:10ß (64%:4%); c) pTsOH, DCM, 78%. 
1.6   Published Approaches towards Merrilactone A 
1.6.1   Fukuyama’s model studies 1+ 2 
Back in 2000, Fukuyama’s group was the first to isolate merrilactone A from Illicium 
merrillianum, and in that research uncovered its intriguing biological activity.11 This 
early research was responsible for much of the subsequent generated research 
interest in anislactone-type sesquiterpenes, culminating in several total syntheses of 
merrilactone A.  Fukuyama’s group has also shown their own desire to complete a 
total synthesis of the natural product and have published two model studies; a 
synthesis of the CD ring motif was reported in 200527 and in 2007 an approach for 
the synthesis of the AB ring system was disclosed.29  
Fukuyama’s group strategy to the CD ring system of merrilactone A is 
presented in Scheme 1-30.  The synthesis began with a Diels-Alder addition of 
Danishefsky’s diene 124 and dimethylmaleic anhydride 20, furnishing bicycle 125, 
which was regioselectively reduced using Super-Hydride (Li(C2H5)3BH), affording 
enone 126. Treating 126 with Pb(OAc)4 followed by an acid-hydrolysis gave an        
α-hydroxyketone, which underwent oxidative cleavage upon treatment with further 
Pb(OAc)4 and the ensuing aldehyde was converted to dibromoalkene 127 via the 
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Corey-Fuchs procedure. Both bromides were then used in a stepwise, palladium 
catalysed coupling sequence consisting of a successive Stille and Heck coupling, 
affording the bicyclic system 128 in 48% yield. Since both reactions utilise Pd(0) as 
the active catalytic species, the feasibility of one-pot procedure was investigated. 
Diluting the first Stille coupling with DMF and adding two equivalents of triethylamine 
to initiate the Heck reaction successfully furnished bicycle 128 in one-pot with a 
slightly improved yield of 52%. Further elaboration of 128 via hydroboration, PDC 
oxidation and mCPBA epoxidation, afforded the tricycle 129. Fukuyama’s model 
study accomplished the synthesis of the densely functionalised intermediate 129 
containing the required CD ring system of the natural product in a total yield of 1.6% 
over 11 steps. 
Scheme 1-30:  Fukuyama’s model study of CD ring system                                                                               
 
a) Toluene, 150 C, 63%; b) Li(C2H5)BH, THF, 74%; c) Pb(OAc)4, PhH, reflux, 87%; d) TsOH, 
MeOH/H2O, 100 C, 72%; e) Pb(OAc)4, PhH, MeOH, 76%; f) CBr4, PPh3, DCM, 74%; g) vinyltributyltin, 
Pd2(dba)3-CH3CN 10 mol%, trifurylphosphine 20 mol%, toluene, 100 C, 62%; h) Pd(OAc)2 20 mol%, 
P(o-tol)3, NEt3, DMF, 100 C, 78%; i) Sia2-BH, Et2O, H2O2, 73%; j) PDC, DMF, 62%; k) mCPBA, DCM, 
44%.  
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The second model study focuses on a synthetic pathway to the ABC ring system of 
merrilactone A. The synthesis started with hydroboration of triene 130, representing 
the C-ring, followed by TBS protection of the resulting primary alcohol. A 
regioselective dihydroxylation and protection of the resulting diol then furnished 
acetonide 131 (Scheme 1-31). A series of four transformations that included 
DIBALH reduction, acetylation, desilylation and PDC oxidation, then supplied the 
substrate 132 for the Tsuji–Trost reaction. The critical Tsuji–Trost reaction of 132 
and subsequent hydroboration of the resultant alkene gave rise to the desired                       
γ-lactone 133.  In a similar fashion to the first model study, the substrate 134 for the 
Stille-Heck coupling sequence was obtained from 133 via oxidation, a Corey-Fuchs 
reaction, acetal hydrolysis, MOM alcohol protection and elimination of the tertiary 
alcohol. Unfortunately, exposure of 134 to the previously optimised conditions of the 
Stille-Heck coupling sequence yielded no desired product with only unreacted 
starting material remaining. Optimisation led to the discovery of dimethyllithium 
cuprate as an effective reagent for the desired regioselective mono-methylation of 
the trans-Br and subsequent Michael-type cyclisation to the conjugated lactone 
moiety. Finally, a MOM deprotection followed by stereospecific mCPBA epoxidation 
furnished epoxide 135, encompassing the ABC ring system of merrilactone A. This 
second model study by Fukuyama has demonstrated the applicability of this 
synthetic route in accessing the ABC core 135 of merrilactone A in 18 steps and 
1.2% combined yield. 
In these two model studies, Fukuyama and co-workers, have demonstrated 
the ability to construct both sides of the merrilactone A carbon skeleton in a 
relatively efficient manner. Research to combine these two approaches in an effort 
towards a total synthesis of the natural product is reportedly ongoing.  
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Scheme 1-31:  Fukuyama’s model study of the ABC ring system                                                        
 
a) (Sia)2BH, THF then aq. NaOH, H2O2, 88%; b) TBSCl, imidazole, DMF, 95%; c) OsO4 3 mol%, NMO, 
THF; d) 2,2-dimethoxypropane, TsOH, DCM, 56% (two steps); e) DIBALH, DCM; f) Ac2O, DMAP, 
pyridine, 89% (two steps); g) TBAF, THF; h) PDC, DMF, 67% (two steps); i) Pd(PPh3)4, NaH, DMF, 
75%; j) BH3-THF complex, THF then aq. NaOH, H2O2, 58%; k) DMP, DCM, quant; l) CBr4, PPh3, DCM, 
64%; m) 1M HCL, THF, 71%; n) MOMCl, DIPEA, DCM, 76%; o) MsCl, NEt3, DCM, 67%; p) Me2CuLi, 
Et2O, 78%; q) DOWEX 500WX2-100, MeOH, 88%; r) mCPBA, DCM, 66%. 
1.7  Published Approaches to Anislactones  A/B 
1.7.1   Hong’s model study towards Anislactones A/B 
The epimeric anislactones A (2) and B (3) have received very little synthetic 
attention with only one reported total synthesis in 2010 by the Greaney group.25 The 
only other report was by Hong et al. in 2002 on an approach to the tricyclic BCD 
core of the anislactone framework.48 In this model study by Hong and co-workers, a 
novel one-pot [6+2] cycloaddition reaction of fulvenes 136 with alkenes 137 was 
shown to be an effective route to the BCD core of the anislactones (Scheme 1-32).  
Scheme 1-32:  [6+2] cycloaddition of fulvenes with alkenes to the anislactone BCD core 
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A few examples of reactions between homologous maleic anhydride and maleimide, 
with various aminofulvenes are outlined in Table 1-1. Reaction of various 
aminofulvenes with maleic anhydride or maleimide in benzene at room temperature, 
furnished the desired tricycle products 139-145 in good yields. In this single 
transformation, three rings are formed and the stereochemistry of two stereocentres 
is established. In entry 3, reaction of a substituted maleic anhydride with 
dimethylaminofulvene under microwave irradiation gave tricycle 145 with one of the 
two required cis-methyl groups installed.  
Table 1-1:  Scope of the reaction of fulvenes and alkenes                                                                      
 
Method A: PhH, 25 C; Method B: microwave irradiation at 10W in DMF, 120 C. 
In summary, Hong and colleagues have demonstrated the applicability of a novel 
one-pot [6+2] cycloaddition of fulvenes to alkenes to access structurally complex 
tricycles constituting the BCD core of the anislactones. Extending this methodology 
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1.8   Greaney’s Unpublished Model Study Towards Anislactones A and B   
Synthesis of anislactone-type sesquiterpenes are a current research focus within the 
Greaney group, and previous work by Jesus Perea-Buceta revealed a nine-step 
route to the ABC core of anislactones A and B (Scheme 1-33).49  




BuLi, Et2O, −78 C, 85%, d.r. 8.5:1 (cis:trans); b) BnBr, TBAI, NaH, THF,  70 C; c) TBAF, 
THF; d) PDC, DCM, 74% (three steps); e) 150, 
t
BuLi, THF, −78 C, 78%, d.r. 2:1 (cis:trans);                  
f) NEt3/TMSCl, LiHMDS, THF, −78 C; g) TiCl4, DCM, −78 C, 47% (two steps); h) I2, PPh3, imidazole, 
PhH, 86%; i) Zn dust, MeOH, 73%. 
Leading off with an organometallic nucleophilic addition using lithiated iodo-
dioxolane 147 to the TBS protected hydroxycyclopentenone 146, yielded tertiary 
alcohol 148 as a 8.5:1 (cis:trans) mixture of diastereomers in 85% yield.  
Benzylation of 148 followed immediately by desilylation and PDC oxidation, 
furnished the alkylated cyclopentenone 149 in 74% yield over three steps. Alkylation 
of cyclopentenone 149 suffered from irreproducibility due to enol-lactone formation 
under the reaction conditions, but still yielded 151 as a 2:1 mixture of diastereomers  
in 78% overall yield. Enone 151 served as the substrate for an extremely hindered 
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Mukaiyama acetal-aldol reaction that installed the triad of neighbouring                     
fully-substituted stereocentres at C1, C9 and C4. The yield of this reaction is a 
meager 47%, and is unfortunately highly selective for the R-configuration at C1 of 
152. Confirmation was obtained by NOESY analysis revealing signal enhancements 
between the methylene protons at C10 and the C15 methyl group. This is in 
agreement with the structural assignments and suggests that the reaction proceeds 
via a chelated transition state in favour of the undesired stereochemistry at C1. 
Conversion of the alcohol 152 to the ethyl iodide 153 and ensuing zinc-mediated 
dealkylation resulted in the clean inversion of stereochemistry at C1 delivering the 
required ABC core 154 in 63% yield over two steps. It was proposed that the tertiary 
alcohol undergoes a retro-aldol/aldol equilibration under the zinc-based reductive 
cleavage conditions, which is a known phenomenon in the anislactone family of 
natural products.13 Under these equilibrating conditions, any α-alkoxide produced 
will immediately lactonise to 154, providing a thermodynamic driving force for the 
transformation. This model study identified two key challenges for successful 
synthesis of anislactones A/B: 
 the alkylation of C9 and the Mukaiyama aldol reaction suffer from 
irreproducibility and mediocre yield, respectively; and 
 there is insufficient functionality present in the C-ring to enable completion of 
the synthesis. 
In this model study, Greaney and coworkers have successfully demonstrated a 
novel approach to the construction of the ABC core of the anislactones A/B via nine 
synthetic steps in an overall yield of 14%. This research laid the foundation for future 
work towards a total synthesis of anislactones A/B.  
 Synthesis of the Bicyclic Core of Anislactones A/B 
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2 Synthesis of the Bicyclic Core of Anislactones A/B 
2.1 Tandem Iodo-Aldol Intramolecular Cyclisation Approach 
In this approach we plan to address the challenges raised in the methodology 
previously developed within this project as discussed in Section 1.8. We envisage 
adding the necessary functionality in the C-ring early on in the synthesis and 
replacing the poor alkylation of C9 and Mukaiyama aldol reactions with a novel 
tandem iodo-aldol intramolecular cyclisation reaction (Scheme 2-1). Iodo-aldol 
cyclisation reactions are a current research interest of the Greaney group and this 
would be a highly appropriate test of that methodology in the natural product arena. 
Scheme 2-1:  Proposed solutions to challenges identified in a previous model study 
 
2.2   Retrosynthetic Analysis 
The proposed retrosynthetic analysis for anislactones A/B reveals four key 
transformations (Scheme 2-2). Our proposed strategy for the total synthesis of 2 and 
3, utilises a late stage alkylation that installs the final γ-lactone D-ring. Next, we aim 
to carry out a stereospecific Stork silicon-tethered radical addition to enone 159 
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giving rise to 158.50 The intramolecularity of the reaction, allied to the relatively low 
sensitivity of radical additions to steric hindrance, will ensure successful addition to 
what would otherwise be a very hindered Michael acceptor in the intermolecular 
variant. Following this critical formation of the C5 quaternary stereocentre, enone 
159 would in turn be prepared by an established deprotection/lactonisation 
sequence (cf. Scheme 1-33). The defining step in our synthesis is the construction 
of the bicyclic BC core via an intramolecular tandem iodo-aldol cyclisation reaction. 
This one-pot reaction forms a five-membered ring and simultaneously sets the 
stereochemistry of three fully substituted stereocentres at C1, C9 and C4. Iodo-aldol 
substrate 161 is anticipated to be available from a stereocontrolled nucleophilic 
addition to cyclopentenone 162, a known compound easily accessed from 
precedented furan-cyclopentenone rearrangement chemistry and an appropriate 
starting point for the synthesis.51 
Scheme 2-2:  Retrosynthesis of anislactones A/B 2/3 including key transformations 
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2.3  Synthesis of the Bicyclic BC Core of Anislactones A/B 
2.3.1   Synthesis of cyclopentenone-diol starting material 
Our first challenge in implementing our synthetic strategy towards anislactones A/B 
lay in accessing hydroxymethylated cyclopentenol 168, a literature compound easily 
accessed from precedented furan-cyclopentenone rearrangement chemistry by 
Stoodely and co-workers.51 Reaction of commerically available chloroacetaldehyde 
163 and ethyl acetoacetate 164, led to furan ester 165 in excellent yield                     
(Scheme 2-3). This step was amenable to efficient scale-up, and after distillation, 
delivered large quantities of the desired 165. A lithium aluminium hydride reduction 
of the ethyl ester in 165 and subsequent treatment with bromine in methanol gave 
dihydrofuran 167 as an inseparable 2:1 mixture of diastereomers. Rearrangement of 
167 to racemic cyclopentenone 168 was achieved by refluxing 167 in aqueous 
dioxane buffered to pH 6.3 with a catalytic amount of hydroquinone. After an 
intramolecular aldol reaction of a 1,4-diketone intermediate, this afforded 168 in 50% 
yield over four steps.52,53 
Scheme 2-3:  Synthesis of hydroxymethylated cyclopentenol 152      
 
a) Pyridine, RT, 94%; b) LiAlH4, Et2O, 0 C, 91%; c) Br2, NEt3, MeOH:Et2O (4:1), −78 C, 89%; d) 
hydroquinone, 1,4-dioxane, 0.2 M potassium phosphate buffer, reflux, 71%. 
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2.3.2   Regioselective protection of the 1° allylic alcohol 
Having prepared cyclopentenone 168, a regioselective protection of the primary 
allylic alcohol in the presence of a secondary alcohol was required. As both alcohols 
will ultimately be differentially protected, it was vital to select protecting groups that 
are orthogonal under deprotection conditions. The possibility of a benzyl protecting 
group was investigated but this proved to be unsuccessful as significant amount of 
decomposition was observed by TLC. We suspected the substrate may be unstable 
under the basic reaction conditions and subsequent treatment alone, with a variety 
of bases such as sodium hydride, sodium methoxide and DBU, resulted in the same 
decomposition. The high density of reactive sites in the ring, the acidic proton in the 
γ-position and the two acidic δ-protons, are perhaps jointly responsible for the 
observed decomposition. Other protecting groups were explored under a variety of 
conditions, and in the event of there being no decomposition, unreacted starting 
material remained with a mixture of mono- and bis-protected products (Figure 2-1). 
Introduction of a benzyl group under acidic conditions using benzyl 
trichloroacetimidate54,55 and the formation of a pivalate ester, which is reportedly 
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Figure 2-1:  A table summarising the various types of protecting groups and conditions 
investigated for the regioselective protection of the primary allylic alcohol 
 
Product Conditions Result 
169 
BnX (X= Cl, Br), TBAI, NaH or NaOMe, 
DCM, DMF or THF, RT to 100 C 
Decomposition 
169 
BnX (X= Cl, Br), TBAI, DIPEA, proton 
sponge, RT to 130C 
SM and mixture of 
products 
169 
Benzyl trichloroacetimidate, PPTS, DMF or 
THF, RT to 100 C 
SM and decomposition 
170 
PMBCl, TBAI, NaH or NaOMe, DCM, DMF 
or THF, RT to 100 C 
Decomposition 
170 
PMBCl, TBAI, DIPEA, Proton sponge, RT 
to 130 C 
SM and mixture of 
products 
171 PivCl, pyridine, RT 
SM and mixture of 
products 
 
Our attention then focussed on the prospect of using hindered silicon-based 
protecting groups because of their ease of formation under neutral conditions, 
removal and stability to a variety of reagents and conditions.57,58 A range of bulky 
silyl-protecting reagents were screened, anticipating that the added steric bulk would 
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Figure 2-2:  Examples of silyl protecting agents used in the regioselective protection of 
168 
 
Entry Conditions Yield (%) Result 
1 





 and bis-protected 
byproduct 
2 





 and bis-protected 
byproduct 
3 




 and 174 (23% yield) 
4 
TDSCl, DMF, imidazole, 
DMAP, RT 
41 175 and bis-protected byproduct 
a 
Method A was used in the synthesis; 
b 
Method B was used in the synthesis 
We were pleased to successfully obtain the desired mono-protected primary alcohol 
with no decomposition using a range of chloro variants of silyl protecting groups but 
only in moderate yields (entries 1,3 and 4). It was hoped that thexyldimethylsilyl 
(TDS) chloride would be more selective as has been demonstrated in the 
literature.59,60 However, TDS protected 175 was obtained with no improvement as 
compared to TBS 172 and TBDPS 173 ethers. Attempts to increase the selectivity 
by decreasing reaction temperature proved unsuccessful as the reaction became 
too sluggish and only unreacted starting material remained. It was hoped that using 
the more reactive tert-butyldimethylsilyl (TBS) triflate at −78 C (entry 2) will 
discriminate between the different reactivities of the allylic alcohols, but this only 
gave a slight improvement in yield. The major byproduct in all cases was the 
formation of the bis-protected alcohol, such as TBDPS bis-protected 174 which was 
isolated in 23% yield. This posed problems during scale-up, although 174 was 
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formed in low yield, its molecular weight is almost double that of the desired mono-
protected which caused difficulties during large scale-up.  
An alternative approach was to preemptively protect the hydroxyl group in 
furan 167 before the furan-cyclopentenone rearrangement, thereby directly 
accessing mono-protected 173, avoiding the regioselective protection and 
purification issues (Scheme 2-4).  
Scheme 2-4:  Pre-emptive protection of primary allylic alcohol for the synthesis of 173 
             
a) i) TBDPSCl, imidazole, DMAP, DMF, RT; ii) hydroquinone, DMF, potassium phosphate buffer, 
reflux, 30% (two steps). 
b
 Method B was used in the synthesis. 
TBDPS ether formation of 167 under standard conditions went as expected and 
afforded the crude 176. This was sufficiently pure to be used in the next step; the 
furan rearrangement to the cyclopentenone. Unfortunately, the now less polar 
dihydrofuran 176 did not rearrange easily due to insolubility in the aqueous buffer. 
The additional steric bulk of the TBDPS group likely contributed to the 
ineffectiveness of the rearrangement. Consequently, the reaction was much slower 
and did not go to completion even after refluxing for 48 hr. A number of different 
solvent combinations were screened and a DMF:phosphate buffer (2:1) mixture 
delivered the best results. However, the reaction was slow, taking 24 hr to reach 
completion and afforded 173 in a mediocre 30% yield over the two steps. As this 
offered no improvement, our efforts then focused on advancing through the 
synthesis taking advantage of the enhanced stability of TBDPS ether 173 obtained 
from diol 168 despite the aforementioned regioselectivity and purification problems.  
 Synthesis of the Bicyclic Core of Anislactones A/B 
62 | P a g e  
 
2.3.3  Synthesis of iodo-aldol cyclisation substrate 
We proceeded towards the key iodo-aldol cyclisation reaction with the synthesis of 
the iodo-aldol substrate as our first target. A 1,1-disubstituted alkene like 184 would 
be necessary for the key cyclisation. This was anticipated to successfully undergo 
the tandem conjugate iodo-aldol cyclisation to furnish the desired BC bicyclic core 
199 (Scheme 2-5). An initial large-scale preparation of 173 provided sufficient multi-
gram quantities to be carried forward through the synthesis. Subsequent protection 
of the secondary alcohol as the TES ether gave diprotected cyclopentenone 178 
(Scheme 2-5). A key feature of silyl protecting groups is their different stabilities 
towards deprotection conditions, such as DDQ, protic acids and fluoride ion 
sources.58 The TES protecting group in the presence of DDQ is substantially less 
stable than more sterically hindered groups such as TBS or TBDPS ethers.61 This 
was investigated and treatment of enone 178 with 0.1 equiv DDQ cleanly 
deprotected the TES alcohol leaving the TBDPS group untouched and afforded 
alcohol 173 in a very good 80% yield. 
 Next, the iodoacetal 147 was prepared from methyl vinyl ketone 179 in a 
one-pot reaction with trimethylsilyl chloride, sodium iodide and ethylene glycol in 
acetonitrile.62 The scene was now set for the key organolithium addition between the 
prepared iodoacetal 147 and cyclopentenone 178. Treatment of 147 with                            
tert-butyllithium in Et2O at −78 C initiated the lithium-iodide exchange forming the 
organometallic nucleophile, which was transferred slowly to cyclopentenone 178 
resulting in the clean formation of tertiary alcohol 180 as a single diastereomer. The 
TES group at stereocentre C7 controlled the facial selectivity of the organolithium 
addition, efficiently transferring stereochemistry to C4. However, this has little 
importance as the C4 stereocentre will be destroyed later in a separate deprotection 
and oxidation sequence. 
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Subsequently, the TBS protection of the sterically hindered tertiary alcohol using the 
highly reactive TBSOTf furnished cyclopentene 181 in almost quantitative yield. A 
concern for the next reaction was the stability of the dioxolane and TBS ether 
moieties to the previously demonstrated catalytic DDQ-mediated TES-deprotection 
conditions. As anticipated, a mixture of products was obtained when 181 was 
treated with DDQ, resulting in both TES ether and ketal deprotection. Tanemura and 
co-workers reported significant reactivity differences of various silyl ethers and 
acetals to DDQ and other π-acceptors.63 Switching to the enhanced 
chemoselectivity of TCNQ, TES deprotected alcohol 182 was obtained in excellent 
yield with the other protecting groups left intact. Subsequent DMP oxidation afforded 
enone 183, which was treated with LDA followed by Eschenmoser’s salt and 
successive elimination of the formed dimethylaminoethylene Mannich base product 
with mCPBA. This successfully delivered the desired exo-methylene 184 in 67% 
yield over two steps and meant we had now achieved our first milestone. 
Scheme 2-5:  Synthesis of the substrate for the key iodo-aldol cyclisation reaction                         
 
a) TESCl, NEt3, DMAP, DCM, reflux, 96%; b) Method C: DDQ, MeCN:H2O (9:1), RT, 80%; c) NaI, 
TMSCl, HO(CH2)2OH, MeCN, 49%; d) 147, 
t
BuLi, Et2O, −78 C to RT, 83%; e) TBSOTf, 2,6-Lutidine, 





THF, −78 C; ii) mCPBA, DCM:NaHCO3 (2:1), RT, 67% (two steps). 
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The synthesis of the substrate for the key intramolecular tandem iodo-aldol 
cyclisation reaction had been accomplished in 12 synthetic steps with an overall 
yield of 10%. At this stage it was apparent that the preparation of the desired 
substrate was for the most part straightforward. However, the regioselective             
mono-protection of either allylic alcohol in cyclopentenone-diol 168 was inefficient 
and the poor regioselectivity, together with purification problems during scale-up, 
provided an opportunity for future improvement.  
2.3.4  Intramolecular iodo-aldol cyclisation reaction 
The iodo-aldol reaction is part of the Morita-Baylis-Hillman (MBH) family of tandem 
conjugate addition/aldol processes and has become a well-developed strategy for 
C–C bond formation.64,65 Typically, these are three-component reactions between an 
enoate or ynoate, aldehyde and a nucleophile. In the case of an enoate with an sp2 
Michael acceptor, the nucleophile is often eliminated, giving rise to MBH adducts 
without incorporation of the nucleophile. Initial work by Taniguchi and co-workers,66 
focused on the intermolecular reaction between α,ß-acetylenic ketones and a 
number of aldehydes in the presence of various reagents such as TiCl4/TMSI, 
TMSOTf/TMSI, TiCl4/Bu4NI, TMSI/Bu4NF, Et2AlI, or TiI4. Screening of conditions 
revealed the stoichiometric reagent combination TiCl4/Bu4NI as particularly effective 
in generating β-iodovinyl Baylis-Hillman adducts in good yield (Scheme 2-6).  
 Following on from this initial pioneering research, Oshima and colleagues 
demonstrated that the same reagent combination could be used for the preparation 
of β-iodo aldol adducts 187 from the reaction between sp2 Michael acceptors 185 
and aldehydes 18667,68 (Scheme 2-6). As in the case of reductive aldol reactions, the 
nucleophile is incorporated in the final product whilst simultaneously creating a new 
chiral centre adjacent to the carbonyl group.  
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Scheme 2-6:  A general intermolecular iodo-aldol reaction between Michael acceptors and 
aldehydes 
 
Interestingly, a number of other research groups including Shi and co-workers69 
(Scheme 2-7, eq 1) and Li et al.70 (Scheme 2-7, eq 2), have independently reported 
that using catalytic amounts of Bu4NI results in the generation of chlorinated                
aldol-type adducts with traces or no iodo-aldol products detected. The reagent 
combination of TiCl4/Bu4NI is considerably more complex than originally thought, 
with several reports of different reaction products dependent on the ratio of TiCl4 to 
Bu4NX (X = I, Br), reaction time and temperature. In general, higher reaction 
temperatures, longer reaction times and a catalytic or zero quantities of Bu4NX 
favoured chlorinated aldol products 193 via elimination (Scheme 2-7, eq 2).64,69,71,72  
Scheme 2-7:  Synthesis of chlorinated aldol products via the Baylis-Hillman reaction 
 
Tandem iodo-aldol reactions have a number of strengths common to all MBH 
reactions; they have excellent atom economy and generate one, two, or three chiral 
centres from simple starting materials in a one-pot reaction: they allow enolate 
chemistry to be performed without the use of a strong base, are amenable to 
asymmetric catalysis, and the installed functional handle can be used for further 
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elaboration.65 A limitation of iodol-aldol processes in general is their relative lack of 
application to the construction of quaternary centres important for natural product 
synthesis. The vast majority of examples reported in the literature use mono- or 1,2-
disubstituted Michael acceptors as substrates, whereas quaternary centre 
construction will require a 1,1-disubstituted Michael acceptor such as 194 (Scheme 
2-9). Although the iodo-aldol reaction has attracted the interest of several research 
groups, the intramolecular variant has not been studied in depth and there are only 
two reports in the literature.65,73 
Scheme 2-8:  Intramolecular iodo-aldol reaction for quaternary centre construction. 
 
In a 2007 publication by the Greaney group,65 an intramolecular iodo-aldol 
cyclization of 1,1-disubstituted alkenes was developed, affording hetero- and 
carbocycles containing quaternary centres. In this transformation, simple prochiral 
starting materials 196 were converted to cyclic alcohols 197 containing vicinal 
quaternary and secondary/tertiary stereocentres in good yields with excellent anti-
diastereoselectivities with respect to the newly formed CH2I and alcohol functional 
groups. (Scheme 2-9).  
Scheme 2-9:  Intramolecular iodo-aldol reaction for quaternary centre construction 
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Anislactones A/B were selected as a highly appropriate test of this iodol-aldol 
cyclisation methodology in the natural product arena and is devised to solve both 
the low yield of the alkylation and Mukaiyama aldol reactions in the previous model 
system (cf. Scheme 1-33). The vicinal C1 tertiary and C9 quaternary stereocentres 
of the AB-ring junction in anislactones A/B are analogous to the C1 and C2 
stereocentres of 198 (Figure 2-3).  
Figure 2-3:  Reasoning for the adoption of an iodo-aldol cyclisation reaction in the 
synthesis of anislactones A/B 
 
In the methodology presented by Greaney, the recently introduced iodomethyl group 
has an anti-relationship with the formed tertiary alcohol whilst in our system a syn-
relationship would be required to allow the successful installation of the                       
γ-lactone A-ring. The effect of a ketal as a replacement for the ketone in the                    
iodo-cyclisation was unknown, but it was hoped this would result in the reversal of 
diastereoselectivity as required for the synthesis of anislactones A and B. Thus,                  
1,1-disubstitued 184 has all the elements of a suitable substrate for the iodo-aldol 
cyclisation and would allow us to examine the potential of this methodology on more 
complex systems. 
 With the crucial iodo-aldol cyclisation substrate in hand, we set about 
applying the previously developed iodo-aldol cyclisation methodology. To our 
delight, when a solution of Bu4NI and TiCl4 in DCM was treated with exo-methylene 
184 in DCM at 0 °C, a separable 5:1 mixture of bicyclic diastereomers 199 and 200 
was acquired in a good 79% overall yield. This one-pot reaction forms a new C–C 
bond between C1 and C9, creates a new five-membered ring and simultaneously 
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sets the stereochemistry of the triad of fully substituted chiral centres at C1, C9 and 
C4 (Scheme 2-10). The reaction is very robust and no problems were encountered 
during scale-up when conducting the reaction in multi-gram quantities. 
Scheme 2-10:  Key intramolecular tandem iodo-aldol cyclisation reaction on ketal 184  
 
a) Bu4NI, TiCl4, DCM, RT, 79% combined, 63% 199 and 16% 200, d.r. 5:1. 
A plausible mechanism for this transformation is proposed in Scheme 2-11, which is 
similar to others reported in the literature for the intermolecular version of the                   
iodo-aldol reaction.67,68 Firstly, formation of 203 is obtained from the Lewis acid-
mediated opening of the dioxolane moiety 202 leaving an oxonium ion. Subsequent                      
1,4-conjugate addition of iodide giving the (Z)-enolate 204 setting the scene for a 5-
exo-trig cyclisation.   
Scheme 2-11:  Proposed mechanism for the intramolecular tandem iodo-aldol   
 cyclisation
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With both cyclisation products 199 and 200 isolated, we set about demonstrating 
their relative stereochemistries. Unfortunately, the use of X-ray crystallography 
proved unfeasible as both formed an oil on standing. Nonetheless, the elucidation of 
the relative stereochemistry was achieved by means of extensive 1D and 2D-NMR 
spectroscopy. Using 1D-1H-NMR, 13C-NMR and DEPT, as well as HSQC, HMBC 
and COSY 2D correlation spectroscopy, allowed us to assign all the proton and 
carbon signals observed for both diastereomers. This eventually permitted us to 
identify the cross peak interactions observed in the NOESY spectrum to specific and 
characteristic through-space interactions, and allowed us to determine the relative 
stereochemistry as outlined in Figure 2-4. 
Figure 2-4:  nOe interactions observed for iodo-aldol cyclisation products syn-199 and 
anti-200 
 
The crucial stereochemical configuration to be assigned was the orientation of the 
C15 methyl group and thus, the relative stereochemistry at C1. If we could 
demonstrate its location to be on the opposite face of ring B to the C10 methylene 
group, we would be able to simultaneously verify the correct orientation of ring B, 
due to the cis-arrangement of the formed BC ring junction. Therefore the key nOe 
interactions to be investigated are the presence of signal enhancements between 
the C15 methyl and the C10 methylene protons. It was hypothesised that if there 
was a syn relationship, then a nOe effect would be anticipated between C15 and 
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both C10 methylene protons. Starting with major diastereomer 199, a 1D NOE 
difference experiment with pre-irradiation of the C15 methyl revealed a strong nOe 
signal enhancement to only a single C10 methylene proton. Additionally, we found 
no observed interactions between the C15 methyl and any of the methyl 
substituents of the TBS group. On the other hand, 1D NOE and 2D NOESY 
experiments revealed nOe effects between C10 and the TBS group at C4, 
suggesting the stereochemical assignments designated above. Further proof was 
obtained from the NOESY analysis of the minor diastereomer 200 which could be 
directly compared with 199. Examination of the NOESY and 1D NOE difference data 
of minor diastereomer 200 revealed strong nOe effects between C15 and both C10 
methylene protons that suggests these have a syn-stereochemical relationship. In 
addition, signal enhancements which were not observed in the NOESY analysis of 
199 are now seen between C15 and methyl substituents of the TBS protected 
alcohol at C4. The direct comparison of the NOESY data from 199 and 200, strongly 
aided our stereochemical assignments as indicated above.  
A more expedient synthetic approach would be to perform the iodo-aldol 
cyclisation on diketone 205, easily obtained by simple deprotection of dioxolane 184 
(Scheme 2-12). This would remove the requirement for the previously developed 
ethyl iodide deprotection sequence49 as the tertiary alcohol would be directly formed, 
reducing the synthesis by a single step. Treatment of ketal 184 with DDQ readily 
afforded diketone 205 in high yield. With the substrate for the iodo-cyclisation in 
hand, we applied the previously developed iodo-aldol methodology to 205 and to our 
delight, a separable 6:1 mixture of diastereomers 206 and 207 were formed in a 
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Scheme 2-12:  Key intramolecular tandem iodo-aldol cyclisation reaction on diketone 205 
     
a) DDQ, MeCN:H2O (9:1), 40 C, 92%; b) Bu4NI, TiCl4, DCM, RT, 84% combined, based on recovered 
starting material , 79% 206 and 5% 207, d.r. 15:1; c) basic alumina, DCM, RT. 
The ratio of diastereomers formed in the cyclisation reaction was easily established 
from the 1H NMR of the crude reaction mixture via the integration of two singlets at 
δmajor 6.52 ppm and δminor 6.37 ppm corresponding to the alkene proton at C6. An 
interesting observation after purification by column chromatography was the 
contamination of major diastereomer 206 with a small but identifiable amount of 
substrate 205 even after repeated attempts at purification. Furthermore, the release 
of iodide was observed in purple coloured fractions containing 206 after column 
chromatography, implying that a retro-aldol process could be responsible for the 
conversion of 206 back to substrate 205.   
We decided to investigate if we could take advantage of this unexpected 
result and recycle the minor diastereomer 207. A solution of 207 was exposed to 
basic alumina conditions at room temperature and monitored by 1H NMR. Time-
dependent formation of starting material 205 and disappearance of 207 was 
observed. After standing overnight, 207 was fully converted back to 205 with no 
observable side products. This was pooled with the previously recovered starting 
material and re‐submitted to the iodo‐aldol reaction conditions. A single attempt at 
recycling culminated in a 15:1 overall isolated diastereomeric ratio with 206 isolated 
in a combined 79% yield and a diminished 5% yield for 207. It was not completely 
surprising that a retro-aldol event could occur with tertiary alcohols 206 and 207, as 
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this was proposed as a possible explanation for the observed epimerisation at C1 in 
the previous model study (cf. Scheme 1-33).49 
 Pleasingly, tertiary alcohols 206 and 207 were formed as solids and on slow 
evaporation of the solvent, crystals could be formed. X-ray crystallographic analysis 
of diastereomers 206 and 207 enabled the unequivocal confirmation of their 
structures and relative stereochemistries, which were in agreement with the above 
stereochemical assignments as depicted above (Figure 2-5).   
Figure 2-5:  X-ray crystal structures for iodo-aldol diastereomers 206 and 207 
 
The crystal structure for major diastereomer 206 clearly shows a syn stereochemical 
relationship between the C15 methyl and the C10 methylene groups. As expected 
from the methodology published by the Greaney group,65 the opposite was seen for 
the minor diastereomer 207 where the C15 methyl group is anti to the C10 
methylene. The complete switch in diastereoselectivity with the diketone 205 as the 
substrate for the iodo-aldol cyclisation was not a complete disappointment. We 
envisaged a successful elaboration of the methylene iodide functional handle to 
ester 208, after which the C1 tertiary alcohol is predicted to undergo a base induced 
retro-aldol/aldol equilibration, producing the required γ-lactone A-ring 210 via the 
epimerisation of C1 (Scheme 2-13). This anticipated retro-aldol/aldol equilibration 
has precedence in the previously observed C1 epimerisation event in the Greaney 
206 207 
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model study49 (Scheme 1-33) but is also a known phenomenon in the anislactone 
family of natural products.12 
Scheme 2-13:  Proposed synthesis of the tricyclic core of anislactones A/B via a retro-aldol 
process 
 
Such complete reversal in diastereoselectivity was attributed to the sensitivity of the 
transition state to the steric congestion around C1. The observed 
diastereoselectivity can be explained using the transition state models as outlined in 
Figure 2-6, which are based on initial conjugate addition of iodide generating a                
(Z)-enolate followed by a diastereoselective aldol reaction. In the case of the ketal 
substrate 204, discrimination between transition states 212 and 213 is likely due to 
the orientation of the bulky ketal side chain, which is pointing away from the least 
hindered convex face in syn-199 rather than pointing towards the more sterically 
crowded concave face in anti-200. The C15 methyl substituent is left pointing 
towards the concave face as it offers less steric congestion as compared to the 
bulkier ketal side chain. The highly differentiated concave and convex faces of the 
ensuing bicycle in 199 and 200 is what drives the observed diastereoselectivity 
leading to the preferential formation of syn-diastereomer 199 via the most stable 
transition state 212.  
The aldol reaction with methyl ketone 211 as the intermediate resulted in the 
complete reversal of diastereoselectivity. In this scenario, the C15 methyl group is 
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considered to be bulkier than the recently formed C1 tertiary alcohol, favouring 
transition state 214 with the methyl substituent aiming away from the convex face 
and the C1 alcohol pointing towards the concave space. This explains the reversed 
diastereoselectivity affording anti-206 as the major diastereomer. 
Figure 2-6:  Proposed stereochemical model for the iodo-aldol cyclisation on ketal 204 
and ketone 211 
 
In addition to the X-ray crystal structures, diastereomers 206 and 207 were fully 
characterised by the full suite of 1D and 2D-NMR spectroscopy techniques. With 
this set of characterisation data in hand, we were able to compare the NOESY data 
of both sets of diastereomers. Particular attention was again given to distinguishing 
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nOe interactions between C15 methyl and C10 protons. We noticed, for major 
diastereomer syn-199 and minor diastereomer syn-207, the same specific nOe 
interaction between C15 and the same single C10 methylene proton. The same was 
seen for minor diastereomer anti-200 and major diastereomer anti-206 where nOe 
cross peak interactions were seen between C15 and both C10 methylene protons. 
Together, these observations strongly supported our original stereochemical 
assessments based on 2D-NOESY and 1D-NOE analysis for diastereomers                 
syn-199 and anti-200.  
2.3.5  Attempts at elaboration of the BC bicyclic core 
With an efficient synthesis of the bicyclic anislactone cores 199 and 206 established, 
we investigated the potential for further elaboration with the aim of installing the         
A-ring γ-lactone. We wanted to perform a one-carbon homologation reaction on the 
recently introduced iodide functional handle. Initial attempts focused on the potential 
of a cyanide-iodide exchange with 199 and 206 using a variety of cyanide sources 
(Figure 2-7). Starting with 206, we were disappointed to observe only unreacted 
starting materials and retro-aldol product 205. Given the previously observed 
propensity for 206 to undergo a retro-aldol process (cf. Scheme 2-12) it certainly 
was not a surprise to witness its reoccurrence.  
Next, we shifted our attention to substrate 199, which as a result of 
containing a protected tertiary alcohol is not anticipated to be susceptible to a retro-
aldol reaction. Consequently 199 would be more stable than 206 to a greater variety 
of reaction conditions. First attempts began with the Kolbe synthesis of nitriles using 
NaCN or KCN in a variety of polar solvents.74,75 Unfortunately, no formation of the 
desired product 217 was achieved at room or elevated temperatures; no reaction 
and cleavage of the silyl protecting groups at high temperatures was observed. 
Then we examined the potential of AgCN, CuCN and ZnCN, but could only observe 
the slow decomposition of the starting materials with no detectable product 
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formation. Final attempts using TMSCN and Et2AlCN resulted in the same 
disappointment; with quantitative recovery of starting materials. At this point, 
investigation into the cyano-iodide exchange was abandoned and other possibilities 
were examined.   
Figure 2-7:  Screening of different cyanide sources for the one-carbon homologation of 
199 and 206 
 
Cyanide Source Conditions Result 
NaCN or KCN 
MeOH, DMSO, DMF, THF, H2O 
as cosolvent, RT to reflux 
199: No reaction or 
TBS/TBDPS deprotection 
206: Retro-aldol product 
AgCN 
MeOH, toluene DMSO, DMF, 
Et2O, THF, H2O as cosolvent,         
RT to reflux 
199: SM and decomposition 
206: No reaction or retro-aldol                                        
product 
CuCN or ZnCN 
MeOH, DMSO, DMF, THF, H2O 
as cosolvent, RT to reflux 
199: SM and decomposition 
206: No reaction or retro-aldol                                        
product 
TMSCN 
Toluene, MeOH, THF, H2O as 
cosolvent, RT to reflux 
199: No reaction 
206: Retro-aldol product 
Et2AlCN Toluene, DCM, RT to reflux 
199: No reaction 
206: Retro-aldol product 
 
Moving forward, we decided to explore a diverse range of reactions to further 
elaborate substrates 199 and 206, which are summarised in Figure 2-8.  
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Figure 2-8:  Attempts at a one-carbon homologation of substrates 199 and 206                              
 
a) Mg turnings, I2 or 1,2-dibromoethane, CO(OMe)2 or ClCO(OMe), Et2O or THF, RT to 50 C;                  
b) Pd(PPh3)4 (10 mol%), CO (balloon pressure) or bubbled into reaction, NEt3, hv (pyrex or quartz,             
254 nm), methanol, RT; or allyltributyltin, AIBN, NEt3, methanol, 80 C; or (Bu3Sn)2, ClCOOMe, 
methanol, hv  (pyrex or quartz, 254 nm); c) i-PrMgCl·LiCl, THF, RT; d) vinylmagnesium bromide, THF, 
RT. 
We began by exploring the possibilty of Grignard formation with either 199 or 206 
followed by quenching with an electrophile such as methyl chloroformate or dimethyl 
carbonate. Unfortunately, no desired product was detected, only starting materials 
were recovered for 199, and 206 was completely converted back to retro-aldol 
product 205. Careful monitoring of the reaction via LCMS at the stage of Grignard 
formation revealed the Grignard had not formed and only starting material was 
detected.  
Next, we investigated the use of Knochel’s procedure for Grignard 
generation.76 Treatment of 206 with i-PrMgCl·LiCl at −78 C yielded no reaction but 
upon warming to RT resulted in the clean and rapid formation of an SN2 type 
product 219 in almost quantitative yield. The concentration of the reaction was an 
important factor in this process and it had to be conducted at 20 mM; more dilute 
conditions directed the reaction towards the retro-aldol product 205 with no traces of 
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isopropyl 219 detected by TLC or LCMS. The synthesis of 219 is an interesting 
result relative not only to the limited success we had with the cyanide-iodide 
exchange, but is due to the steric bulk of the isopropyl nucleophile and the absence 
of any retro-aldol product 205. A plausible explanation for this is that this process 
occurred by a radical-type reaction, which is known to have low sensitivity to steric 
hindrance and is a recognised phenomenon in Grignard formation of alkyl halides 
with magnesium metal.77 Nonetheless, the unexpected compound 219 did not have 
the required functionality to move forward in the synthesis and so had to be 
abandoned.  
We postulated that if we could functionalise with the hindered i-PrMgCl·LiCl 
then a similar success would be predicted for vinylmagnesium bromide. Introduction 
of a vinyl group would allow further elaboration to the required aldehyde via a 
dihydroxylation/oxidative cleavage sequence (Scheme 2-14).  
Scheme 2-14:  Proposed possible elaboration of iodo-aldol cyclisation products 
 
This would provide aldehydes 224 and 225 of which 224, with its naked tertiary 
alcohol, would be expected to undergo a base-induced retro-aldol/aldol equilibration 
resulting in lactolisation, similar to the epimerisation observed in the model study 
(Scheme 1-33).49 We were perplexed to find that after applying the same reaction 
conditions optimised for i-PrMgCl·LiCl, we could not obtain either 220 or 221. 
Screening of many conditions resulted in the identification of starting materials or 
retro-aldol 205 as the only artefacts of the reaction. We suspected the lack of 
reactivity observed for these two substrates could stem from the high steric 
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congestion around C10. In fact the vicinity around the electrophilic reactive site at 
C10 is structurally similar to neopentyl iodide (Figure 2-9) which is notorious for 
being unreactive especially to SN2-type processes.
75 The steric encumbrance 
around C10, which is adjacent to a quaternary stereocentre would block any 
approaching nucleophile in an SN2 type reaction. 
Figure 2-9:  Highlighted is the structural similarity between 199 and neopentyl iodide 
 
With this in mind we turned our attention to free radical chemistry which unlike    
ionic-type reactions is relatively less sensitive to steric hindrance. We explored an 
ambitious atom transfer carbonylation approach that would lead to methyl esters 
208 and 218. Carbonylation reactions of primary alkyl iodides are acknowledged in 
the literature but these tend to be sluggish compared to their secondary and tertiary 
counterparts.78,79 For this transformation there are two competing approaches, 
photoirradiation or thermal initiation. Ryu and colleagues reported the carbonylation 
of alkyl iodides 226 in an autoclave with photoirradiation in the presence of a Pd 
catalyst and pressurised carbon monoxide.78 Equally as effective are the thermal 
initiation conditions developed by Komatsu and co-workers that included the reagent 
combination of allyltributyltin, AIBN and 50 atm carbon monoxide (scheme 2-16).80 
Scheme 2-16:  Intramolecular synthesis of lactones via atom transfer carbonylation methods 
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We attempted to replicate these conditions, but due to the absence of an 
autoclave, we performed the reactions with only balloon pressure of carbon 
monoxide. A Rayonet photochemical reactor was used with its emission centred at 
around 254 nm and a pyrex or quartz filter was applied. To our dismay, only 
substrate decomposition or retro-aldol product was detected for substrates 199 and 
206. Study of the literature revealed these types of reactions have much better 
success with more reactive substrates such as aryl halides, allyl halides and 
benzylic halides,81-84 which could be accomplished sometimes under just 
atmospheric pressure of carbon monoxide. Therefore it was not a complete surprise 
that these reactions were ineffective.  
 Additionally, we examined photoirradiation of bis(tributyltin) and instead of 
carbon monoxide, methyl chloroformate was used as a carboxyl radical                    
acceptor,85-87 but this only afforded similar results with no traces of product identified 
by LCMS. As is evident from the outcome of these reactions, further elaboration of 
iodo-aldol products 199 and 206, was not as straightforward as expected. We 
attributed the low reactivity at C10 to the extreme steric congestion making any type 
of nucleophilic displacement process near impossible. It was at this stage that we 
decided to consider a cyano-aldol as a replacement for the iodo-aldol cyclisation, 
which would introduce the required functionality to install the γ-lactone. Due to the 
advanced nature of exo-methylene 184 its availability was limited and for that 
reason, we chose to resynthesise starting materials. This provided the opportunity to 
develop a more efficient route to starting materials that would deal with the 
protecting group issues previously discussed (cf. Section 2.3.2). NMR 
characterisation spectra for select compounds along this route are presented in the 
appendix. 
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3 Synthesis of the Tricyclic Cores of Anislactones A/B 
and Merrilactone A 
A cyanide variant of the iodo-aldol cyclisation reaction was investigated after the 
shortcomings of attempts at further functionalising iodo-aldol products 199 and 206. 
In contrast to having iodide as the nucleophile, cyanide will, in one-pot, install the 
necessary functionality to deliver the γ-lactone A-ring without any need for further 
carbon homologation. Additionally, if left in place during the ethyl iodide deprotection 
sequence, the cyanide could undergo in situ lactonisation/hydrolysis without any 
need for a pre-hydrolysis to the carboxylic ester. Incorporating the cyano-aldol 
reaction into the synthesis did not require any significant modifications to the original 
retrosynthesis but it did, however, provide an ideal opportunity to improve our route 
to starting materials.  
3.1    Morita–Baylis–Hillman Route to Cyclopentenone Starting Materials 
Although our previous route to cyclopentenone intermediate 173 was successful, it 
was not as efficient as we would have liked, since it was plagued with 
regioselectivity protection issues and purification problems during scale-up. We first 
attempted to address these issues by adapting methodology previously used by 
Nicolaou and co-workers in their total synthesis of sporolide B (Scheme 3-1).88  
In Nicolaou’s synthesis, the Luche reduction89 of enantiomerically pure 
iodoenone 228 afforded 229 and after subsequent benzylation, gave vinyl iodide 
230 in excellent yield. Next, a carboxymethylation of the latter compound under 
palladium-catalysed conditions and balloon pressure of carbon monoxide led to 
methyl ester 231. It was this final transformation that grabbed our attention, since 
this could be applied to our own synthesis which would allow the stepwise 
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introduction of both allylic alcohols, eliminating any requirement for regioselective 
alcohol protection. 
Scheme 3-1:  Functionalisation of 228 by Nicolaou et al. in the synthesis of sporolide B               
 
a) NaBH4, CeCl3·7H2O, MeOH, −78 C; b) BnBr, NaH, THF, 0 C, 95% (two steps); c) [PdCl2(PPh3)2], 
NEt3, CO (balloon pressure), MeOH, 70 C, 95%. 
In our attempt at implementing this methodology, we started with the acid-promoted 
Bac-Piancatelli90 rearrangement of commercially available furfuryl alcohol 232, 
forming cyclopentenol 233, which after subsequent protection as the TES ether 
under standard conditions, yielded 234 in 48% yield over two steps (Scheme 3-2).91 
Next, α-iodination88,92 of 234 by means of iodine in DCM:pyridine resulted in the 
formation of iodoenone 235. Unfortunately repeated attempts at the addition 
between iodoacetal 147 and iodoeneone 235 under conditions previously 
demonstrated (cf. Scheme 2-5) were unsuccessful. A mixture of unidentifiable 
products was seen and no product could be isolated cleanly form the reaction 
mixture. The presence of the iodide functional group in the substrate likely 
complicated matters as it too could undergo lithium exchange with the formed 
organometallic nucleophile leading to a multitude of undesirable side-reactions. This 
was a major disappointment since it was anticipated that, had the key addition been 
effective, the subsequent palladium-catalysed carbonylation and ester reduction 
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Scheme 3-2:  Attempted new route to starting materials via a palladium-catalysed 
carbonylation reaction 
 
a) hydroquinone, sodium phosphate buffer, 1,4-dioxane, H2O, pH 4.1, reflux, 60%; b) TESCl, DMAP, 
NEt3, DCM, RT, 80%; c) I2, DCM:Pyridine, RT, 57%; d) 147 
t
BuLi, Et2O, −78 C. 
Fortunately, success was later achieved with the Morita–Baylis–Hillman64,93,94 
reaction of 239 obtained from the TBS protection of the Bac-Piancatelli 
rearrangement product 233 (Scheme 3-3). Modified conditions from the work of 
Gatri and El GaIed95 were adopted for the MBH reaction. Gratifyingly, exposure of 
239 to imidazole and excess formaldehyde over 6 days at room temperature 
resulted in the formation of primary alcohol 240 in moderate yield with a small 
amount of unwanted dialkylated by-product 241. The extended reaction time was 
necessary to achieve the reported yields and any attempts to accelerate the reaction 
via elevating the temperature only resulted in the attenuation of 240.  
Scheme 3-3:  Morita–Baylis–Hillman route to starting materials                                                                                                        
 
a) hydroquinone, NaH2PO4, H2O, 1,4-dioxane, pH 4.1, reflux, 60%; b) TBSCl, DMAP, NEt3, DCM, 
reflux, 85%; c) HCOH, imidazole, THF:H2O (1:1), RT, 40% 240 and 11%  241 . 
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Next, we attempted a protection of the most recently formed primary alcohol with an 
orthogonal benzyl protecting group (Scheme 3-4). Previous experience with 
substrate decomposition directed us towards introduction of the benzyl group under 
neutral or acidic conditions rather than the relatively harsh basic conditions of the 
Williamson ether synthesis (cf. Section 2.3.2). In addition to benzyl 
trichloroacetimidate,53,54 we examined the feasibility of using                                              
2-benzyloxy-1-methylpyridinium triflate,96 a reagent used for benzyl protection under 
comparatively neutral conditions. However, in our hands both methods were 
ultimately unsuccessful with either poor conversion to the desired benzyl-ether 242 
or bis-benzylated 243 as the only isolatable product. Under both conditions,                   
bis-benzylated 243 by-product was obtained suggesting that the reaction conditions 
must have been sufficiently acidic to cleave the TBS group in situ with subsequent 
re-protection as the benzyl ether.  
Scheme 3-4:  Attempts at protection of the primary alcohol   
 
a) Method A: 2-benzyloxy-1-methylpyridinium triflate, MgO, PhCF3, 85 C, 15% 242 and 50% 243;                
b) TBDPSCl, imidazole, DMAP, DMF, RT, 74%; c) Method B: benzyl trichloroacetimidate, TfOH, 
cyclohexane:DCM (2:1), RT, 16%. 
This set of results directed us to select the TBDPS group due to its robust stability, 
as its removal was planned much later towards the end of the synthesis and the 
ability to deprotect the TBS ether in its presence under mildly acidic conditions. 
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Therefore, simple protection of the allylic alcohol as a TBDPS ether provided 
cyclopentenone 244 in an overall yield of 14% over 4 steps. Even with the moderate 
yield of the MBH reaction, this synthetic sequence offers considerable advantages 
over the previous cyclopentenone-diol route (Section 2.3.2). Firstly, the overall 
number of steps in the sequence is reduced by two and more importantly the MBH 
reaction was ideal for scale-up; multigram batches of crude product could be pooled 
together and purified without difficulty. 
3.2    Synthesis of the Cyano-Aldol Cyclisation Substrate 
At this juncture, we decided to attempt to remove the TBS group first and then 
perform the key addition step on the free alcohol 173 (Scheme 3-5). This order of 
transformations was chosen to avoid ketal deprotection during the DDQ-mediated 
TBS removal.97 We were pleased to find that treatment of 251 with DDQ63 brought 
about the clean deprotection of the TBS ether and left the TBDPS group untouched 
furnishing secondary alcohol 173 in 85% yield. We were now set for the key addition 
which began with the generation of the organometallic nucleophile from iodoketal 
147 and tert-butyllithium in Et2O at −78 C. This was later transferred to a solution of 
173 at −78 C, resulting in the formation of tertiary alcohol 245 in good yield as an 
inseparable 6:1 mixture of diastereomers. At present, the facial selectivity of the 
addition could not be confidently determined from the analysis of the 2D-NOESY 
spectrum. However, the assignments indicated below in Scheme 3-5 were based on 
the elucidation of stereochemistry at a later stage (vide infra) and were assigned 
retrospectively (cf. Section 3.5.3). Subsequent DMP oxidation of the secondary 
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Scheme 3-5:  Key nucleophilic addition and synthesis of tertiary alcohol intermediate 246                                                                                          
 
a) DDQ, THF:H2O (9:1), 40 C, 85%; b) 147, 
t
BuLi, Et2O, −78 C to RT, 72%, d.r. 6:1; c) DMP, 
NaHCO3, DCM, RT, 92%. 
Next, we investigated the potential of performing the methylenation on 246 using 
Eschenmoser’s salt with the free alcohol, but unfortunately even after numerous 
attempts at chromatographic purification, we could only obtain an impure mixture of 
247 and unreacted starting material 246 in an approximate yield of 27% (Scheme 3-
6). Moving forward, we decided upon TES protection of the sterically hindered 
tertiary alcohol using the reactive TESOTf in DMF at RT which afforded 248 in 
excellent yield. Methylenation of 248 using Eschenmoser’s salt in THF at −78 C to 
RT, followed by elimination of the Mannich base product with mCPBA98 gave the 
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Scheme 3-6:  Exo-methylene formation using Eschenmoser’s salt                                                                                              
  




, THF, −78 C to RT; ii) mCPBA, DCM:NaHCO3 (2:1), RT, 27% (two steps);    




, THF, −78 C to RT; ii) mCPBA, 
DCM:NaHCO3 (2:1), RT, 85% (two steps). 
3.3   Intramolecular Cyano-Aldol Cyclisation Reaction 
Although halo-aldol MBH-type processes have generated much chemical interest, 
there has been no reported examples of cyano-tandem aldol or MBH-type 
processes in the literature making this transformation of particular interest. We first 
had to select an appropriate cyanide source for the conjugate addition and decided 
to familiarise ourselves with the Michael addition before attempting the cyclisation. 
Our first effort using tetrabutylammonium cyanide resulted in no observable reaction 
with full recovery of starting materials (Scheme 3-7). Switching to diethylaluminium 
cyanide, a reagent used in the Nagata hydrocyanation reaction,99 immediately 
garnered success affording a 1.1:1 separable mixture of diastereomers 251 and 
252, in a combined yield of 66%. The NOESY spectrum for 251 revealed strong 
correlation peaks between the single proton at C9 and the methylene protons of the 
TES protecting group. The absence of such interactions for 252 established the 
relative stereochemistry at C9 for both diastereomers and confirmed the 
stereochemical assignments given below. Next, we attempted the same procedure 
on ketone 205 which yielded the Michael adduct 253 as the only diastereomer. No 
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traces of cyano-aldol cyclisation products were detected by TLC or LCMS in any of 
these examples. This demonstrates that a strong Lewis acid such as TiCl4 is 
required to activate the ketone/ketal for the intramolecular cyclisation to proceed.  
Scheme 3-7:  Examination of the feasibility of a cyano 1,4-conjugate addition reaction                                                  
 
a) Bu4NCN, DCM, RT; b) Et2AlCN, DCM, RT, 66%, d.r. 1.1:1; c) Et2AlCN, DCM, RT, 57%. 
We attempted the cyano-aldol cyclisation using the same procedure used in                   
iodo-aldol cyclisation (cf. section 2.3.4) but replacing tetrabutylammonium iodide 
with diethylaluminium cyanide. Interestingly, this only led to rapid decomposition of 
the substrate to a complex mixture of unidentifiable products. Knowing the cyano 
conjugate addition proceeded well with the substrate 249 in the absence of TiCl4 as 
a Lewis acid, we decided to modify the procedure by changing the addition order of 
TiCl4 and diethylaluminium cyanide. First, treating a solution of 249 in toluene at           
0 C with diethylaluminium cyanide, followed in 10 mins by the addition of a solution 
TiCl4 in toluene, resulted in a separable 15:1 diastereomeric mixture of 254 and 255 
with a good overall yield of 77% (Scheme 3-8). 
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Scheme 3-8:  Key intramolecular tandem cyano-aldol cyclisation reaction                                                                                                       
 
a) Et2AlCN, TiCl4, toluene, 0 C, 77% combined, 72% 254, 5% 255, d.r. 15:1. 
The diastereoselectivity for the cyclisation was expected to be the same as the iodo-
aldol cyclisation with ketal 184 as the substrate (cf. Scheme 2-10), and indeed this 
was the case. Analysis of the 2D NOESY data of syn-254 revealed nOe signal 
enhancements between C15 and a single C10 methylene proton, which is in 
agreement with the previous NOESY data obtained for syn-199. Likewise, NOESY 
analysis of anti-255 showed strong nOe effects between the C15 methyl and both 
the C10 methylene protons, which closely matches the nOe signal enhancements 
observed with anti-200 (Figure 3-1).  
Figure 3-1:  nOe signals observed for cyano-aldol cyclisation products syn-254 and              
anti-255 
 
With major diastereomer 254 isolated as a solid, we were fortunate enough to obtain 
single crystals after slow evaporation, which were used for X-ray crystallographic 
analysis (Figure 3-2). 
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Figure 3-2:  X-ray crystal structures for cyano-aldol product 254 
 
The crystal structure for major diastereomer 254 visibly shows the desired anti 
stereochemical relationship between the C15 methyl and the C10 methylene 
groups. No crystalline forms could be obtained for minor diastereomer 255 as it is a 
viscous oil. Even without a crystal structure for 255, the extensive NOESY analysis 
of both diastereomers combined with the conclusive proof from the X-ray crystal 
structure of the other diastereomer 254, undoubtedly confirmed the stereochemical 
assignments given above.  
The triad of stereocentres at C1, C4 and C9 have now been installed with 
the required relative stereochemistry. Incorporation of the cyanide functional handle 
in 254 during the key cyclisation was intended to side-step the problems 
encountered with the one-carbon homologation attempts of 199 and 206 (cf. Section 
2.3.5). It was anticipated that the introduced cyanide functional handle would be 
more open to further elaboration. Its susceptibility to hydrolysis would allow the 
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3.4   In-Situ Lactonisation to Tricyclic ABC Core of Anislactones A/B 
Turning our attention to the installation of the γ-lactone A-ring, we decided to press 
forward in the synthesis with bicycle 254. We first wanted to explore the prospect of 
leaving the cyano group in place to undergo an in situ cyclisation/hydrolysis during 
the ethyl iodide deprotection sequence. Functional group conversion of 254 from the 
primary alcohol 254 to ethyl iodide 256 proceeded smoothly leading us to attempt 
the one-pot ethyl iodide deprotection and in situ lactonisation sequence. We first 
attempted the ethyl iodide deprotection in the absence of water, which meant the 
only products we would expect to observe are the tertiary alcohol or cyclisation to an 
imidate. Interestingly, only reduction product 257 and unreacted starting material 
were observed with no trace of lactone 258 or the formation of an imidate (Scheme 
3-9).  
Scheme 3-9:  Synthesis of the tricyclic core of anislactones A/B                                                            
 
a) I2, imidazole, PPh3, DCM, RT, 94%; b) Zinc dust,
100
 MeOH, 50 C, 44%; c) Zinc dust,
100
 THF:0.1 M 
AcOH (9:1), reflux, 89%. 
Our efforts then focused on optimising the conditions for the one-pot ethyl iodide 
deprotection and in situ cyclisation/hydrolysis sequence. It was immediately found 
that refluxing ethyl iodide 256 with activated zinc dust100,101 in a solvent mixture of 
THF:0.1M acetic acid (9:1) resulted in the clean formation of the desired γ-lactone 
258 in a very good yield of 89%. We were pleased to find that 258 was formed as a 
solid, and after slow evaporation in a solvent combination of hexane and DCM, 
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single crystals were formed and used for X-ray crystallographic analysis. It is evident 
from the X-ray crystal structure of 258 as shown in Figure 3-3, that the tricyclic core 
has the desired relative stereochemistries at C1, C4 and C9, confirming the 
stereochemical assignments given above. 
Figure 3-3:  X-ray crystal structure of 258, the tricycle core of anislactones A/B 
 
This represented a significant milestone in our synthesis as the tricyclic core of 
anislactones A/B had been accomplished in 13 synthetic steps. With three of the 
four rings of anislatones A/B now formed, 258 was then taken forward towards the 
next crucial transformation, a stereospecific Stork radical addition.50 
3.5    Attempts at Formation of the C5 Quaternary Stereocentre  
3.5.1    Stereospecific Stork silicon tethered radical addition 
Having now secured the synthesis of the tricyclic core 258, the next challenge was 
to introduce a methyl group stereospecifically forming the critical C5 quaternary 
stereocentre. We intended to perform a stereospecific Stork silicon-tethered radical 
addition to the enone and we envisioned the end-game strategy for the synthesis of 
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Scheme 3-10:  Envisioned synthetic sequence for Stork radical addition to enone and end-
game strategy for anislactones A/B                                                                                                             
 
a) TBAF; b) ClCOOMe, NEt3; c) BrCH2SiMe2Cl, NEt3; d) Bu3SnH, AIBN, PhH; e) NaH; f) TBAF;            
g) NaH, MeI; h) NaBH4. 
A global silyl deprotection of 258 was expected to proceed without difficulty followed 
by regioselective carbonate formation of the more sterically accessible primary 
alcohol to furnish 260. Next, the silicon tether would be introduced by standard 
procedure, setting the stage for the stereospecific radical addition to the enone. The 
relatively low sensitivity of radical additions to steric hindrance was anticipated to 
facilitate, what would otherwise be, a very inaccessible Michael addition. Following 
this critical formation of the C5 quaternary stereocentre, the lactone could be built 
using well precedented alkylation chemistry.102 A critical step is the fluoride-cleavage 
of the silicon tether to afford the C13 methyl group in 263. This is a less common 
application of the silicon-tethered radical addition, but it has precedent in Stork’s 
own research.103 The methylation is expected to approach from the more accessible 
convex face followed by a reduction of the hindered ketone. As anislactones A/B are 
epimeric at C7 of the ketone then the diastereoselectivity of the reduction would 
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have little importance as it will likely lead to a successful total synthesis of at least 
one or both of anislactones A and B.  
 We expected the global silyl deprotection of 258 to be a straightforward 
transformation, but surprisingly we encountered a number of difficulties associated 
with substrate instability to basic reaction conditions and the formation of several 
unidentifiable side-products (Figure 3-4). 
Figure 3-4:  Screening of reaction conditions for silicon protecting group removal 
 
Conditions Result 
TBAF, THF, RT, 24 hr 
Substrate decomposition and           
side-products 
5% HF:pyridine (7:3), THF, RT, 24 hr 
264,  265 and                              
side-products 
AcOH:THF (1:1), TBAF (4 equiv), RT, 24 hr No reaction 
AcOH:THF (1:1), TBAF (4 equiv), reflux, 24 hr 
SM, 264, 265 and                         
side-products 
48% Aq HF:MeCN (1:6), 50 C,  Substrate decomposition 
0.5 M HCl, THF, RT, 24 hr 
264, SM and unknown                             
side-products 
0.5 M HCl, THF, reflux, 2 hr  264, 265 and side-products 
0.05 M HCl,  THF, reflux, 7 hr 71% 264  
 
Initial efforts began with the standard TBAF silyl deprotection conditions which 
resulted in only substrate decomposition and significant amounts of unidentified     
by-products — none of the expected possible products 259, 264 and 265, were 
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observed. Switching to 5% HF:pyridine resulted in less decomposition, but 
unfortunately a mixture of products remained and as seen previously, no formation 
of 259 could be seen. We envisaged better success with the use of TBAF buffered 
with AcOH,58 but when conducted at room temperature, mostly starting materials 
remained. Elevating the temperature resulted in a mixture of products with 
significant quantities of starting materials left even after 24 hr and no formation of 
the desired 259 was detected.  
These first set of observations made us turn our attention to acidic reaction 
conditions in the expectation that we would be able to selectivity remove the TES 
protecting group. Carrying out the reaction in THF with 0.5 M HCl led to the selective 
removal of the TES group leaving the TBDPS in place, but after 24 hr substantial 
quantities of by-products were observed together with unreacted starting materials. 
Elevating the reaction temperature led to the full consumption of starting materials 
but additional by-products were seen. However, this was encouraging, and finally 
refluxing 258 under less acidic conditions using 0.05 M HCL in THF over 7 hr, 
afforded TES deprotected 264 in a good 71% yield.  
 Having selectively uncapped the tertiary alcohol, we were now ready to 
install the required silicon tether. We chose to explore two possible paths, A and B, 
to the key intramolecular radical addition; the first being with the TBDPS group left in 
position; the second with a methyl carbonate in place of the TBDPS ether (Figure 3-
5). Our incentive to remove the TBDPS ether was to reduce the steric congestion 
around the ß-carbon at C5 of the cyclopentenone, as this may adversely impact the 
ease at which the radical cyclisation proceeds. The substrates for the radical 
addition, 266 and 270, were prepared via a set of relatively routine transformations. 
For 266 this included the capping of the free tertiary alcohol with the silicon tether 
whist carbonate 270 was obtained from 264 via a three step sequence of TBDPS 
deprotection under acidic HF:MeCN104 conditions, carbonate formation and 
subsequent installation of the silicon tether. Attempts at the standard fluoride-
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cleavage of the TBDPS group met with failure as only substrate decomposition was 
initially observed by TLC and LCMS analysis. 
Figure 3-5:  Attempts at the silicon tethered Stork radical addition on 266 and 270                                                                                                                                 
a) BrCH2SiMe2Cl, imidazole, DMAP, DCM, reflux, 95%; b) 48% Aq HF:MeCN (1:5), 50 C, 89%;                      
c) ClCOOMe, NEt3, DMAP, THF, reflux, 82%; d) BrCH2SiMe2Cl, imidazole, DMAP, DCM, reflux, 82%. 
Conditions Result: Path A Result: Path B 
Bu3SnH (1.5 equiv), AIBN (0.2 equiv), 
degassed benzene, toluene or 
t
BuOH, 
80 C, 0.004 M to 0.02 M under Argon, 
24 hr 
SM decomposition, 
unknown                    
side-products 
SM and unknown                                        
side-products 
Bu3SnH (1.5 equiv), AIBN (0.2 equiv, 
slow addition over 8 hr), degassed 
benzene or toluene, 80 C, 0.02 M, 
under Argon, 24 hr 
SM, unknown                  
side-products  
No reaction 
Bu3SnCl (0.2 equiv), NaCNBH3 (2 
equiv), AIBN (0.2 equiv), 
t
BuOH, reflux 
SM consumed,              
side-products 
SM consumed,             
side-products 
(Bu3Sn)2, sunlamp, benzene, 80 C,           
24 hr 
SM and unknown 
side-product 
SM and unknown  
side-products 
Mg, I2, THF, RT to 50 C 
Unknown                     
side-products 
Unknown                          
side-products 
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Due to the highly advanced nature of these substrates, their availability was very 
limited and for that reason, the reactions were conducted on a very small scale 
ranging from 1 to 10 mg. Numerous attempts at the radical addition to the enone of 
both substrates 266 and 270 were conducted using the original conditions reported 
by Stork and colleagues.50,103 Treatment of either substrate with AIBN, Bu3SnH in 
one portion or slow addition over several hours and heated in a variety of solvents, 
led to substrate decomposition and unidentified side products. The isolation and 
purification of any products were complicated by the presence of tin-related 
byproducts, even after attempting to remove them by filtration following the common 
practice of a caesium fluoride workup.105  
The side-products were difficult to identify by 1H NMR due to presence of            
tin-related impurities that complicated the NMR spectrum. We did suspect that 
dehalogenation could be a competing reaction and thus, we investigated the in situ 
catalytic generation of Bu3SnH using a procedure again developed by Stork.
103,106 
The use of catalytic quantities of Bu3SnCl in combination with NaCNBH3 would 
result in the production of Bu3SnH in low concentration. This has a number of 
benefits including a reduction of hydride transfer and thus dehalogenation, and a 
significant reduction in the amount of tin species making the purification process 
less problematic. To our disappointment, no such improvement was found and only 
unidentifiable side-products were detected by LCMS analysis. We attempted to 
avoid tin hydrides altogether by using bis(tributyltin) to produce the requisite tin 
radicals, but unfortunately after subsequent sunlamp irradiation similar 
unsatisfactory results were obtained. Finally, we investigated the formation of a 
Grignard from the alkyl bromide of the silicon tether which was expected to 
immediately perform a stereospecific conjugate addition to the enone. This reaction 
consumed starting materials, but afforded just byproducts that were unable to be 
identified.  
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At this stage, the Stork radical addition was abandoned and our next aim 
was to find a path forward using the remaining limited quantities of advanced 
intermediate 264.  
3.5.2    1,4-Conjugate additions to Anislactone A/B tricyclic core 
A common method for the introduction of substituents to the ß-carbon of enone-type 
systems is the Michael addition. This has widespread use as a classic C–C bond 
forming reaction in organic synthesis and is able to generate tertiary and quaternary 
stereocentres. There are a variety of reagents that are commonly used in such 
transformations such as Grignard, dialkylzinc, organolithium, trialkylaluminium 
reagents and organocuprate species such as Gilman’s reagent.107-110 We decided to 
investigate the prospect of introducing the methyl substituent via a conjugate-type 
reaction, expecting the nucleophile to approach selectively from the more accessible 
exo-face due to either sterics or because of the potential directing effect of the 
tertiary alcohol at C4. There is literature precedent for the alcohol-directed syn-
addition of Grignards111,112 and trialklyaluminiums113-115 to structurally similar 
cyclopentenone substrates. As shown below in Figure 3-6, we performed an 
extensive screen of reagents and reaction conditions for the 1,4-addition of a methyl 
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Figure 3-6: Attempts at methyl 1,4-conjugate addition to enones 264, 268 and 269 
 
Entry Conditions Result 
1 MeMgBr, THF or Et2O, RT or reflux No reaction 
2 




MeMgBr, CuI or CuBrSMe2, THF or 
Et2O, RT to reflux 
No reaction 
4 AlMe3, toluene, −78 C to RT, No reaction 
5 
AlMe3, Ni(acac)2 or Cu(OTf)2, toluene or 
THF, −78 C to RT, 
No reaction 
6 
Zn(Me)2, Ni(acac)2 or Cu(OTf)2, THF, 
Et2O or toluene 
No reaction 
7 MeLi, CuI, THF or Et2O, −78 C to RT, 
SM consumed and complex 
mixture 
8 
Me2CuLi, THF or Et2O, −78 C                           
or −45 C to  RT 
No reaction; decomposition 
at higher temperature               
(−45 C) 
Our attempts began with methylmagnesium bromide, hoping that an intramolecular 
chelation-directed delivery of the Grignard species to the ß-carbon of enones 264, 
268 and 269 would yield the desired products.112 Unexpectedly, we observed no 
reaction with only starting materials left untouched, even after adding an excess of 
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Grignard and elevating the temperature (entry 1). The addition of Lewis acid or 
copper salts did not lead to any improvement with unreacted starting materials again 
left behind (entries 2 and 3). Use of trimethylaluminium was investigated next on its 
own or with catalysts, Ni(acac)2
116 or Cu(OTf)2,
117,118 and we were met with the same 
disappointment with no conversion of starting materials, even when treated with an 
excess of trimethylaluminum (entries 4 and 5). Organozinc derivatives are typically 
less reactive but additionally have a tendency to add in a conjugate fashion to                          
α,ß-unsaturated carbonyl compounds in contrast to their relative inertness towards 
saturated ketones. However, when dimethylzinc was employed together with 
Ni(acac)2
119-122 or Cu(OTf)2,
123 only starting materials were identified in the reaction 
mixture by TLC and LCMS analysis (entry 6). Consequently, we made the decision 
to examine the use of more reactive alkylating reagents such as methyllithium and 
Gilman’s reagent, which was prepared from methyllithium and copper iodide.124 For 
the first time we observed the consumption of starting materials with both 
methyllithium and Me2CuLi. With methyllithium in the presence of a catalytic amount 
of CuI at −78 C, we detected only starting materials but ambient temperatures 
resulted in the instant formation of a complex mixture (entry 7). Similarly, treatment 
with Me2CuLi offered no improvement at −78 C and a slight increase in the 
temperature to -45 C resulted in immediate decomposition of the substrate (entry 
8). 
 In summary, we were quite astounded at the stability of the three substrates 
to Grignard, organoaluminium and organozinc reagents, even at elevated 
temperatures. This could be reasoned by the extreme steric congestion at the fully 
substituted C5 carbon, particularly in the case of 264, which has the bulky TBDPS 
group as an element capable of blocking the approach of any nucleophile.  
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3.5.3    Attempts at alcohol-directed cyclopropanation 
As a last effort in progressing carbonate 269 through the synthesis, we examined 
the possibility of a diastereoselective cyclopropanation using the alcohol at C4 as a 
directing group.125,126 First, a Luche reduction of carbonate 269 was required to 
provide a suitable substrate for the cyclopropanation on the isolated trisubstituted 
alkene (Scheme 3-11). The reduction was preferred to be syn-diastereoselective 
with respect to the C4 alcohol but unfortunately, we were not able to ascertain the 
relative stereochemistry of the single diastereomer 275, even with extensive NOESY 
analysis. In the event that the following cyclopropanation successfully afforded the 
desired diastereomer 276, we anticipated that a simple oxidation of the secondary 
alcohol, followed by a regioselective cleavage of the cyclopropyl bond by a 
samarium iodide-induced single electron transfer reaction would selectively furnish 
277.127 The regioselective cyclopropyl bond cleavage was expected because of the 
inherent stability of the formed ketyl radical intermediate.128  
Scheme 3-11:  Directed cyclopropanation approach to the formation of the C5 quaternary 
stereocentre                                                                                                                                                
 
a) NaBH4, CeCl3.7H2O, 0 °C, 64 %, single diastereomer. 
There were limited amounts of 269 available and therefore, we decided to develop 
the cyclopropanation conditions on an earlier intermediate 245 for which we had an 
ample quantity for the optimisation process. Benzyl protection of the secondary 
alcohol of 245 went smoothly, furnishing the desired substrate 278 for the 
cyclopropanation in a respectable 63% yield. We were able to assign the relative 
stereochemistries at C4 and C7 because of the absence of any nOe interactions 
between the benzyl ether at C7 and the dioxolane side-chain at C4 (Figure 3-7). 
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Figure 3-7:  Cyclopropanation model system        
 
a) BnBr, Bu4NI, NaH, THF, RT, 63%.  
Entry Conditions Result 
1 Zn-Cu,
129
 CH2I2, Et2O, reflux 25% yield
a 
2 
Et2Zn, CH2I2, Et2O, DCM or DME/DCM,                       




Si(CH3)3CHN2, CuI, or CuCl, Et2O or 
toluene, RT 
SM and by-products  
4 Sm, HgCl2, CH2I2, THF, −78 C to RT 
SM, traces of product and 
decomposition 
5 Sm, CH2I2, THF, RT No reaction 
a
 Method A was used in the synthesis; 
b
 Method B was used in the synthesis. 
We first explored the well-known Simmons–Smith method for cyclopropanation. One 
of the most important features of the Simmons-Smith reaction is its ability to use 
functional groups containing heteroatoms to direct the cyclopropanation from the 
face of the double bond having closer proximity to the functional group.130 In our 
system, there are two possible functional groups that can exert a directing effect, the 
C4 alcohol and the C7 benzyl ether. The original conditions of Simmons–Smith were 
employed and a single diastereomer of the desired product 279 was furnished in a 
poor 25% yield. Applying the Furukawa modification131,132 using diethylzinc did not 
offer any improvement, furnishing the same 279 in 18% yield (entry 2). Upon 
increasing the amounts of the diethylzinc, no further rise in the yield was observed. 
The use of the diazomethane equivalent, trimethylsilyldiazomethane (entry 3), 
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samarium metal with mercuric chloride128 (Molander modification,133 entry 4) and 
samarium in diiodomethane134 (entry 5) resulted, at best, in the detection of trace 
amounts of product as identified by LCMS. The stereochemistry of cyclopropane 
279 could not be determined as the 2D-NOESY spectrum proved inconclusive but 
we hoped if successful, the NOESY data of tetracycle 276 would be more decisive.  
 The supply of the starting material 245 was depleted after this initial screen 
and even though the yield was not as desirable as we hoped, we nevertheless 
decided to apply the conditions developed above to our late-stage intermediate, 
carbonate 269 (Scheme 3-12).  




 CH2I2, Et2O, reflux; b) Et2Zn, CH2I2, Et2O, 0 C to RT. 
We were met with disappointment as both the conditions of Simmons-Smith and 
Furukawa were fruitless, with no desired product detected by TLC or LCMS analysis 
and only unreacted starting materials remained. This outcome combined with the 
previous attempts at installing the angular methyl at C5 represented a major setback 
to our planned synthesis of anislactones A/B. With three of the four carbocycles of 
anislactones A/B completed, it was very frustrating that we encountered so many 
difficulties in establishing the C5 quaternary stereocentre. The lack of success in the 
attempts at diastereoselective conjugate addition and cyclopropanation reactions 
are perhaps not altogether surprising given the extreme steric congestion around 
the fully substituted ß-carbon of the enone. This was the main driving force behind 
the intramolecular stereospecific Stork radical addition approach which after much 
experimentation was in our hands unsuccessful. 
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It was at this juncture that we decided a modification to the original synthetic 
route was necessary. This new retrosynthesis would still employ the efficient 
intramolecular cyano-aldol reaction, but would incorporate a new strategy for the 
installation of the two angular methyls, creating the C5 and C6 quaternary 
stereocentres. The next chapter shall be concerned with the development of this 
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3.6    Synthesis of the Tricyclic ABC Core of Merrilactone A  
Anislactones A/B and merrilactone A are structurally related as demonstrated by 
Fukuyama during the successful chemical conversion of anislactone B to 
merrilactone A via a simple three-step synthetic sequence (cf. Section 1.5). 
Additionally, the Greaney group syntheses of merrilactone A and anislactone A 
showed that both natural products could be accessed through a regiodivergent 
approach from a common intermediate.25 Careful inspection of the carbon 
frameworks reveals that the ABC tricyclic core for both merrilactone A and 
anislactones A/B differ only in the position of the A-ring lactone as highlighted in 
Figure 3-8. In merrilactone A, the A-ring lactone forms a ring junction with the C-ring 
in contrast to the B ring in anislactones A/B. 
Figure 3-8:  Position of the lactone A-ring in anislactones A/B and merrilactone A 
 
After our effort towards anislactones A/B had come to a temporary halt, we explored 
an opportunity to access the tricyclic core of merrilactone A. The cyano-aldol 
product 254 contains the full carbon skeleton of both ABC tricyclic cores of the 
natural products, enabling a divergent approach to both natural products by 
regioselective formation of the A-ring lactone. We have already successfully 
demonstrated the synthesis of the anislactone tricyclic core, which then led us to 
focus our attention on tackling merrilactone A. It was anticipated that a selective 
TES ether deprotection of 254 could undergo in situ cyclisation/hydrolysis, forming 
the desired A-ring lactone in a one-pot reaction. If this proved unfeasible, then a 
step-wise synthesis of the lactone via a carboxylic methyl ester would be carried out. 
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Our previous experiences with selective silyl deprotections led us to consider the 
Lewis acid BF3·Et2O as a possible selective reagent.
135 
 Subsequent exposure of bicycle 254 with excess BF3·Et2O in DCM at RT led 
to the formation of tricycle 280 in a good 68% yield (Scheme 3-13). We reasoned 
that a trace amount of water in the BF3·Et2O was sufficient to hydrolyse the imidate 
intermediate in situ. It was evident from the TLC that other side-products were 
formed and subsequent LCMS analysis of the crude reaction mixture led to the 
unexpected detection of trace amounts of endo-bicycle 281, exo-bicycle 282,                      
endo-tricycle 283 and exo-tricycle 284.  
Scheme 3-13:  Synthesis of tricyclic core of merrilactone A via either a one-pot multi step 
system or a linear step-wise synthetic sequence                                                                                                                                    
 
a) Method B: BF3·Et2O, DCM, reflux, 13 % 280, 19% endo-281 and exo-282,1:1.5, 7% endo-283  and 
exo-284 (1:0.6), 7% recovered 254; b) Method A: BF3·Et2O, DCM, 30 C, 68%; c) I2, PPh3, imidazole, 
DCM, RT, 73%; d) Zn dust, THF:0.1 M AcOH (9:1), reflux, 65 % yield; e) Burgess reagent, DCM, 
reflux, endo-283 and exo-284, 76%, 1:1.2 mixture of regioisomers. 
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This is an astonishing result and our initial thought was that with careful 
manipulation of the reaction conditions, we could alter the direction of the reaction 
towards the selective formation of the desired endo-tricycle 283. If successful, this 
would represent a one-pot multi-step system incorporating a selective TES 
deprotection, in situ cyclisation followed by subsequent hydrolysis, and selective 
ethane-diol elimination. Using the same procedure but under refluxing conditions in 
DCM, we were able to isolate 280 (13% yield), a 1:1.5 regioisomeric inseparable 
mixture of endo-281 and exo-282 (19% combined yield), a 1:0.6 inseparable mixture 
of regioisomers endo-283 and exo-284 (7% combined yield), and recovered starting 
materials 254 (7% yield). Attempts at more forcing conditions, such as elevated 
temperatures in toluene, resulted in an increasingly complex mixture together with 
the gradual removal of the TBDPS group. Although we were not able to achieve a 
selective and efficient synthesis of endo-283, it did however demonstrate that the 
core of merrilactone A could be synthesised in a very respectable 12 synthetic steps 
via the common intermediate 254. 
 Next, we wanted to establish the step-wise conversion of common 
intermediate 254 into the desired merrilactone A core 283. Continuing from lactone 
280, a conversion of the primary alcohol to an iodide went smoothly, affording 
ethyliodide 285 in a good 73% yield. The well-rehearsed reductive cleavage of 285 
provided tertiary alcohol 286 which, after syn-elimination of the alcohol using 
Burgess136 reagent, furnished an inseparable 1:1.2 mixture of double bond 
regioisomers endo-283 and exo-284, in a combined yield of 76%. Finally, we 
attempted the isomerisation of exo-284 by treatment with p-TsOH·H2O in refluxing 
benzene. Although this increased the regioisomeric ratio from 1:1.2 to 3:1 (endo-
283:exo-284) this was achieved in a disappointing 23% yield (Scheme 3-14). The 
reaction was monitored by LCMS and from the analysis of these data we were able 
to attribute the poor yield to the instability of the TBDPS group under the refluxing 
acidic conditions.  
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Scheme 3-14:  Double bond isomerisation of an inseparable diastereomeric mixture of                  
endo-283 and exo-284                                                                                                 
 
a) p-TsOH, benzene, reflux, 23% endo-283:exo-284 (3:1). 
Further elaboration of 283 was not possible because of the limited supply of 
advanced material and knowing that we may have faced similar difficulties to those 
previously encountered enroute to anislactones A/B. Additionally, we needed to 
factor sufficient research time for our proposed modified synthetic route to both 
natural products. Even so, we have now successfully demonstrated that the tricyclic 
cores of anislactones A/B and merrilactone A can be accessed via a common 
intermediate. Furthermore, we discovered an unexpected one-pot reaction of the 
common BC ring intermediate 254 to the tricyclic ABC core 283 which would 
otherwise require several linear synthetic transformations if conducted in a step-wise 
manner. NMR spectra for select compounds along both the anislactone A/B and 
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4 Formal Synthesis of Merrilactone A and the Carbon 
Skeleton of Anislactones A/B  
A modification to our synthetic plans was required to advance our research. It was 
the introduction of the C5 quaternary stereocentre that had halted our progress, and 
we endeavoured to first address this challenge. The successful cyano-aldol 
cyclisation reaction was to remain a key part of the newly proposed synthetic route 
which meant that any changes would have to be compatible with this transformation. 
We decided upon incorporating a [2+2] photocycloaddition, adapted from Mehta’s 
synthesis of merrilactone A,22 as a possible method for the late-stage introduction of 
both C5 and C6 quaternary stereocentres. Such an approach would be amenable to 
the synthesis of both sets of natural products, but it would it would undoubtedly 
require the synthesis of different starting materials.  
4.1  Retrosynthetic Analysis 
In our proposed retrosynthesis, we envisaged the BC intermediate from the product 
of the key cyano-aldol cyclisation 289 would enable regiodivergent synthesis of both 
anislactone A/B and merrilactone A (Scheme 4-1). Bicycle 289 has the complete 
carbon framework of the tricyclic ABC cores of both sets of natural products and 
could be directed to either via orthogonal lactonisation sequences. Beginning with 
merrilactone A (1), we expect the well-established two-step sequence 
transformation of 32 to merrilactone A via stereoselective epoxidation and 
subsequent homo-Payne rearrangement to proceed without difficulty.17,23 The 
substrate for this two-step sequence would be available from selective lactonisation 
and oxidative cleavage of cyclobutene 287 installing the γ-lactone D ring. Next, a 
crucial diastereoselective late-stage [2+2] photocycloaddition of tricycle 288 with 
dichloroethylene was envisaged to give the desired diastereomer. This represents 
the most significant change to our previous approaches and has literature 
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precedence on structurally related substrates in Mehta’s synthesis of merrilactone A 
and related model studies.22,26 The tricyclic substrate 288 for this reaction would in 
turn be available from the previously developed Lewis acid treatment of BC common 
intermediate 289. If unsuccessful, a feasible backup would be a stepwise sequence 
of transformations. In a similar fashion, anislactones A/B could be obtained from 
cyclobutene 291 via oxidative cleavage and selective lactonisation. Cyclobutene 291 
would in turn be accessed by a [2+2] photocycloaddition of tricycle 290, which is 
hoped to be selective for the required diastereomer 291. The installation of the        
γ-lactone A-ring was then envisioned to be achieved by the familiar procedure of 
zinc-mediated reductive cleavage and in situ lactonisation of BC intermediate 289. 
The key intramolecular cyano-aldol cyclisation reaction of exo-methylene 292 would 
provide BC bicycle 289, which represents the common intermediate used for the 
regiodivergent synthesis of both natural products. The substrate for the cyano-aldol 
cyclisation would itself be prepared from the 1,2-nucleophilic addition between 
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Scheme 4-1:  Retrosynthetic analysis for the regiodivergent approach to merrilactone A 
 and anislactones A/B 
 
4.2    Synthesis of the Cyano-Aldol Cyclisation Substrate 
In our new strategy towards both anislactones A/B and merrilactone A, we had to 
synthesise new starting materials. Fortunately, the desired dimethylcyclopentenone 
293 is a literature compound prepared via a straightforward two-step synthesis.137 
Thus, treatment of 294 with aqueous KOH for six days, followed by bubbling carbon 
dioxide and the addition of pyruvaldehyde into the reaction afforded 1,4-diketone 
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295 in moderate yield (Scheme 4-2). Addition of potassium carbonate to a solution 
of diketone 295 in MeOH whilst ensuring the internal temperature did not exceed      
8 C, successfully afforded the desired dimethylcyclopentenone in a good 72% yield. 
Subsequently, a routine TES ether formation followed by organolithium addition of 
the prepared iodoacetal 147 cleanly furnished tertiary alcohol 298 as a single 
diastereomer. The bulky TES ether group at the C4 stereocentre efficiently 
controlled the facial selectivity of the organolithium addition, transferring 
stereochemistry to C7. The assigned stereochemistry is a result of extensive 
NOESY analysis that revealed key nOe signal enhancements between CH at C4 
and the introduced ketal side chain. The absence of any nOe interactions between 
the TES group at C4 and the ketal supported the stereochemical assignments 
assigned below.  
Scheme 4-2:  Synthesis of the key cyano-aldol cyclisation substrate 302                                                    
 
a) KOH, H2O, CO2, 4 C to RT, then pyruvaldehyde 58%; b) K2CO3, MeOH, 0 C to RT, 72%; c) 
TESCl, NEt3. DMAP, RT, 89%; d) 147, 
t
BuLi, Et2O, −78 C, 86%; e) TCNQ, THF:H2O (9:1), RT, 51%; f) 





, THF, −78 C to RT; ii) mCPBA, DCM:NaHCO3 (2:1), RT, 65% (two steps). 
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We first attempted a TCNQ cleavage of the TES ether, a procedure successfully 
used on a structurally related substrate (cf. Scheme 2-5). Unexpectedly, we did not 
detect any desired product but instead were able to isolate an intriguing by-product 
in 51% yield which we characterised to be enone 299. This surprising outcome 
seems to be a result of a number of different transformations including silyl 
deprotection, oxidation and reduction in the same step. We were not able to propose 
a reasonable mechanism but this reaction would perhaps warrant further 
investigation. Switching to the one-pot reaction of standard fluoride-cleavage of the 
TES group and immediate TPAP oxidation yielded tertiary alcohol 300 in an 
excellent 93% yield over two steps. Finally, TES protection of the hindered tertiary 
alcohol 300 and subsequent methylenation using Eschenmoser’s salt and 
consecutive mCPBA elimination, furnished the cyano-aldol substrate 302 in a yield 
of 65% over two steps.  
 Pleasingly, we were thus able to demonstrate the viability of the new 
synthetic route using different starting materials in the synthesis of exo-methylene 
302, a suitable substrate for the upcoming crucial cyano-aldol cyclisation.  
4.3    Intramolecular Cyano-Aldol Cyclisation Reaction 
With the stage now set for the key cyano-aldol reaction, we were pleased to 
discover that treatment of 1,1-disubstituted alkene 302 with diethylaluminium 
cyanide followed by TiCl4 at −20 C successfully afforded a separable 7:1 mixture of 
diastereomers 303 and 304 in a 70% combined yield (Scheme 4-3). Our previous 
experiences with the cyano-aldol reaction (cf. Section 3.3) meant that we expected 
major diastereomer 303 to have the desired relative stereochemistry at the newly 
formed triad of stereocentres C1, C4 and C9.  
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Scheme 4-3:  Key intramolecular tandem cyano-aldol cyclisation reaction                                                             
 
a) Et2AlCN, TiCl4, toluene, 0 C, 70% combined, 62% 303, 8% 304, d.r. 7:1. 
X-ray crystallography proved unfeasible, as diastereomers 303 and 304 were both 
formed as oils. To confirm our predictions, we attempted to determine the relative 
stereochemistry of both diastereomers by means of extensive 1D and 2D-NMR 
spectroscopy. Using 1D-1H-NMR, 13C-NMR, and DEPT, as well as COSY, HSQC 
and HMBC 2D correlation spectroscopy allowed us to assign all the proton and 
carbon signals observed. Unfortunately, analysis of the NOESY spectrum was 
inconclusive and thus, we were not able at this stage to assign the relative 
stereochemistry of both diastereomers (the stereochemical assignments 
represented in Scheme 4-3 were confirmed at a later stage and are assigned 
retrospectively). Nevertheless, we were fortunate that the fluoride-cleavage of the 
TES ether of major diastereomer 303 led to diol 305 as a solid (Scheme 4-4).  
Scheme 4-4:  Formation of a single crystal of 305 for X-ray analysis                                                                        
 
a) TBAF, THF, RT, 82%. 
This allowed us to obtain a single crystal for X-ray crystallographic analysis that 
would provide the absolute proof of its stereochemistry and its progenitor 303 
(Figure 4-1). As highlighted in the crystal structure, the important C15 methyl and 
C10 CH2CN substituents have the desired anti stereochemical relationship, which is 
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in agreement with our predictions and the previous stereochemical assignments of 
diastereomers 303 and 304.  
Figure 4-1:  X-ray crystal structure of TES deprotected cyano-aldol product 305 
 
4.4    Synthesis of the Carbon Framework of Anislactones A/B 
4.4.1    [2+2] Photocycloaddition 
With the key cyano-aldol cyclisation reaction now established, we began to move 
towards the crucial [2+2] photocycloaddition. We first employed the previously 
developed methodology to obtain the tricyclic substrate 307 for the cycloaddition (cf. 
Section 3.4). Opening with the cyano-aldol product 303, we were able to simply 
obtain ethyl iodide 306 which was then subjected to zinc-mediated reductive 
cleavage conditions (Scheme 4-5). This resulted in the same pot, clean deprotection 
of the ethyliodide, in situ cyclisation and subsequent hydrolysis, yielding the 
anislactone tricyclic core 307 in a very good 87% yield. Without the possibility of 
complications observed for diprotected 258 (cf. Figure 3-4), TBAF treatment of 
tricycle 307 cleanly removed the TES group yielding 308 containing the fully 
established stereocentres at C1, C4 and C9. With the substrate 307 for the crucial 
photocycloaddition in hand, we proceeded to examine the potential of this [2+2] 
305 
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cyclisation reaction in the hope that the TES group would impart the necessary 
steric hindrance resulting in the desired facial selectivity for the cycloaddition.  
Scheme 4-5:  Synthesis of key [2+2] photocycloaddition substrate 307                                                                                                                             
 
a) I2, PPh3, imidazole, DCM, RT, 94%; b) Zn dust, THF:0.1 M AcOH (79:1), reflux, 87%; c) TBAF, THF, 
RT, 97%. 
Our first attempts were based on methodology published in Mehta’s synthesis of 
merrilactone A, but exact details of the conditions employed were not available from 
the available supporting information.22 A medium-pressure mercury vapour lamp 
was used as the initial irradiation light source. The spectral output of mercury arc 
lamps ranges from 254 nm to 580 nm with multiple peak wavelengths at 365 nm, 
405 nm and 436 nm. A Pyrex filter was first employed which only allows radiation of 
wavelengths of 280 nm or longer to pass through and thus cuts off high-energy 
short-wavelength radiation.  
We then screened a variety of conditions including solvent and light filter as 
summarised in Figure 4-2. Unfortunately in our hands, the combination of a Pyrex 
filter and a variety of solvents led to mostly full recovery of starting materials even 
after 72 hr of irradiation (entry 1). Traces of product were detected by LCMS with 
concurrent formation of significant amounts of TES-deprotected byproducts. 
Increasing the substrate concentration by seven-fold and using trans-
dichloroethylene as the solvent provided no improvement even over similar time 
lengths (entries 2 and 3). Due to mostly starting materials being recovered and only 
a minor conversion to product as detected by LCMS, we decided to investigate the 
influence of wavelength of light employed. Immediate success came in the form of a 
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Rayonet photochemical reactor equipped with 254 nm bulbs (6 × 10 W) and a quartz 
filter. With just four hours of irradiation in cyclohexane, we successfully obtained 
tetracyclic 309 in a fair 42% yield, but was complicated by some unwanted reduction 
byproducts of the enone (entry 4). This marked improvement was attributed to the 
full transmission of high-energy 254 nm light, which would be mostly cut-off in the 
case of a Pyrex filter. We discovered optimal conditions to be neat                               
trans-dichloroethylene at a substrate concentration of 0.07 mM, which significantly 
reduced the amount of reduction by-products and furnished tetracyclic 309 as a 
clean single diastereomer in a reasonable 44% yield (entry 5). In this transformation 
we installed both angular methyls at C5 and C6 in a syn-fashion, forming two 
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Figure 4-2:  Key [2+2] photocycloaddition approach to the full carbon framework of 
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The relative stereochemistry of cycloadduct 309 could not be confidently established 
by the full suite of NMR spectroscopic techniques, including 2D-NOESY analysis. 
Nevertheless, 309 was furnished as a white solid, which after slow evaporation in 
hexane and DCM, yielded single crystals suitable for X-ray analysis. The outcome of 
the X-ray crystallographic analysis confirmed cycloadduct 309 to be the undesired 
diastereomer with the trans-dichloroethylene predominantly approaching from the    
α-face (Figure 4-3). This was unexpected as it was rationalised that the bulky TES 
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protecting group would impart enough steric congestion to provide at least some ß-
facial selectivity in the approach of dichloroethylene. 
Figure 4-3:  X-ray structure of photocycloaddition product 309 
 
At this juncture, we had to abandon our approach to anislactones A/B and focus the 
limited amount of remaining research time towards the synthesis of merilactone A. 
We would have liked to have more time to explore the scope of this cycloaddition on 
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4.5   Formal Total Synthesis of Merrilactone A 
4.5.1    Lewis acid mediated one-pot multi-step reaction  
After ending our pursuit of anislactones A/B, we turned our attention immediately to 
the synthesis of merrilactone A. We anticipated the BF3·Et2O multi-step reaction 
would likely be more efficient as cyano-aldol product 303 lacks the TBDPS group 
that was previously shown to be labile at elevated temperatures in the presence of 
BF3·Et2O (cf. Section 3.6). Gratifyingly, exposure of 303 with BF3·Et2O in toluene at 
75 C furnished the desired endo-tricycle 288 with the installed γ-lactone A-ring as a 
single double bond regioisomer in a 35% yield (Scheme 4-6). This marked a 
significant step forward, as the original reaction delivered an inseparable 
regioisomeric mixture of endo- and exo-tricycles 283 and 284 in very poor yield    
(cf. Section 3.6). There was obvious room for improvement and, thus we were 
interested if an analogue such as 305, without the TES protecting group, would be a 
more suitable substrate. A straightforward fluoride induced silyl deprotection 
provided tertiary alcohol 305, which was subsequently treated with the Lewis acid, 
BF3·Et2O.  
Scheme 4-6:  Lewis acid assisted one-pot reaction for the synthesis of the tricyclic ABC 
core of merrilactone A 
 
a) Method A: BF3·Et2O, toluene, 75 C, 35%; b) TBAF, THF, RT, 82%; c) Method B: BF3·Et2O, toluene, 
100 C, 86%; d) TBAF, THF, RT, 82%; e) BF3·Et2O, toluene, 100 C, 82%. 
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To our complete satisfaction, endo-288 was afforded as a single double bond 
regioisomer in a very good 86% yield. We were fortunate to obtain endo-288 as a 
solid, from which X-ray analysis unambiguously confirmed its structure (Figure 4-4).  
This represents a highly efficient one-pot multi-step transformation that 
would otherwise have required a linear series of up to six synthetic steps. 
Additionally, we demonstrated that because the C1 stereochemistry is destroyed 
and replaced by an sp2 carbon centre, we could also funnel through the remaining 
minor diastereomer product 304 of the cyano-aldol reaction. In a similar fashion as 
before, endo-288 was thus obtained with comparable yields.  
Figure 4-4:  X-ray structure of the key tricyclic ABC core 288 of merrilactone A 
 
We have now achieved the synthesis of the tricyclic core of merilactone A core in a 
relatively short 11 synthetic steps via both diastereomeric products of the key cyano-
aldol cyclisation reaction.   
4.5.2    [2+2] Photocycloaddition 
With tricycle 288 in hand, we next turned our attention to the installation of the                  
γ-lactone D-ring and quaternisation of the two vicinal methyl groups. We adopted 
the same method of [2+2] photocyclisation conditions used in the synthesis of the 
tetracyclic core of anislactones A/B (cf. Section 4.4.1). However, this time our 
substrate is more representative of the compound used in Mehta’s synthesis and we 
288 
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expected to observe a similar diastereoselectivity. On our first attempt, the 
irradiation of 288 proceeded with moderate degree of β-facial selectivity leading to 
the formation of a 2:1 mixture of diastereomers in favour of tetracyclic 312 and in a 
reasonable combined yield of 60% (Scheme 4-7). 
Scheme 4-7:  End-game strategy for the formal total synthesis of merrilactone A                                      
 
a) neat trans-1,2-dichloroethylene, h (254 nm, quartz), RT, 41% 312, 19% 313, d.r. 2:1; b) Zn dust, 
Ac2O, TMSCl, toluene, 100 C, 73%; c) Zn dust, Ac2O, TMSCl, toluene, 100 C, 74%; d) OsO4                     
(4 mol%), NMO, ± pyridine Acetone:H2O, RT; e) i) O3, DCM:MeOH (9:1), −78 C; ii) NaBH4, −78 C to 
RT; f) i) O3, DCM:MeOH (9:1), −78 C; ii) Me2S, −78 C to RT. 
Although the cyclobutanes 312 and 313 were prepared successfully, no crystalline 
forms could be obtained for X-ray crystallographic analysis. Since confirmation of 
the structures of 312 and 313 was thus not possible via crystallographic methods, 
we turned our attention to 2D-NMR spectroscopy. Unfortunately, it was not possible 
to completely assign the stereochemistry of either diastereomer, even with extensive 
analysis of the NOESY spectrum. The assignments given in Scheme 4-7 are based 
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on the elucidation of stereochemistry at a later stage (vide infra) and were assigned 
retrospectively.   
 The zinc-mediated eliminative dechlorination21 of either 312 or 313, turned 
out to be more problematic than expected, but eventually with the use of a large 
excess of activated zinc in toluene, we were able to obtain cyclobutenes 287 and 
314 in 73% and 74% yield, respectively. Again we were not able to assign the 
relative stereochemistry for either cyclobutene. For the moment, we assumed the 
major diastereomer had the desired relative stereochemistry and thus, moved 
forward through the synthesis with 287. The next challenge was the regioselective 
formation of the γ-lactone D-ring from the chemically equivalent cyclobutene ring. 
Our first approach was to attempt an OsO4 induced regioselective dihydroxylation
138 
of the cyclobutene ring. This was rationalised because of the lower reactivity and the 
steric encumbrance around the trisubstituted alkene of the B ring. It was envisaged 
after a NaIO4-mediated cleavage and reduction of the resultant dialdehyde, that the 
ensuing diol could be selectively oxidised to the desired γ-lactone 316. The 
regioselective oxidation of the C12 alcohol using Fetizon’s reagent139 has literature 
precedence in both Hirama’s and Greaney’s own synthesis of merrilactone A (cf. 
Scheme 1-12).19,25 Thus, exposing 287 to catalytic OsO4, stoichiometric NMO and 
excess pyridine138,140 only resulted in a slow conversion to 315 with a lesser amount 
of the bis-dihydroxylation product. After leaving for 48 hr at room temperature, no 
further conversion was observed with only traces of product detected by LCMS. 
Elevating the temperature or increasing the catalytic loading of OsO4 resulted in 
more of the unwanted double dihydroxylation of both alkenes and less of 315.  
 With this disappointment, we decided to investigate the prospect of 
ozonolysis as another means of selectively cleaving the cyclobutene ring. We 
initially adopted the general conditions used by Mehta22 and following treatment of 
287 with ozone at −78 C, the solution turned a pale blue colour indicating the full 
consumption of starting materials which was additionally confirmed by TLC. A 
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subsequent reductive NaBH4 workup yielded only a complex mixture from which no 
desirable product could be isolated or detected by TLC or LCMS. An attempt at the 
oxidation of both C7 and C12 alcohols via a successive PDC oxidation of the crude 
mixture to 318 provided no improvement. Likewise, the option of forming the 
dialdehyde 319 by way of quenching with dimethyl sulfide was examined but this 
again proved to be fruitless.  
 We suspected that in addition to the cyclobutene, the trisubstituted alkene 
was also reactive towards ozone which would offer an explanation for the observed 
complex mixtures. This was somewhat surprising as in Mehta’s synthesis of 
merilactone A, the ozonolysis of the cyclobutene 320 proceeded without difficulty 
affording lactol 321 in 45% yield over two steps (Scheme 4-8).22 
Scheme 4-8:  Regioselective lactonisation in Mehta’s synthesis of merrilactone A                                
 
a) i). O3, MeOH, −78 C; ii). NaBH4, MeOH, −78 C, 45% (two steps). 
Our substrate is similar but not identical, and it could be reasoned that the bulky 
TBS ether at C7 of 320 provided the necessary steric congestion to block any direct 
approach of ozone to the trisubstituted alkene.  
At this point in our research, the availability of advanced intermediates was 
extremely limited and so we chose to halt all attempts at forming the γ-lactone D 
ring. Instead, we focussed on completing a formal total synthesis of merrilactone A 
via a known intermediate in Mehta’s synthesis (Scheme 4-9).22 Reduction of the C7 
ketone with NaBH4 delivered hydride from the more accessible α-face, affording 322 
as a single diastereomer in a very good 81% yield. Protection of the newly formed 
tertiary alcohol as a TBS ether required the highly reactive reagent TBSOTf, due to 
the extreme sterically congested environment around C7. Even so, it was essential 
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for the reaction to be left for five days before the reaction was predominantly 
complete, furnishing Mehta’s advanced intermediate 320 in 81% yield. Tetracycle 
320 represents the entire carbon skeleton of merilactone A, featuring all the required 
functionalisation to advance it to the natural product as previously been 
demonstrated by Mehta and colleagues.22  
Scheme 4-9:  End-game sequence for the formal total synthesis of merrilactone A                      
 
a) NaBH4, MeOH, RT, 81%; b) TBSOTf, NEt3, DCM, 30 C, 81%. 
An X-ray crystal structure of tetracycle 320 would have been the definitive proof of 
its stereochemistry but it formed only as a clear viscous oil from which no solids 
could be obtained. Our attention then turned towards the use of extensive 1D and 
2D-NMR spectroscopic methods. We were able to assign all observed proton and 
carbon signals via advanced COSY, DEPT, HSQC and HMBC NMR experiments. 
This allowed us to identify the key nOe interactions in the NOESY spectrum, 
enabling us to determine its structure and relative stereochemistry. Additionally, we 
analysed the spectroscopic data for its precursor, tertiary alcohol 322 to substantiate 
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Figure 4-5:  nOe signals observed for 322 and known intermediate 320 
 
The defining stereochemical configuration was the orientation of the secondary 
alcohol in 322 and the TBS ether in 320. If we could demonstrate their location to be 
on the ß-face and opposite to the methyl substituents at C8 and C13, we would be 
able to confirm the stereoselectivity of two key reactions, the [2+2] 
photocycloaddition of 288 and the facial selectivity of the NaBH4 reduction of ketone 
287. Strong correlation peaks were observed between the C8 methyl and the single 
proton at C7, for both 320 and 322. Additionally, nOe interactions were seen for the 
proton at C7 and the C10 methylene protons, and the methyl substituents of the 
TBS group to both the C15 methyl and alkene proton at C12. These observations 
combined with the comparison of both NOESY data sets, proved that the NaBH4 
delivered the hydride selectively from the α-face of 287. In addition, this also 
strongly suggested that the C8 and C13 methyl substituents are positioned on                  
α-face confirming moderate ß-facial selectivity during the photocycloaddition. These 
observed specific nOe interactions provided the proof for the stereochemical 
assignments given above and previous retrospective assignments. 
 With the characterisation data for Mehta’s intermediate 320 freely available, 
we were also able to perform a direct comparison of the signals detected in the 1H- 
and 13C-NMR spectra. We were pleased to find a perfect alignment of our proton 
and carbon signals to those reported.22 However, an anomaly in Mehta’s 1H-NMR 
data was discovered; the single proton at C7 was absent, but unfortunately we could 
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not inspect the original 1H-NMR spectrum to confirm this as a copy of the original 
spectrum was not provided in the supporting information. Nevertheless, we are 
convinced that our stereochemical assignments are correct and that we successfully 
synthesised 322, which represents a racemic formal synthesis of merrilactone A. 
In Mehta’s own synthesis of merrilactone A, known intermediate 320 could 
be converted to merrilactone A via a five-step synthetic sequence (Scheme 4-10). 
We therefore achieved the formal synthesis of merrilactone A in 15 synthetic steps 
(20 steps to merrilactone A) with an overall yield of 2%. NMR characterisation 
spectra for the compounds along this route are presented in the appendix. 
Scheme 4-10:  Synthesis of merrilactone A from known intermediate 320 
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5  Conclusions 
In our initial work on the intramolecular iodo-aldol cyclisation reaction (cf. Section 
2.3), we successfully synthesised the BC bicyclic core of the anislactones and 
demonstrated that this one-pot reaction could be used for the synthesis of 
carbocycles containing vicinal  quaternary and tertiary stereocentres (Scheme 5-1). 
Scheme 5-1:  The intramolecular iodo-aldol cyclisation approach 
  
Although the synthesis of bicycle 199 was achieved, attempts at further elaboration 
and installation of the γ-lactone A-ring was met repeatedly with disappointment.  We 
then focused our attention on the development of a new synthetic route 
incorporating a MBH reaction for a more efficient synthesis of starting materials (cf. 
Section 3.1) and replaced the iodo-aldol reaction with a novel cyano-aldol cyclisation 
reaction (cf. Section 3.3). The intramolecular cyano-aldol cyclisation reaction proved 
to be a success and enabled a regiodivergent synthesis of the tricyclic cores of 
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Scheme 5-2:  Regiodivergent approach to the tricyclic cores of anislactones A/B and 
merrilactone A via a novel intramolecular cyano-aldol cyclisation reaction 
 
The absence of any tandem cyano-aldol reactions in the literature and its successful 
application in this research for the synthesis of complex fused-ring structures makes 
this transformation even more exciting. Additionally, whilst developing the route to 
the merrilactone A core, we discovered an unexpected transformation during a 
routine silyl deprotection of cyano-aldol product 254 using the Lewis acid, BF3·Et2O. 
We were able to access the tricyclic core of merrilactone A via a linear sequence of 
synthetic transformations from 254, but found that simple treatment with BF3·Et2O at 
slightly elevated temperatures furnished in one-pot, the tricyclic cores endo-283 and 
exo-284, albeit in a very low 7% combined yield. Although the yield is of concern, 
the number of transformations taking place in this one-pot reaction is nevertheless 
impressive.  
We were disappointed to find that further advancement of both tricyclic cores 
of anislactones A/B and merrilactone A were not possible. The proposed Stork 
silicon-tethered radical addition (cf. Section 3.5.1) and numerous attempts at a 
methyl 1,4-conjugate addition were ultimately fruitless (cf. Scheme 3.5.2). This came 
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as a major setback as we had to abandon and make modifications to the originally 
planned synthetic route. This new strategy involved a late-stage [2+2] 
photocycloaddition that was expected to lead to the γ-lactone D-ring via a chemically 
equivalent cyclobutene. New starting materials were chosen to be amenable to the 
three key reactions, [2+2] photocycloaddition, cyano-aldol reaction and the one-pot 
Lewis acid mediated in situ lactonisation and elimination reaction.  
Entry to this new approach was gained from commerically available methyl 
propionylacetate 294 that was used in the literature preparation of the desired 
dimethyl-cyclopentenone 296 (Scheme 5-3). The cyano-aldol cyclisation product 
303 was synthesised from dimethylcyclopentenone 296 via a secondary alcohol 
protection, 1,2-nucleophilic addition, one-pot TES deprotection/oxidation, and 
methylenation. Cyano-aldol product 303 was used as the common intermediate for 
the regiodivergent synthesis of anislactones A/B and merrilactone A. Starting with 
anislactones A/B, the γ-lactone A-ring was introduced via a one-pot reductive 
ethyliodide deprotection and in situ lactonisation, affording the tricyclic core 307. 
This was used as the substrate for the key [2+2] photocycloaddition and cyclobutene 
309 was isolated as the only diastereomer. Unfortunately, 309 has the undesired 
stereochemistry at the newly formed quaternary stereocentres at C5 and C6, 
confirmed by an X-ray crystal structure. This was a major disappointment, and 
consequently, we had to abandon our approach for the synthesis of anislactones 
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Scheme 5-3:  A regiodivergent approach to the total formal synthesis of merrilactone A and 
the tetracyclic core of anislactones A/B  
Synthesis towards merrilactone A began with the silyl deprotection of common 
intermediate 303 furnishing the substrate for the one-pot BF3·Et2O induced reaction, 
which proceeded smoothly to afford 288, the tricyclic core of merrilactone A. In this 
one-pot reaction, multiple transformations had taken place including in situ 
cyclisation/hydrolysis and regioselective elimination of the ethane-diol side-chain. An 
interesting aspect of this reaction is the selective formation of the endo double bond 
in 288 as this negates the need for a separate alkene isomerisation step, common 
to most of the published total syntheses of merrilactone A.17,23,25 Finally, the [2+2] 
photocycloaddition represents a crucial C–C bond forming reaction that pleasingly 
afforded the desired cyclobutene with the required stereochemistry, albeit with low 
levels of stereoselectivity. Subsequent selective NaBH4 reduction and TBS 
protection of the extremely hindered secondary alcohol led to the synthesis of the 
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known intermediate 320 in Mehta’s synthesis of merrilactone A.22 Confirmation of 
the stereochemistry of 320 was obtained via extensive 2D-NOESY analysis and the 
comparison with NOESY data of 322. The exact match of the proton and carbon 
NMR signals of 320 to those published by Mehta22 substantiated the stereochemical 
assignments and our claim of a successful synthesis of 320.  
This signified a 15 synthetic step sequence to the formal total synthesis of 
merrilactone A and 20 steps to the natural product. The synthesis describes a direct 
approach to the BC bicyclic core 303 via the first novel demonstration of a 
diastereoselective cyano-aldol cyclisation as the defining transformation. A 
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6  Experimental Procedures 
6.1  General Procedures 
NMR spectra were recorded at ambient temperature on a Brüker AVA600                      
(600 MHz), Brüker AVA500 (500 MHz), Brüker DPX360 (360 MHz) and Brüker 
AC250 (250 MHz) instruments and calibrated to residual solvent peaks: 1H – CDCl3, 
7.26 ppm and 13C – CDCl3, 77.0 ppm. The 
1H-NMR data are presented as follows: 
chemical shift (in ppm on the δ scale), integration, multiplicity (s= singlet, d= doublet, 
t= triplet, q= quartet, m= multiplet), coupling constant (J in Hz) and structural 
assignment. The 13C-NMR data are reported in ppm on the δ scale, followed by the 
structural assignment, based on DEPT spectra. The single X-ray crystallographic 
data were collected via Single Crystal X-Ray Diffraction (SXRD) using an Agilent 
Technologies SuperNova instrument equipped with a Gemini Source and Atlas 
detector. IR spectra were recorded on a JASCO FT/IR-460 Plus instrument, using    
4 mm sodium chloride or KBr discs and wavelengths of the maximum absorbance (ν 
max) are quoted in cm-1. High-resolution mass spectrometry was performed by the 
EPSRC National Mass Spectrometry Service Centre, Swansea, using LTQ Orbitrap 
XL, Finnigan MAT 95XP and Finnigan MAT 900XLT instruments for FAB, ESI and 
ASA analysis. The data are presented as the ionisation method, followed by the 
calculated and measured masses. Elemental composition results were provided by 
NRM laboratories Ltd and the data are quoted as the % w/w. TLC was performed on 
Merck 60 F254 silica plates and visualised by UV light and/or anisaldehyde§ or 
                                               
§
 Anisaldehyde stain was prepared by carefully adding concentrated sulfuric acid (10 mL) to a stirred 
ethanol solution (200 mL) of p-methoxybenzaldehyde (10 mL). 
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potassium permanganate** stain. Compound purification was carried out by wet flash 
column chromatography, using Merck Kieselgel 60 (particle size 35-70) under 
positive pressure. Eluent constitution is quoted as ratios or percentages. Solvents 
were dried before use unless otherwise stated. Anhydrous solvents were obtained 
from a solvent purification system supplied by www.glasscontour.com or a PureSolv 
solvent purification system supplied by Innovative Technologies Inc. All other 
chemicals were purchased from a chemical supplier and used as received. 
Experiments were performed under an inert atmosphere of nitrogen gas under 
anhydrous conditions using oven dried glassware unless otherwise stated. 
Photoreactions were carried out in either a photoreactor supplied by Photochemical 
Experimental Reactors Ltd., Reading, UK, using a 400 W medium pressure mercury 
vapour lamp under a N2 atmosphere and water cooling, or a Rayonet photochemical 
reactor supplied by Southern New England Ultraviolet Company, Connecticut, USA, 









                                               
**
 Potassium permanganate stain was prepared by dissolving potassium permanganate (3 g) and 
potassium carbonate (20 g) in sodium hydroxide (5%, 5 mL) and H2O (300 mL). 
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A solution of sodium iodide (51.3 g, 0.34 mol, 1.2 equiv) and 3-buten-2-one 179                 
(20 g, 0.29 mol, 1 equiv) in anhydrous acetonitrile (350 mL) was vigorously stirred 
whilst rapidly adding chlorotrimethylsilane (37.2 g, 0.34 mol, 1.2 equiv). This 
generated a suspension that was left stirring for 25 mins at which time a solution of 
ethylene glycol (21.3 g, 0.34 mol, 1.2 equiv) was added rapidly and the mixture was 
stirred for a further 25 mins. The reaction mixture was then poured onto                           
5% NaHCO3 (100 mL)overlaid with hexane (400 mL). This produced three distinct 
layers, the bottom layer being the aqueous, the middle acetonitrile and top layer 
hexane. The bottom aqueous layer was removed and the remaining organic phases 
were washed with 5% sodium thiosulfate (Na2S2O3, 1 x 100 mL). The aqueous 
extracts were combined and extracted twice with EtOAc (400 mL). The organic 
layers were combined, dried over MgSO4 and concentrated in vacuo with the water 
bath set to less than 25 °C to prevent decomposition. Flash column chromatography 
(SiO2, hexane/EtOAc 9:1) furnished dioxolane 147 as a colourless oil (33.7 g, 49% 
yield).  
1H NMR (500 MHz, CDCl3) δ 4.04 – 3.86 (m, 4H, OCH2CH2O), 3.20 – 3.13 (m, 2H, 
ICH2CH2), 2.34 – 2.26 (m, 2H, ICH2CH2), 1.31 (s, 3H, CH3C); 
13C NMR (126 MHz, 
CDCl3) δ 110.0 (q), 65.0 (CH2), 44.4 (CH2), 23.9 (CH3), -2.2 (CH2). 
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2-Methylfuran-3-carboxylic acid ethyl ester 165 
 
A mixture of ethyl acetoacetate 164 (300 g, 2.30 mol, 1 equiv) and pyridine (547 g, 
6.92 mol, 3 equiv) was stirred on ice, while a solution of 45% aqueous 
chloroacetaldehyde 163 (362 g, 4.61 mol, 2 equiv) was slowly added over a period 
of 30 mins. This was allowed to stir at RT for 24 hr and completion of the reaction 
was confirmed by TLC. Diethyl ether was added to the reaction mixture which was 
poured into a separating funnel and washed with 25% NaHSO4 (4 x 100 mL), 
followed by two 2M HCl washes and a brine wash, dried over MgSO4 and 
evaporated under reduced pressure. The crude product was purified by vacuum 
distillation, which afforded 165 as a pale yellow oil (333.4 g, 94% yield).  
1H NMR (360 MHz, CDCl3) δ 7.19 (d, J = 2.0 Hz, 1H, OCH=CH), 6.61 (d, J = 2.0 Hz, 
1H, OCH=CH), 4.25 (q, J = 7.1 Hz, 2H, CH2CH3), 2.54 (s, 3H, CCH3), 1.31 (t, J = 7.1 
Hz, 3H, CH2CH3); 
13C NMR (91 MHz, CDCl3) δ 164.2 (q), 159.2 (q), 140.3 (CH), 
113.6 (q), 110.8 (CH), 60.1 (CH2), 14.4 (CH3), 13.7 (CH3). 
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A mixture of lithium aluminium hydride (10.6 g, 0.28 mol, 1.2 equiv) and anhydrous 
Et2O (300 mL) was stirred for 20 mins and cooled on ice. A solution of ethyl ester 
165 (36 g, 0.23 mol, 1 equiv) in anhydrous Et2O (230 mL) was added dropwise over 
a period of 1 hr under an atmosphere of inert N2 gas. The temperature of the 
reaction did not exceed 28 °C during the addition of the ester. After all of the ester 
had been added, the reaction was left stirring at 0 °C for a further 1.5 hr at which 
time all of the starting material had completely disappeared by TLC. The reaction 
was then quenched with water (3.2 mL, 0.18 mol, 3 equiv), which was added 
dropwise over 20 mins during which time the temperature did not exceed 23 °C. The 
reaction mixture was then poured into diethyl ether (200 mL), dried over MgSO4 and 
filtered. The unfiltered residue was extracted an additional four times with diethyl 
ether and all extracts were combined and evaporated under reduced pressure to 
yield alcohol 166 as a pale yellow oil (23.4 g, 91% yield). No further purification was 
required. 
1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 1.9 Hz, 1H, OCH=CH), 6.35 (d, J = 1.9 Hz, 
1H, OCH=CH), 4.45 (s, 2H, CH2OH), 2.27 (s, 3H, CH3); 
13C NMR (91 MHz, CDCl3) δ 
149.4 (q), 140.6 (CH), 118.9 (q), 111.0 (CH), 56.7 (CH2), 11.6 (CH3). 





 Experimental Procedures 




A solution of (2-methylfuran-3-yl)methanol 166 (87.5 g, 0.78 mol, 1 equiv) in 
MeOH:Et2O (4:1, 600 mL) was cooled to −78 °C and stirred. A mixture of bromine in 
MeOH:Et2O was made by slowly adding bromine (137.2 g, 0.86 mol, 1.1 equiv) to a 
solution of MeOH:Et2O (4:1, 450 mL) that was cooled on ice. The solution of 
bromine was added dropwise to the reaction mixture during 1.5 hr. The reaction was 
left stirring for a further 1.5 hr, after which time the starting material had completely 
disappeared as confirmed by TLC. Triethylamine (272 mL, 1.95 mol, 2.5 equiv) was 
slowly added to the mixture, which was then allowed to warm to room temperature 
and left to stand for 1 hr. Et2O (400 mL) was added to the reaction mixture which 
was filtered to remove salts and the filtrate was evaporated under reduced pressure 
to remove solvent. Salts were repeatedly precipitated from the crude product by 
adding diethyl ether (2 x 200 mL). The filtrate was then poured into a separating 
funnel containing diethyl ether (400 mL) and washed with brine (2 × 100 mL). The 
aqueous phases were re-extracted with DCM (2 x 200 mL) and the organic phases 
were combined, dried over MgSO4 and evaporated under reduced pressure to yield 
a dark orange oil. Flash column chromatography (SiO2, hexane/EtOAc 1:9) afforded 
a ~2:1 inseparable diastereomeric mixture of dihydrofuran 167 as a colourless clear 
oil (120.2 g, 89% yield). 
Major diastereoisomer: 1H NMR (500 MHz, CDCl3) δ 5.92 – 5.89 (m, 1H, 
OCHCH=C), 5.46 – 5.43 (m, 1H, HCCH=C), 4.31 – 4.18 (m, 2H, CCH2OH), 3.49 (s, 
3H, CHOCH3), 3.19 (s, 3H, COCH3), 1.50 (s, 3H, CCH3); Minor diastereoisomer:   
δ 5.95 – 5.92 (m, 1H, OCHCH=C), 5.73 – 5.71 (m, 1H, HCCH=C), 4.31 – 4.18 (m, 
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2H, CCH2OH), 3.42 (s, 3H, OCH3), 3.11 (s, 3H, OCH3), 1.56 (s, 3H, CCH3); Major 
diastereoisomer: 13C NMR (91 MHz, CDCl3) δ 146.9 (q), 124.3 (CH), 111.2 (q), 
106.1 (CH), 58.2 (CH2), 56.3 (CH3), 50.4 (CH3), 25.4 (CH3); Minor 
diastereoisomer: δ 147.4 (q), 124.6 (CH), 112.3 (q), 107.2 (CH), 58.2 (CH2), 55.2 
(CH3), 49.8 (CH3), 25.9 (CH3). 
The spectroscopic data were in agreement with those previously published.51,52 
4-Hydroxy-2-(hydroxymethyl)cyclopent-2-enone 168 
 
A solution of dihydrofuran 167 (17.3 g, 0.1 mol, 1 equiv) in 1,4-dioxane (110 mL) 
and 0.2 M potassium phosphate buffer (pH 6.3, 250 mL) was stirred and 
hydroquinone (0.17 g, 1.6 mmol, 0.016 equiv) was then added.  This mixture was 
heated under reflux for 3.5 hr, after which time all of the starting material had 
disappeared by TLC. The solvent was evaporated by azeotropic distillation using 
ethanol, which left a residue that was extracted 8 times with boiling ethylacetate. 
The extracts were combined and evaporated under reduced pressure, which left a 
dark orange oil. Flash column chromatography (SiO2, EtOAc/MeOH 19:1) gave 
racemate 168 as a pale off-white solid (9.09 g, 71% yield).  
1H NMR (500 MHz, CD3COCD3) δ 7.32 – 7.28 (m, 1H, CH=C), 4.90 – 4.81 (m, 1H, 
CHOH), 4.39 (d, J = 5.9 Hz, 1H, CHOH), 4.18 – 4.13 (m, 2H, CCH2OH), 4.00 (t, J = 
5.5 Hz, 1H, CH2OH), 2.66 (dd, JAB, AX = 18.3, 6.0 Hz, 1H, CH2CO), 2.12 (dd, JBA, BX = 
18.3, 2.0 Hz, 1H, CH2CO); 
13C NMR (91 MHz, CD3COCD3) δ 207.2 (q), 158.5 (CH), 
148.4 (q), 69.4 (CH), 57.6 (CH2), 46.7 (CH2). 
The spectroscopic data were in agreement with those previously published.51,52 
 Experimental Procedures 




Method A: A solution of cyclopentenone-diol 168 (120 mg, 0.94 mmol, 1 equiv), 
imidazole (134 mg, 1.96 mmol, 2.1 equiv) and DMAP (11.4 mg, 0.093 mmol, 0.1 
equiv) was dissolved in dry DMF (4 mL) and was stirred for 10 mins under an 
atmosphere of N2. This mixture was then cooled to 0 °C at which time a solution of 
TBSCl (155 mg, 1.03 mmol, 1.1 equiv) in dry DMF (2 mL) was cannulated dropwise 
into the reaction mixture. The reaction was left for 24 hr at RT, after which time most 
of the starting material had disappeared as confirmed by TLC. The reaction was 
quenched with water (1 mL) and poured into a separating funnel containing EtOAc 
(75 mL). The organic layer was washed with saturated NH4Cl (1 x 20 mL) and 
followed by a brine wash (2 x 20 mL). The aqueous phases were saturated with 
NaCl and re-extracted twice with EtOAc. This left an orange oil which was poured 
into a separating funnel containing Et2O (150 mL). The organic layer was washed 
with distilled water (4 x 10 mL) to remove any remaining DMF. The aqueous layers 
were saturated with NaCl and re-extracted twice with Et2O. The organic layers were 
combined, dried over MgSO4 and solvent evaporated under reduced pressure. 
Flash column chromatography (SiO2, hexane/EtOAc 6:4) furnished enone 172 as a 
white crystalline solid (91 mg, 41% yield).  
Method B: A solution of cyclopentenone-diol 168 (200 mg, 1.56 mmol, 1 equiv) was 
dissolved in dry DMF (5 mL) and was stirred for 10 mins under an atmosphere of 
inert N2. This was then cooled to -45 °C, at which time a solution of TBSOTf        
(430 mg, 4.64 mmol, 1.05 equiv) and 2,6-lutidine (0.35 g, 3.28 mmol, 2.1 equiv) in 
dry DMF (1 mL) was cannulated dropwise into the reaction mixture. The reaction 
was left for 45 mins, after which time all of the starting material had disappeared as 
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confirmed by TLC. The reaction mixture was raised to RT, quenched with water       
(5 mL) and poured into a separating funnel containing EtOAc (75 mL). The organic 
layer was washed with saturated NH4Cl (1 x 20 mL) followed by a brine wash          
(2 x 20 mL). The aqueous phases were saturated with NaCl and re-extracted twice 
with EtOAc. The organic phases were combined, dried over MgSO4 and solvent was 
evaporated under reduced pressure. This left a colourless oil which was poured into 
a separating funnel containing Et2O (150 mL).  The organic layer was washed with 
water (4 x 10 mL) to remove any remaining DMF. The aqueous layers were 
saturated with NaCl and re-extracted twice with Et2O. The organic layers were 
combined, dried over MgSO4 and solvent evaporated under reduced pressure. 
Flash column chromatography (SiO2, hexane/EtOAc 6:4) delivered 172 as a white 
crystalline solid (170 mg, 45% yield).  
1H NMR (360 MHz, CDCl3) δ 7.38 – 7.31  (m, 1H, CH=C), 5.01 – 4.87 (m, 1H, 
CHOH), 4.33 (t, J = 2.1 Hz, 2H, CH2OSi), 2.81 (dd, JAB, AX = 18.6, 6.0 Hz, 1H, 
CH2CO), 2.32 (dd, JBA, BX = 18.6, 2.0 Hz, 1H, CH2CO), 0.88 (s, 9H, SiC(CH3)3), 0.09-
0.00 (m, 6H, 2 x SiCH3); 
13C NMR (91 MHz, CDCl3) δ 205.1 (q), 156.5 (CH), 147.7 
(q), 68.4 (CH), 57.7 (CH2), 45.5 (CH2), 25.8 (CH3), 18.2 (q). -5.6 (CH3), -5.5 (CH3); 
IR (thin film, NaCl plate, cm-1) 3419, 2929, 2251, 1705, 1471; HRMS (ESI) m/z calcd 
for C12H23O3Si [M+H]
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2-((tert-Butyldiphenylsilyloxy)methyl)-4-hydroxycyclopent-2-enone 173,                           
4-(tert-Butyldiphenylsilyloxy)-2-((tert-butyldiphenylsilyloxy)methyl)cyclopent-2-enone 
174 and                                                                                                                                       
tert-Butyl((2,5-dimethoxy-2-methyl-2,5-dihydrofuran-3-yl)methoxy)diphenylsilane 
176                                                                                                                             
 
Method A: A solution of cyclopentenone-diol 168 (300 mg, 2.34 mmol, 1 equiv), 
imidazole (351 mg, 5.15 mmol, 2.2 equiv) and DMAP (57 mg, 0.47 mmol, 0.2 equiv) 
in dry DMF (1 mL) was stirred for 10 mins under an atmosphere of inert nitrogen 
gas. This mixture was then cooled to 0 °C at which time a solution of TBDPSCl                 
(680 mg, 2.46 mmol, 1.1 equiv) in dry DMF (1 mL) was cannulated dropwise into the 
reaction mixture. The reaction was left for 6 hr at RT, after which time most of the 
starting material had disappeared as confirmed by TLC. The reaction was quenched 
with water (1 mL) and poured into a separating funnel containing EtOAc (75 mL). 
The organic layer was washed with saturated NH4Cl (1 x 20 mL) and followed by a 
brine wash (2 x 20 mL). The aqueous phases were saturated with NaCl and re-
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extracted twice with EtOAc. The organic phases were combined, dried over MgSO4 
and solvent was evaporated under reduced pressure.  This left an orange oil which 
was poured into a separating funnel containing Et2O (150 mL). The organic layer 
was washed with water (4 x 10 mL) to remove any remaining DMF. The aqueous 
layers were saturated with NaCl and re-extracted twice with Et2O.  The organic 
layers were combined, dried over MgSO4 and solvent evaporated under reduced 
pressure. Flash column chromatography (SiO2, hexane/EtOAc 6:4) afforded enone 
173 as a white crystalline solid (0.34 g, 40% yield) and byproduct 174 as a white 
crystalline solid (0.32 g, 23% yield). 
Method B:  A solution of alcohol 167 (0.6 g, 3.44 mmol, 1 equiv), imidazole (0.49 g, 
7.23 mmol, 2.1 equiv) and DMAP (0.08 g, 0.69 mmol, 0.2 equiv) in dry DMF (8 mL) 
was stirred for 10 mins under an atmosphere of inert nitrogen gas. This mixture was 
then cooled to 0 °C at which time a solution of TBDPSCl (0.99 g, 3.62 mmol,          
1.1 equiv) in dry DMF (1 mL) was cannulated dropwise into the reaction mixture. 
The reaction was allowed to warm to room temperature for 4 hr, after which time all 
of the starting material had disappeared as confirmed by TLC. The reaction was 
quenched with water (5 mL) and poured into a separating funnel containing EtOAc 
(75 mL). The organic layer was washed with saturated NH4Cl (1 x 20 mL) and 
followed by a brine wash (2 x 20 mL). The aqueous phases were saturated with 
NaCl and re-extracted twice with EtOAc. The organic phases were combined, dried 
over MgSO4 and solvent was evaporated under reduced pressure.  A sample of the 
crude dihydrofuran 176 was was purified by flash column chromatography (SiO2, 
hexane/EtOAc 1:9) and used for characterisation. The remaining crude 176 was 
sufficiently pure to be used in the following step. A solution of the crude 176 (0.47 g, 
1.14 mmol, 1 equiv) in DMF (10 mL) and 0.2 M potassium phosphate buffer (pH 6.3, 
5 mL) was stirred and hydroquinone (0.002 g, 0.018 mmol, 0.016 equiv) was then 
added. This mixture was heated under reflux for 24 hr, after which time the water 
was evaporated by azeotropic distillation using ethanol, which left a residue that was 
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extracted 8 times with boiling ethylacetate. The extracts were combined and 
evaporated under reduced pressure. This left an orange oil which was purified by 
flash column chromatography (SiO2, hexane/EtOAc 6:4) to furnish alcohol 173 as a 
white crystalline solid (0.13 g, 30% yield over two steps).  
Method C:  A solution of bis-protected 178 (75 mg, 0.16 mmols, 1 equiv) was 
dissolved in MeCN:H2O, 9:1 (0.56 mL) under nitrogen before addition of DDQ (4 mg, 
0.016 mmols, 0.1 equiv) in MeCN:H2O (9:1, 0.56 mL). The resulting mixture was left 
to stir for 1 hr at room temperature, after which time all of the starting material had 
disappeared as confirmed by TLC. Subsequently, the reaction mixture was 
evaporated under reduced pressure to leave a residue which was purified by flash 
column chromatography (SiO2, hexane/EtOAc 6:4) and gave 173
 as a white 
crystalline solid (45.5 mg, 80% yield). 
Method D:  A solution of cyclopentenone 244 (4.4 g, 9.2 mmol, 1 equiv) in THF:H2O 
(60 mL, 9:1) was treated with DDQ (311 mg, 1.37 mmol, 0.15 equiv) and stirred at 
40 °C for 22 hr before adding an excess of saturated NH4Cl solution. EtOAc 
extractions followed by drying over MgSO4, filtering and solvent removal afforded a 
crude mixture which was purified by flash column chromatography (SiO2, 
hexane/EtOAc 6:4) to afford secondary alcohol 173 as a white crystalline solid (2.84 
g, 85% yield). 
Dihydrofuran 176, major diastereoisomer: 1H NMR (360 MHz, CDCl3) δ 7.75 – 7.62 
(m, 4H, ArH), 7.51 – 7.32 (m, 6H, ArH), 6.08 – 6.04 (m, 1H, OCHCH=C), 5.49 – 5.45 
(m, 1H, HCCH=C), 4.33 – 4.15 (m, 2H, CCH2OH), 3.52 (s, 3H, CHOCH3), 3.07 (s, 
3H, COCH3), 1.39 (s, 3H, CCH3), 1.10 (s, 9H, SiC(CH3)3); The 
1H NMR signals of 
the minor diastereoisomer were too weak to be confidently assigned; Major 
diastereoisomer:  13C NMR (91 MHz, CDCl3) δ 146.5 (q), 135.6 (CH), 135.6 (CH), 
133.2 (q), 133.0 (q), 130.0 (CH), 130.0 (CH), 127.9 (CH), 124.2 (CH), 110.8 (q), 
105.9 (CH), 59.6 (CH2), 56.1 (CH3), 50.0 (CH3), 26.9 (CH3), 25.5 (CH3), 19.4 (q); 
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The 13C NMR signals of the minor diastereoisomer were too weak to be confidently 
assigned; IR (thin film, NaCl plate, cm-1); 2932, 1589, 1472, 1428, 1367; HRMS 
(ESI) m/z calcd for C24H36NO4Si [M+NH4]
+ 430.2408, found 430.2405; MP 54-56 C. 
Mono-protected 173: 1H NMR (360 MHz, CDCl3) δ 7.72 – 7.60 (m, 4H, ArH), 7.51 – 
7.47 (m, 1H, CH=C), 7.47 – 7.34 (m, 6H, ArH), 5.00 – 4.89 (m, 1H, CHOH), 4.49 – 
4.39 (m, 2H, CH2OSi), 2.80 (dd, JAB, AX = 18.6, 6.0 Hz, 1H, CH2CO), 2.45 (s, 1H, 
CHOH), 2.31 (dd, JBA, BX = 18.6, 1.9 Hz, 1H, CH2CO), 1.09 (s, 9H, SiC(CH3)3); 
13C 
NMR (63 MHz, CDCl3) δ 204.8 (q), 156.2 (CH), 147.7 (q), 135.6 (CH), 135.6 (CH), 
133.1 (q), 130.0 (CH), 127.9 (CH), 68.7 (CH), 58.8 (CH2), 45.6 (CH2), 26.9 (CH3), 
19.4 (q); IR (thin film, NaCl plate, cm-1) 3426, 2931, 2859, 2250, 1702, 1112; HRMS 
(ESI) m/z calcd for C22H30N O3Si [M+NH4]
+ 384.1989, found 384.1989; MP 38-40 C. 
Bis-protected 174: 1H NMR (360 MHz, CDCl3) δ 7.81 – 7.58 (m, 8H, ArH), 7.53 – 
7.28 (m, 13H, 12 × ArH, CH=C), 4.95 – 4.88 (m, 1H, CHOSi), 4.49 – 4.32 (m, 2H, 
CH2OSi), 2.63 (dd, JAB, AX = 18.4, 5.8 Hz, 1H, CH2CO), 2.46 (dd, JBA, BX = 18.4, 2.1 
Hz, 1H, CH2CO), 1.13 (s, 9H, SiC(CH3)3), 1.09 (s, 9H, SiC(CH3)3); 
13C NMR (91 
MHz, CDCl3) δ ppm 204.6 (q), 156.9 (CH), 146.9 (q), 135.6 (CH), 135.5 (CH), 133.6 
(q), 133.3 (q), 133.1 (q), 133.0 (q), 130.2 (CH), 130.0 (CH), 129.9 (CH), 128.0 (CH), 
127.9 (CH), 70.0 (CH), 58.8 (CH2), 46.1 (CH2), 27.0 (CH3), 19.4 (q), 19.1 (q); IR (thin 
film, NaCl plate, cm-1) 2931, 2858, 1708, 1472, 1428, 1112; HRMS (ESI) m/z calcd 
for C38H45O3Si2 [M+H]
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A solution of cyclopentenone-diol 168 (0.15 g, 1.17 mmol, 1 equiv), imidazole                         
(0.17 g, 2.46 mmol, 2.1 equiv) and DMAP (0.03 g, 0.23 mmol, 0.2 equiv) in dry DMF       
(1 mL) was stirred for 10 mins under an atmosphere of inert nitrogen gas. This 
mixture was then cooled to 0 °C, at which time a solution of TDSCl (0.22 g,                   
1.23 mmol, 1.05 equiv) in dry DMF (2 mL) was cannulated dropwise into the 
reaction mixture. The reaction was left for 24 hr, after which time most of the starting 
material had disappeared as confirmed by TLC. The reaction was quenched with 
water (1 mL) and poured into a separating funnel containing EtOAc (75 mL). The 
organic layer was washed with saturated NH4Cl (1 x 20 mL) and followed by a brine 
wash (2 x 20 mL). The aqueous phases were saturated with NaCl and re-extracted 
twice with EtOAc. This left an orange oil which was poured into a separating funnel 
containing Et2O (150 mL).The organic layer was washed with water (4 x 10 mL) to 
remove any remaining DMF. The aqueous layers were saturated with NaCl and re-
extracted twice with Et2O. The organic layers were combined, dried over MgSO4 and 
solvent evaporated under reduced pressure. This left an orange oil which was 
purified by flash column chromatography (SiO2, hexane/EtOAc 6:4) to afford 175 as 
a deep orange clear oil (0.13 g, 41% yield).  
1H NMR (360 MHz, CDCl3) δ 7.39 – 7.33 (m, 1H, CH=C), 5.03 – 4.92 (m, 1H, 
CHOH), 4.34 (s, 2H, CH2OSi), 2.83 (dd, JAB, AX = 18.6, 5.9 Hz, 1H, CH2CO), 2.53 (s. 
br, 1H, CHOH), 2.34 (dd, JBA, BX = 18.6, 1.7 Hz, 1H, CH2CO), 1.71 – 1.56 (m, 1H, 
CHC(CH3)2), 0.96 – 0.80 (m, 12H, C(CH3)2C(CH3)2), 0.16 – 0.04 (m, 6H, 2 × SiCH3); 
13C NMR (91 MHz, CDCl3) δ 205.1 (q), 156.3 (CH), 148.2 (q), 68.7 (CH), 57.8 (CH2), 
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45.7 (CH2), 34.3 (CH) 25.3 (q), 20.4 (CH3), 18.6 (CH3), -3.4 (CH3), -3.5 (CH3); IR 
(thin film, NaCl plate, cm-1) 3421, 2959, 1700, 1466, 1397, 1254; HRMS (ESI) m/z 
calcd for C14H27O3Si [M+H]
+ 271.1724, found 271.1729.   
2-(tert-Butyldiphenylsilanyloxymethyl)-4-(triethylsilanyloxy)cyclopent-2-enone 178 
 
Enone 173 (5.6 g, 15.3 mmol, 1 equiv), triethylamine (5.83 mL, 41.7 mmol, 2.73 
equiv) and DMAP (187 mg, 1.53 mmol, 0.1 equiv) were dissolved in dry DCM             
(25 mL) and cooled to 0°C before addition of TESCl (2.99 g, 19.9 mmol, 1.3 equiv)  
under an inert atmosphere of N2. The resulting mixture was then heated under reflux 
for 24hr, after which time the starting material had disappeared as confirmed by 
TLC. The reaction was quenched with water (5 mL) and was poured into a 
separating funnel containing EtOAc (75 mL). The organic layer was washed with 
saturated NH4Cl (2 x 20 mL) and followed by a brine wash (2 x 20 mL). The 
aqueous phases were re-extracted with EtOAc and the organic phases were 
combined, dried over MgSO4 and solvent was evaporated under reduced pressure. 
This left an orange oil which was purified by flash column chromatography                   
(SiO2, hexane/EtOAc 19:1) to give enone 178 as a pale yellow oil (7.05 g, 96% 
yield).  
1H NMR (360 MHz, CDCl3 ) δ 7.70 – 7.62 (m, 4H, ArH ), 7.48 – 7.35 (m, 7H, 6 × 
ArCH, CH=C), 4.97 – 4.90 (m, 1H, CHOSi), 4.44 (t, J = 2.1 Hz, 2H, CH2OSi), 2.78 
(dd, JAB, AX = 18.3, 5.9 Hz, 1H, CH2CO), 2.35 (dd, JBA, BX = 18.3, 2.1 Hz, 1H, CH2CO), 
1.11 (s, 9H, SiC(CH3)3), 1.02 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.69 (q, J = 7.6 Hz, 
6H, Si(CH2CH3)3); 
13C NMR (91 MHz, CDCl3) δ 204.7 (q), 157.0 (CH), 147.0 (q), 
135.6 (CH), 135.6 (CH), 133.2 (q), 133.1 (q), 130.0 (CH), 130.0 (CH), 127.9 (CH), 
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68.9 (CH), 58.9 (CH2), 46.3 (CH2), 26.9 (CH3), 19.4 (q) , 6.8 (CH3), 4.9 (CH2); IR 
(thin film, NaCl plate, cm-1) 3072, 2956, 1714, 1589, 1471, 1427, 1112; HRMS (ESI) 
m/z calcd for C28H44NO3Si2 [M+NH4]




2-(2-Iodoethyl)-2-methyl[1,3]dioxolane 147 (0.81 g, 3.33 mmol, 1.6 equiv) was 
dissolved in dry Et2O (18 mL), cooled to −78 °C under an atmosphere of N2 before 
slow addition of tBuLi (4.16 mL, 1.7 M in pentane, 7.1 mmol, 3.4 equiv). The 
resulting mixture was stirred at −78 °C under N2 for 1 hr before warming to room 
temperature and stirring for another 1 hr. At which time, the mixture was cannulated 
into a solution of cyclopentenone 178 (1 g, 2.08 mmol, 1 equiv) in dry Et2O (18 mL) 
at −78°C during 20 mins. The resulting reaction mixture was stirred at −78 °C for 3 
hr before warming to room temperature and left for 30 mins. After this time, the 
reaction was quenched with water (10 mL) and poured into a separating funnel 
containing saturated NH4Cl solution (40 mL) and EtOAc (250 mL). The organic layer 
was washed with brine (2 x 40 mL) and the aqueous layer re-extracted twice with 
EtOAc before combining the organic layers which were dried over MgSO4 and 
evaporated under reduced pressure. Purification by flash column chromatography 
(SiO2, hexane/EtOAc 8:2) furnished a single diastereomer of tertiary alcohol 180 as 
an oil (1.03 g, 83% yield). 
1H NMR (360 MHz, CDCl3) δ 7.75 – 7.63 (m, 4H, ArH), 7.48 – 7.33 (m, 6H, ArH), 
5.83 – 5.79 (m, 1H, CH=C), 4.66 – 4.54 (m, 1H, CHOSi), 4.45 – 4.24 (m, 2H, 
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CCH2OSi), 3.99 – 3.72 (m, 4H, OCH2CH2O), 2.56 (s, 1H, CH2COH), 2.43 (dd, JAB, AX 
= 13.7, 6.8 Hz, 1H, CH2COH), 1.86 – 1.41 (m, 5H, CH2COH, CCH2CH2), 1.26 (s, 3H, 
CH3CCH2), 1.07 (s, J = 3.6 Hz, 9H, SiC(CH3)3), 0.98 (t, J = 7.9 Hz, 9H, 
Si(CH2CH3)3), 0.62 (q, J = 7.9 Hz, 6H, Si(CH2CH3)3); 
13C NMR (91 MHz, CDCl3) δ 
149.2 (q), 135.7 (CH), 135.7 (CH), 133.2 (q), 130.6 (CH), 129.9 (CH), 129.9 (CH), 
127.9 (CH), 109.9 (q), 83.4 (q), 73.2 (CH), 64.7 (CH2), 60.6 (CH2), 49.4 (CH2), 33.9 
(CH2), 32.6 (CH2), 26.9 (CH3), 23.9 (CH3), 19.3 (q), 6.9 (CH3), 4.9 (CH2); IR (thin 
film, NaCl plate, cm-1) 3455, 2929, 2359, 1777, 1589, 1463; HRMS (ESI) m/z calcd 
for C34H56NO5Si2 [M+NH4]




Tertiary alcohol 180 (5.80 g, 9.7 mmol, 1 equiv) was dissolved in dry DMF (30 mL) 
and cooled to 0 °C under an atmosphere of N2. The resulting mixture was stirred for 
5 mins before dropwise addition of a solution containing TBSOTf (12.95 g, 48.5 
mmol, 5 equiv) and 2,6-lutidine (11 g. 102.8 mmol, 10.5 equiv) in dry DMF (5 mL). 
The reaction mixture was stirred for 20 mins before warming to RT and left for a 
further 2 hr until the reaction was complete as confirmed by TLC. This was then 
poured into a separating funnel containing saturated NH4Cl solution (20 mL) and 
extracted with Et2O (100 mL). The organic layer was washed with distilled water (2 x 
20 mL) and the aqueous fractions were combined and again extracted twice with 
Et2O (2 x 100mL). The organic fractions were combined, dried over MgSO4, filtered 
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and concentrated in vacuo. Flash column chromatography (SiO2, hexane/EtOAc 
19:1) supplied TBS ether 181 as a white crystalline solid (6.85 g, 99% yield). 
1H NMR (360 MHz, CDCl3) δ 7.75 – 7.65 (m, 4H, ArH ), 7.47 – 7.33 (m, 6H, ArH), 
5.88 – 5.84 (m, 1H, CH=C), 4.70 – 4.59 (m, 1H, CHOSi)), 4.45 – 4.16 (m, 2H, 
CH2OSi), 3.96 – 3.76 (m, 4H, OCH2CH2O),  2.48 (dd, J = 13.3, 7.0 Hz, 1H, CH2CO), 
1.96 (dd, J = 13.3, 5.1 Hz, 1H, CH2CO), 1.73 – 1.33 (m, 4H, CH3CCH2CH2), 1.24 (s, 
3H, CH3CCH2), 1.08 (s, 9H, CH2OSiC(CH3)3), 1.00 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 
0.75 (s, 9H, COSiC(CH3)3), 0.64 (q, J = 7.6 Hz, 6H, Si(CH2CH3)3), 0.04 (s, 3H, 
SiCH3), 0.01 (s, 3H, SiCH3); 
13C NMR (91 MHz, CDCl3) δ 150.4 (q), 135.7 (CH), 
135.6 (CH), 133.9 (q), 133.6 (q), 129.8 (CH), 129.7 (CH), 128.5 (CH), 127.8 (CH), 
127.8 (CH), 110.1 (q), 84.9 (q), 73.6 (CH), 64.7 (CH2), 64.7 (CH2), 60.2 (CH2), 50.1 
(CH2), 35.7 (CH2), 34.0 (CH2), 27.0 (CH3), 25.9 (CH3), 23.9 (CH3), 19.4 (q), 18.3 (q), 
7.0 (CH3), 5.1 (CH2), -2.1 (CH3), -2.9 (CH3); IR (thin film, NaCl plate, cm
-1) 3072, 
2956, 2251, 1462; HRMS (ESI) m/z calcd for C40H70NO5Si3 [M+NH4]
+ 728.4556, 




Cyclopentene 181 (5.7 g, 8.04 mmol, 1 equiv) was dissolved in a solution of 
THF:H2O (9:1, 35 mL) and stirred for 10 mins at RT. TCNQ (164 mg, 0.80 mmol, 0.1 
equiv) was subsequently added to the resulting mixture and stirred for 24 hr until the 
reaction was complete as confirmed by TLC. The reaction mixture was then poured 
into a separating funnel containing saturated NH4Cl solution (1 x 20 mL) and 
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extracted with EtOAc (1 x 150 mL). The organic layer was washed with brine                    
(2 x 20 mL) and the aqueous layers were combined and re-extracted twice with 
EtOAc. The combined organic layers were dried over MgSO4 and removed under 
reduced pressure. Residual TCNQ was removed by triturating three times with Et2O 
and filtering off the solid residue.  Evaporation of the solvent under reduced 
pressure gave a yellow oil which was purified by flash column chromatography 
(SiO2, hexane/EtOAc 7:3) to afford secondary alcohol 182 as a clear crystalline solid 
(4.2 g, 88% yield).   
1H NMR (360 MHz, CDCl3) δ 7.76 – 7.64 (m, 4H, ArH ), 7.49 – 7.33 (m, 6H, ArCH ), 
5.98 – 5.92 (m, 1H, CH=C), 4.64 (s, 1H, CHOH), 4.47 – 4.18 (m, 2H, CH2OSi), 3.96 
– 3.75 (m, 4H, OCH2CH2O), 2.58 (dd, JAB, AX  = 13.5, 7.0 Hz, 1H, CH2COSi), 1.88 
(dd, JBA, BX  = 13.5, 5.1 Hz, 1H, CH2COSi), 1.80 – 1.34 (m, 5H, CCH2CH2, CH2COH), 
1.23 (s, 3H, CH3CCH2), 1.09 (s, 9H, CH2OSiC(CH3)3), 0.75 (s, 9H, COSiC(CH3)3 ), 
0.04 (s, 3H, SiCH3), 0.02 (s, 3H, SiCH3); 
13C NMR (91 MHz, CDCl3) δ 152.1 (q), 
135.6 (CH), 135.6 (CH), 133.6 (q), 133.6 (q), 129.8 (CH), 127.8 (CH), 127.8 (CH), 
127.6 (CH), 109.9 (q), 85.2 (q), 73.8 (CH), 64.7 (CH2), 64.7 (CH2), 60.1 (CH2), 50.0 
(CH2), 35.2 (CH2), 34.0 (CH2), 27.0 (CH3), 25.8 (CH3), 23.9 (CH3), 19.4 (q), 18.2 (q), 
-2.1 (CH3), -2.6 (CH3); IR (thin film, NaCl plate, cm
-1) 3452, 3072, 2856, 2247, 1959, 
1589, 1471; HRMS (ESI) m/z calcd for C34H56NO5Si2 [M+NH4]
+ 614.3692, found 
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Alcohol 182 (1.0 g, 1.67 mmol, 1 equiv) and NaHCO3 (0.70 g, 8.38 mmol, 5 equiv) 
was dissolved in dry DCM (10 mL) and stirred for 10 mins at RT before addition of 
DMP (1.07 g, 2.51 mmol, 1.5 equiv). The resulting mixture was stirred for 2.5 hr until 
the reaction was complete as confirmed by TLC. The reaction mixture was then 
poured into a separating funnel containing brine (1 × 20 mL) and DCM (100 mL). 
The organic layer was separated, washed again with brine, dried over MgSO4, 
filtered and the solvent removed under reduced pressure. Flash column 
chromatography (SiO2, hexane/EtOAc 3:1) furnished enone 183 as a white solid 
(0.92 g, 95% yield).   
1H NMR (600 MHz, CDCl3) δ 7.71 – 7.61 (m, 4H, ArH ), 7.49 – 7.34 (m, 6H, ArCH), 
6.39 (s, 1H, C=CH), 4.65 (d, J = 18.7 Hz, 1H, CH2OSi), 4.45 (d, J = 18.7 Hz, 1H, 
CH2OSi), 3.92 – 3.73 (m, 4H, OCH2CH2O), 2.57 (s, 2H, CH2CO), 1.84 – 1.30 (m, 
4H, CCH2CH2), 1.21 (s, 3H, CH3CCH2), 1.08 (s, 9H, CH2OSiC(CH3)3), 0.73 (s, 9H, 
COSiC(CH3)3), 0.02 (s, 3H, SiCH3), -0.05 (s, 3H, SiCH3);
 13C NMR (151 MHz, CDCl3) 
δ 204.2 (q), 182.6 (q), 135.6 (CH), 135.5 (CH), 133.0 (q), 132.8 (q), 130.1 (CH), 
128.3 (CH), 128.0 (CH), 109.5 (q), 80.7 (q), 64.8 (CH2), 60.4 (CH2), 50.0 (CH2), 34.9 
(CH2), 34.1 (CH2), 26.9 (CH3), 25.7 (CH3), 24.0 (CH3), 19.4 (q), 18.1 (q), -2.4 (CH3), -
3.0 (CH3); IR (thin film, NaCl plate, cm
-1) 3072, 2251, 1716, 1631, 1255; HRMS 
(ESI) m/z calcd for C34H50O5Si2Na [Na]
+ 617.3089, found 617.3085; MP 46-48 C. 
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Cyclopentenone 183 (500 mg, 0.84 mmol, 1 equiv) was dissolved in dry THF         
(15 mL) under N2, cooled to −78 °C and stirred for 10 mins before slow addition of 
LDA (1.4 mL, 1.8M in THF/heptane/ethylbenzene, 2.52 mmol, 3 equiv) and left to 
stir for a further hr. The resulting solution was then cannulated dropwise over 10 
mins to a mixture of Eschenmoser’s salt (466 mg, 2.52 mmol, 3 equiv) in dry THF 
(7.5 mL), which was pre-cooled to −78 °C. The reaction was left at −78 °C for 2 hr 
before allowing to warm to RT and stirred for a further 30 mins. The reaction mixture 
was then poured into a separating funnel containing Et2O (75 mL) and saturated 
NaHCO3 (25 mL). The aqueous phase was re-extracted with DCM (2 x 75 mL) and 
the organic fractions were combined and evaporated under reduced pressure. The 
crude orange residue was dissolved in a mixture of DCM (10 mL) and NaHCO3      
(5 mL).  Under vigorous stirring, one portion of mCPBA (435 mg, 2.52 mmol, 3 
equiv) was added and left to stir for 1 hr before separating the organic layer. The 
aqueous layer was extracted with DCM and the combined organic fractions were 
dried over MgSO4, filtered and the solvent removed under reduced pressure leaving 
an orange crude oil. Flash column chromatography (SiO2, Hexane/EtOAc 85:15) 
afforded 184 as a white solid (351 mg, 67 % yield over two steps). 
1H NMR (360 MHz, CDCl3) δ 7.76 – 7.61 (m, 4H, ArH), 7.51 – 7.34 (m, 6H, ArCH), 
6.67 (s, 1H, C=CH), 6.17 (s, 1H, CH2=C), 5.50 (s, 1H, CH2=C), 4.67 (dd, JAB, AX = 
18.9, 1.6 Hz, 1H, CH2OSi), 4.45 (dd, JBA, BX = 19.0, 1.8 Hz, 1H, CH2OSi), 3.93 – 3.63 
(m, 4H, OCH2CH2O), 1.93 (td, J = 13.1, 4.3 Hz, 1H, CH2), 1.67 (td, J = 12.9, 4.2 Hz, 
1H, CH2), 1.29 (td, J = 13.0, 4.2 Hz, 1H, CH2), 1.16 (s, 3H, CH3CCH2), 1.09 (s, 10H, 
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9 × CH2OSiC(CH3)3, CH2), 0.74 (s, 9H, COSiC(CH3)3), -0.08 (s, 3H, Si(CH3), -0.15 
(s, 3H, SiCH3); 
13C NMR (91 MHz, CDCl3) δ 193.6 (q), 177.8 (q), 148.3 (q), 135.6 
(CH), 135.5 (CH), 132.8 (q), 130.2 (CH), 130.1 (CH), 130.1 (CH), 128.0 (CH), 117.3 
(CH2), 109.4 (q), 79.8 (q), 64.6 (CH2), 60.2 (CH2), 33.9 (CH2), 33.3 (CH2), 26.8 
(CH3), 25.8 (CH3), 23.7 (CH3), 19.4 (q), 18.3 (q), -2.5 (CH3), -3.3 (CH3); IR (thin film, 
NaCl plate, cm-1) 3070, 2931, 1705, 1657, 1618, 1252; Elemental Analysis (%, w/w) 
calcd for C35H50O5Si2 C(69.3), H(8.30), found C(68.8), H(8.31); HRMS (ESI) m/z 
calcd for C35H54NO5Si2 [M+NH4]
+ 624.3535, found 624.3524; MP 82-84 C. 
3a-(tert-Butyldimethylsilyloxy)-3-((tert-butyldiphenylsilyloxy)methyl)-6-(2-
hydroxyethoxy)-6a-(iodomethyl)-6-methyl-4,5,6,6a-tetrahydropentalen-1(3aH)-one 
199 and 200 
 
TBAI (292 mg, 0.79 mmol, 1.2 equiv) was dissolved in dry DCM (5 mL) under N2, 
cooled to 0 °C and left to stir for 10 mins. TiCl4 (2.64 mL, 1 M in DCM, 2.64 mmol,   
4 equiv) was added dropwise over a period of 10 mins to the cooled mixture and the 
resulting dark-red solution was left to stir for a further 5 mins before being warmed to 
RT. To the reaction mixture a solution of exo-methylene 184 (400 mg, 0.66 mmol, 1 
equiv) in dry DCM (10 mL) at RT was cannulated dropwise over 15 mins. The 
reaction was left to stir for a further 1 hr at which time the reaction was quenched 
with saturated NH4Cl aqueous solution (15 mL). This was poured into a separating 
funnel and the organic phase was washed with brine and the aqueous phases were 
combined and re-extracted twice with DCM. The combined organic layers were 
dried over MgSO4, filtered and solvent evaporated under reduced pressure to leave 
 Experimental Procedures 
155 | P a g e  
 
a crude mixture which was further purified by flash column chromatography (SiO2, 
hexane/EtOAc, 6:4) which afforded a separable diastereomeric mixture of 199:200 
(5:1) (d.r. calculated from 1H-NMR of crude). Major diastereomer 199 (304 mg, 63% 
yield) and minor diastereomer 200 (79 mg, 16% yield) were both obtained as a 
brown oil in a combined overall yield of 79% (383 mg).   
Major diastereoisomer 199: 1H NMR (600 MHz, CDCl3) δ 7.69 – 7.62 (m, 4H, ArH), 
7.46 – 7.33 (m, 6H, ArH), 6.41 – 6.39 (m, 1H, C=CH), 4.66 (dd, JAB, AX = 18.5, 1.8 
Hz, 1H, CH2OSi), 4.43 (dd, JBA, BX = 18.5, 1.6 Hz, 1H, CH2OSi), 3.75 – 3.60 (m, 2H, 
OCH2CH2O), 3.53 – 3.44 (m, 2H, OCH2CH2O, CH2I), 3.33 – 3.23 (m, 2H, 
OCH2CH2O, CH2I), 1.96 (td, J = 12.8, 6.3 Hz, 1H, CH3CCH2CH2), 1.88 (dd, J = 14.0, 
6.2 Hz, 1H, CH3CCH2CH2), 1.68 (dd, J = 12.4, 6.3 Hz, 1H, CH3CCH2CH2), 1.35 (s, 
3H, CH3CCH2), 1.10 (s, 9H, CH2OSiC(CH3)3), 1.00 (td, J = 13.7, 6.4 Hz, 1H, 
CH3CCH2CH2), 0.77 (s, 9H, COSiC(CH3)3), 0.07 (s, 3H, SiCH3), -0.15 (s, 3H, 
SiCH3); 
13C NMR (91 MHz, CDCl3) δ 205.4 (q), 180.5 (q), 135.9 (CH), 133.4 (q), 
132.9 (q), 130.4 (CH), 130.4 (CH), 128.4 (CH), 128.3 (CH), 127.4 (CH), 90.0 (q), 
85.6 (q), 67.6 (q), 62.4 (CH2), 62.3 (CH2), 62.0 (CH2), 35.6 (CH2), 33.0 (CH2), 27.2 
(CH3), 26.3 (CH3), 19.7 (q), 18.9 (q), 17.9 (CH3), 2.6 (CH2), -1.6 (CH3), -1.8 (CH3); IR 
(thin film, NaCl plate, cm-1) 3447, 2931, 2858, 1703, 1634, 1105; HRMS (ESI) m/z 
calcd for C35H55INO5Si2 [M+NH4]
+ 752.2658, found 752.2659. 
Minor diastereoisomer 200: 1H NMR (600 MHz, CDCl3) δ 7.69 – 7.61 (m, 4H, ArH), 
7.46 – 7.33 (m, 6H, ArH), 6.48 – 6.44 (m, 1H, C=CH), 4.60 (dd, JAB, AX = 18.4, 1.9 
Hz, 1H, CH2OSi), 4.41 (dd, JBA, BX = 18.3, 1.6 Hz, 1H, CH2OSi), 3.76 – 3.64 (m, 3H, 
OCH2CH2O), 3.61 (d, JAB = 9.3 Hz, 1H, CH2I), 3.52 – 3.44 (m, 1H, OCH2CH2O), 3.12 
(d, J BA = 9.3 Hz, 1H, CH2I), 1.86 – 1.80 (m, 1H, CH2), 1.79 – 1.70 (m, 2H, CH2), 1.57 
– 1.49 (m, 1H, CH2), 1.28 (s, 3H, CH3CCH2), 1.10 (s, 9H, CH2OSiC(CH3)3), 0.78 (s, 
9H, COSiC(CH3)3), 0.06 (s, 3H, SiCH3), -0.16 (s, 3H, SiCH3); 
13C NMR (91 MHz, 
CDCl3) δ 204.9 (q), 179.3 (q), 135.6 (CH), 133.0 (q), 132.6 (q), 130.2 (CH), 130.1 
(CH), 128.1 (CH), 128.1 (CH), 88.5 (q), 83.3 (q), 66.3 (q), 64.8 (CH2), 62.1 (CH2), 
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61.5 (CH2), 36.2 (CH2), 36.1 (CH2), 26.9 (CH3), 26.0 (CH3), 19.4 (q), 19.1 (CH3), 
18.7 (q), 2.0 (CH2), -1.2 (CH3), -2.1 (CH3); IR (thin film, NaCl plate, cm
-1) 3449, 2931, 






Exo-methylene 184 was dissolved in a solvent mixture of MeCN:H2O (23 mL, 9:1) 
and DDQ (150 mg, 0.66 mmol, 0.2 equiv) was added in one portion. The reaction 
mixture was stirred at 40 °C for 4 hr before adding excess brine. The mixture was 
extracted with EtOAc, dried over MgSO4, filtered and the solvent removed in vacuo. 
Flash column chromatography (SiO2, hexane/EtOAc 17:3) afforded ketone 205 as a 
white solid (1.7 g, 92% yield). 
1H NMR (600 MHz, CDCl3) δ 7.69 – 7.62 (m, 4H, ArH), 7.48 – 7.36 (m, 6H, ArH), 
6.66 (s, 1H, C=CH), 6.17 (s, 1H, CH2=C), 5.49 (s, 1H, CH2=C), 4.66 (dd, JAB, AX = 
18.8, 1.7 Hz, 1H, CH2OSi), 4.37 (dd, JBA, BX = 18.8, 1.8 Hz, 1H, CH2OSi), 2.16 – 2.00 
(m, 2H, CH2), 1.98 (s, 3H, CH3CO), 1.91 – 1.80 (m, 2H, CH2), 1.09 (s, 9H, 
CH2OSiC(CH3)3), 0.74 (s, 9H, COSiC(CH3)3), -0.08 (s, 3H, SiCH3), -0.16 (s, 3H, 
SiCH3); 
13C NMR (151 MHz, CDCl3) δ 206.8 (q), 193.2 (q), 177.4 (q), 148.1 (q), 
135.6 (CH), 135.5 (CH), 132.7 (q), 132.6 (q), 130.4 (CH), 130.2 (CH), 128.1 (CH), 
128.0 (CH), 117.7 (CH2), 79.5 (q), 60.1 (CH2), 38.2 (CH2), 33.0 (CH2), 30.1 (CH3), 
26.9 (CH3), 25.7 (CH3), 19.4 (q), 18.3 (q), -2.5 (CH3), -3.3 (CH3); IR (thin film, NaCl 
plate, cm-1) 3072, 2930, 2251, 1700, 1656, 1115; Elemental Analysis (%, w/w) calcd 
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for C33H46O4Si2 C(70.4), H(8.24), found C(70.4), H(8.24); HRMS (ESI) m/z calcd for 
C33H50NO4Si2 [M+NH4]
+ 580.3273, found 580.3273; MP 78-80 C. 
3a-(tert-Butyldimethylsilyloxy)-3-((tert-butyldiphenylsilyloxy)methyl)-6-hydroxy-6a-
(iodomethyl)-6-methyl-4,5,6,6a-tetrahydropentalen-1(3aH)-one 206 and 207 
 
TBAI (1.31 g, 3.55 mmol, 2 equiv) was dissolved in dry DCM (20 mL) under N2, 
cooled to 0 °C and left to stir for 10 mins. TiCl4 (7.11 mL, 1 M in DCM, 7.11 mmol,    
4 equiv) was added dropwise over a period of 10 mins to the cooled mixture and the 
resulting dark-red solution was left to stir for a further 5 mins before being warmed to 
RT. To the reaction mixture was added slowly a solution of ketone 205 (1 g, 1.78 
mmol, 1 equiv) in dry DCM (10 mL) over 15 mins. The reaction was left to stir for a 
further 1 hr at which time the reaction was quenched with saturated NH4Cl aqueous 
solution (15 mL). This was poured into a separating funnel and the organic phase 
was washed with brine and the aqueous phases were combined and re-extracted 
twice with DCM. The combined organic layers were dried over MgSO4, filtered and 
solvent evaporated under reduced pressure to leave a crude mixture which was 
further purified by flash column chromatography (SiO2, Hexane/EtOAc, 9:1) which 
afforded a separable diastereomeric mixture of 206:207 (6:1) (d.r calculated from 
1H-NMR of crude). Major diastereomer 206 was obtained as a white solid (733 mg, 
60% yield) and minor diastereomer 207 as a white solid (125 mg, 10% yield) and 
unreacted starting material 205 (250 mg). Minor diastereomer 207 (125 mg) was 
dissolved in DCM (5 mL), treated with basic alumina (1 g) in DCM and stirred 
overnight. All minor 207 was recycled back to starting material 205 (via a retro-aldol 
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process) as determined by 1H-NMR of the crude reaction mixture. The stocks of 
unreacted starting material 205 were combined (330 mg, 0.59 mmol) and 
resubmitted again to the reaction conditions. After a single attempt of recycling, the 
combined overall yield of major diastereomer 206 was increased (936 mg, 79% 
combined yield) with a diminished quantity of minor diastereomer 207 (55 mg, 5% 
combined yield) in an isolated diastereomeric ratio of 206:207 (15:1). 
Major diastereoisomer 206: 1H NMR (600 MHz, CDCl3) δ 7.69 – 7.61 (m, 4H, ArH), 
7.47 – 7.33 (m, 6H, ArH), 6.52 (s, 1H, C=CH), 4.66 (d, J = 18.8 Hz, 1H, CH2OSi), 
4.63 (s, 1H, OH), 4.41 (d, J = 18.8 Hz, 1H, CH2OSi), 3.49 (d, J = 9.6 Hz, 1H, CH2I), 
3.14 (d, J = 9.6 Hz, 1H, CH2I), 1.83 – 1.69 (m, 3H, CH2, CH2), 1.41 – 1.29 (m, 1H, 
CH2), 1.21 (s, 3H, CH3CCH2), 1.11 (s, 9H, CH2OSiC(CH3)3), 0.76 (s, 9H, 
COSiC(CH3)3), 0.08 (s, 3H, SiCH3), -0.17 (s, 3H, SiCH3); 
13C NMR (126 MHz, 
CDCl3) δ 209.7 (q), 182.6 (q), 135.6 (CH), 132.9 (q), 132.5 (q), 130.2 (CH), 130.2 
(CH), 128.1(CH), 128.1 (CH), 127.1 (CH), 87.5 (q), 79.4 (q), 64.2 (q), 61.7 (CH2), 
39.1 (CH2), 36.6 (CH2), 26.9 (CH3), 25.9 (CH3), 22.6 (CH3), 19.4 (q), 18.7 (q), 0.9 
(CH2), -1.1 (CH3), -2.2 (CH3); IR (thin film, NaCl plate, cm
-1) 3420, 2957, 2251, 1693, 
1633; Elemental Analysis (%, w/w) calcd for C33H47IO4Si2 C(57.4), H(6.86), found 
C(57.6), H(6.91); HRMS (ESI) m/z calcd for C33H47IO4Si2 [M+H]
+, 691.2130, found 
691.2134; MP 102-104 C. 
X-ray crystal structure for 206:  
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Minor diastereoisomer 207: 1H NMR (700 MHz, CDCl3) δ 7.68 – 7.63 (m, 4H, ArH), 
7.46 – 7.34 (m, 6H, ArH), 6.37 (t, J = 1.7 Hz, 1H, C=CH), 4.68 (dd, JAB, AX = 18.5, 1.9 
Hz, 1H, CH2OSi), 4.45 (dd, JBA, BX = 18.5, 1.7 Hz, 1H, CH2OSi), 3.45 (d, J = 9.7 Hz, 
1H, CH2I), 3.26 (d, J = 9.7 Hz, 1H, CH2I), 2.22 (td, J = 12.8, 6.7 Hz, 1H, CH2), 1.72 
(dd, J = 12.6, 6.6 Hz, 1H, CH2), 1.65 (dd, J = 13.4, 6.6 Hz, 1H, CH2), 1.43 (s, 3H, 
CH3CCH2), 1.25 (td, J = 13.2, 6.7 Hz, 1H, CH3CH2CH2), 1.11 (s, 9H, 
CH2OSiC(CH3)3), 0.78 (s, 9H, COSiC(CH3)3), 0.10 (s, 3H, SiCH3), -0.12 (s, 3H, 
SiCH3); 
13C NMR (176 MHz, CDCl3) δ 205.4 (q), 180.5 (q), 135.6 (CH), 133.2 (CH), 
132.7 (CH), 130.1 (CH), 130.1 (CH), 128.1 (CH), 128.0 (CH), 126.6 (CH), 89.9 (q), 
80.8 (q), 66.9 (q), 61.7 (CH2), 38.5 (CH2), 35.8 (CH2), 27.0 (CH3), 26.0 (CH3), 23.9 
(CH3), 19.4 (q), 18.6 (q), 1.8 ((CH2), -2.1 (CH3), -2.2 (CH3); IR (thin film, NaCl plate, 
cm-1) 3449, 2930, 2251, 1693, 1632; HRMS (ESI) m/z calcd for C33H47IO4Si2 [M+H]
+, 
691.2130, found 691.2131; MP 106-108 C. 
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Bicycle 206 (30 mg, 0.04 mmol, 1 equiv) was dissolved in anhydrous THF (2 mL) 
and cooled to 0 °C before dropwise addition isopropylmagnesium chloride lithium 
chloride (0.1 mL, 1.3 M in THF, 0.13 mmol, 3 equiv). The reaction mixture was 
stirred for 30 mins at 0 °C before quenching with brine, extracted with DCM, dried 
over MgSO4 filtered and solvent removed in vacuo. Flash column chromatography 
(SiO2, hexane/EtOAc 9:1) afforded the title compound 219 as a colourless oil        
(26 mg, 98% yield). 
1H NMR (600 MHz, CDCl3) δ 7.67 – 7.60 (m, 4H, ArH), 7.47 – 7.34 (m, 6H, ArH), 
6.46 (s, 1H, C=CH), 5.14 (s, 1H, OH), 4.64 (dd, JAB, AX = 18.7, 1.6 Hz, 1H, CH2OSi), 
4.44 (dd, JBA, BX = 18.7, 1.6 Hz, 1H, CH2OSi), 1.79 – 1.62 (m, 1H, CH2), 1.60 – 1.50 
(m, 3H, CH2, CH2), 1.18 (s, 3H, CH3CCH2), 1.10 (s, 9H, CH2OSiC(CH3)3), 0.84 (d, J 
= 6.7 Hz, 3H, CH3CH), 0.82 (d, J = 6.5 Hz, 3H, CH3CH), 0.71 (s, 9H, COSiC(CH3)3), 
0.07 (s, 3H, SiCH3), -0.18 (s, 3H, SiCH3); 
13C NMR (91 MHz, CDCl3) δ 213.2 (q), 
183.3 (q), 135.5 (CH), 135.5 (CH), 132.8 (q), 132.6 (q), 130.2 (CH), 128.1 (CH), 
88.1 (q), 79.0 (q), 66.0 (q), 61.8 (CH2), 38.5 (CH2), 37.8 (CH2), 36.6 (CH2), 26.9 
(CH3), 26.0 (CH3), 25.7 (CH3), 24.2 (CH) 24.2 (CH3), 22.9 (CH3), 19.4 (q), 18.6 (q), -
1.1 (CH3), -1.9 (CH3); IR (thin film, NaCl plate, cm
-1) 3446, 2956, 1683, 1632, 1471, 
1113; HRMS (ESI) m/z calcd for C36H54O4Si2Na [M+Na]
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Furfuryl alcohol 232 (15 g, 153 mmol, 1 equiv) was dissolved in deionised water 
(500 mL) and the resulting solution was deoxygenated with a stream of N2 for 1 hr. 
Following addition of hydroquinone (160 mg, 1.45 mmol, 0.0095 equiv) and sodium 
dihydrogenphosphate (734 mg, 6.1 mmol, 0.04 equiv), the pH was adjusted to 4.1 
by careful addition of 0.25 M orthophosphoric acid and the reaction mixture was 
then heated to reflux for 24 hr. Formation of a thick brown oil was observed, which 
was dispersed by addition of 1,4-dioxane (200 mL) before returning the mixture to 
reflux for a further 48 hr. After cooling to RT, the solution was washed with toluene 
and the aqueous layer was concentrated in vacuo to approximately 200 mL. 
Azeotropic distillation under reduced pressure with ethanol to remove the remaining 
water left a dark brown oil. The crude was diluted with EtOAc, dried over MgSO4, 
filtered and solvent removed under reduced pressure. Flash column 
chromatography (SiO2, EtOAc) furnished cyclopentenol 233 as an orange oil (8.98 
g, 60% yield).   
1H NMR (600 MHz, CDCl3) δ 7.56 (dd, JAB, AX = 5.6, 2.2 Hz, 1H, CHCH=CH ), 6.16 
(d, J = 5.6 Hz, 1H, CHCH=CH), 4.99 (d, J = 4.5 Hz, 1H, CHOH ), 3.50 (s, 1H, 
CHOH), 2.71 (dd, JAB, AX = 18.5, 6.0 Hz, 1H, CH2), 2.23 (dd, JBA, BX = 18.5, 1.9 Hz, 
1H, CH2); 
13C NMR (151 MHz, CDCl3) δ 207.5 (q), 164.1 (CH), 134.9 (CH), 70.3 
(CH), 44.3 (CH2). 
The spectroscopic data were in agreement with those previously published.90  
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A solution of cyclopentenol 233 (15.2 g, 155 mmol, 1 equiv), triethylamine (59.3 mL, 
423 mmol, 2.73 equiv) and DMAP (1.9 g, 15 .5 mmol, 0.1 equiv) in anhydrous DCM 
(160 mL) and was stirred at RT for 10 mins under an atmosphere of N2. This mixture 
was then cooled to 0°C at which time TESCl (25.7 g, 171 mmol, 1.1 equiv) was 
slowly added to the reaction mixture and left for 3 hr at RT. The reaction mixture 
was poured into a separating funnel containing saturated NH4Cl solution, extracted 
with DCM and the organic layer washed with brine, dried over MgSO4 and 
evaporated to dryness. Flash column chromatography (SiO2, hexane/EtOAc 9:1) 
furnished 234 as a clear pale yellow oil (26.3 g, 80% yield). 
1H NMR (400 MHz, CDCl3) δ 7.46 (dd, JAB, AX = 5.7, 2.3 Hz, 1H, CHCH=CH), 6.18 
(dd, JBA, BX = 5.6, 1.3 Hz, 1H, CHCH=CH), 5.01 – 4.95 (m, 1H, CHOSi), 2.71 (dd, JAB, 
AX = 18.2, 6.0 Hz, 1H, CH2CO), 2.26 (dd, JBA, BX = 18.2, 2.2 Hz, 1H, CH2CO), 1.03 – 
0.93 (m, 9H, Si(CH2CH3)3), 0.70 – 0.55 (m, 6H, Si(CH2CH3)3); 
13C NMR (151 MHz, 
CDCl3) δ 206.5 (q), 163.9 (CH), 134.6 (CH), 70.6 (CH), 45.1 (CH2), 6.7 (CH3), 4.8 
(CH2). 
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Enone 234 (17.7g, 83 mmol, 1 equiv) was dissolved in a solvent mixture of 
DCM:pyridine (125 mL, 1:1.5) and  stirred for 10 mins before iodine (63.8 g, 250 
mmol,  3 equiv) was added in one portion. The reaction mixture was left stirring at 
RT for 2 hr before being poured into a separating funnel containing saturated 
sodium thiosulfate, extracted with DCM and the organic layer washed with brine, 
dried over Na2SO4 and evaporated under reduced pressure. Flash column 
chromatography (SiO2, hexane/EtOAc 19:1) afforded α-iodo enone 235 as a yellow 
oil (16.1 g, 57% yield). 
1H NMR (600 MHz, CDCl3) δ 7.78 (d, J = 2.5 Hz, 1H, CH=CI ), 4.93 (dt, J = 6.0, 2.3 
Hz, 1H, CHOSi), 2.85 (dd, JAB, AX = 18.2, 6.1 Hz, 1H, CH2CO), 2.34 (dd, JBA, BX = 18.2, 
2.1 Hz, 1H, CH2CO), 0.96 (t, J = 8.0 Hz, 9H, Si(CH2CH3)3), 0.63 (q, J = 7.9 Hz, 6H, 
Si(CH2CH3)3); 
13C NMR (151 MHz, CDCl3) δ 200.2 (q), 169.2 (CH), 105.0 (q), 71.9 
(CH), 42.5 (CH2), 6.7 (CH3), 4.8 (CH2). 
The spectroscopic data were in agreement with those previously published.141 
4-(tert-Butyldimethylsilyloxy)cyclopent-2-enone 239 
 
A solution of cyclopentenol 233 (6.2 g, 63 mmol, 1 equiv), triethylamine (20.2 mL, 
145 mmol, 2.3 equiv) and DMAP (772 mg, 6.3 mmol, 0.1 equiv) in DCM (40 mL) 
was stirred for 10 mins at 0 °C before addition of TBSCl (10.5 g, 70 mmol, 1.1 
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equiv). The resulting mixture was then heated to reflux for 2 hr before addition of 
saturated NH4Cl solution. After separation of the organic layer, the aqueous phase 
was extracted with DCM and the combined organic layers were dried over MgSO4, 
filtered and solvent removed under reduced pressure. Purification by flash column 
chromatography (SiO2, hexane/EtOAc 9:1) yielded cyclopentenone 239 as orange 
needlelike crystals (11.39 g, 85% yield). 
1H NMR (360 MHz, CDCl3) δ 7.45 (dd, JAB, AX = 5.6, 2.2 Hz, 1H, CHCH=CH), 6.18 
(dd, JBA, BX = 5.6, 1.1 Hz, 1H, CHCH=CH), 5.04 – 4.95 (m, 1H, CHOSi), 2.71 (dd, JAB, 
AX = 18.2, 6.0 Hz, 1H, CH2CO), 2.24 (dd, JBA, BX = 18.2, 2.2 Hz, 1H, CH2CO), 0.91 (s, 
9H, Si(CH3)3), 0.16 – 0.10 (m, 6H, 2 × SiCH3); 
13C NMR (151 MHz, CDCl3) δ 206.5 
(q), 163.9 (CH), 134.5 (CH), 71.0 (CH), 45.1 (CH2), 25.8 (CH3), 18.2 (q), -4.6 (CH3), 
-4.6 (CH3) ; MP 30-32 C 
The spectroscopic data were in agreement with those previously published.142 
4-(tert-Butyldimethylsilyloxy)-2-(hydroxymethyl)cyclopent-2-enone 240 and                         
4-(tert-Butyldimethylsilyloxy)-2,5-bis(hydroxymethyl)cyclopent-2-enone 241 
 
A solution of cyclopentenone 239 (5 g, 24 mmol, 1 equiv), imidazole (802 mg, 11.8 
mmol, 0.5 equiv), formaldehyde (9.65 mL, 37% Aq solution, 130 mmol, 5.5 equiv) in 
THF:H2O (48 mL, 1:1) was stirred at RT for six days before addition of EtOAc. The 
organic layer was separated and the aqueous layer was extracted twice with EtOAc 
and the combined organic extracts were dried over MgSO4, filtered and solvent 
removed under reduced pressure. Flash column chromatography (SiO2, 
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hexane/EtOAc 7:3) yielded a separable mixture of products, alcohol 240 (2.28 g, 
40% yield) and diol 241 (0.63 g, 11% yield), both as colourless oils. 
Alcohol 240: 1H NMR (500 MHz, CDCl3) δ 7.29 – 7.24 (m, 1H, CH=C), 4.96 – 4.91 
(m, 1H, CHCH=C ), 4.43 – 4.31 (m, 2H, CH2OH), 2.78 (dd, J = 18.4, 5.9 Hz, 1H, 
CH2CO), 2.38 – 2.27 (m, 2H, CH2CO, OH), 0.90 (s, 9H, Si(CH3)3), 0.15 – 0.10 (m, 
6H, 2 × SiCH3); 
13C NMR (126 MHz, CDCl3) δ 206.1 (q), 157.6 (CH), 145.6 (q), 69.2 
(CH), 57.5 (CH2), 46.0 (CH2), 25.9 (CH3), 18.2 (q), -4.6 (CH3), -4.6 (CH3); IR (thin 
film, NaCl plate, cm-1) 3435, 2930, 1710, 1471, 1254, 1088; HRMS (ESI) m/z calcd 
for C12H23O3Si [M+H]
+, 243.1411, found 243.1412. 
Diol 241: 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.28 (m, 1H, CH=C), 4.88 – 4.82 (m, 
1H, CHCH=C), 4.45 – 4.32 (m, 2H, CCH2OH), 4.15 – 4.06 (m, 1H, CHCH2OH), 3.90 
– 3.81 (m, 1H, CHCH2OH), 2.53 – 2.46 (m, 1H, CHCH2OH), 2.26 – 2.09 (m, 2H, 2 × 
OH), 0.91 (s, 9H, Si(CH3)3), 0.17 – 0.14 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 
206.8 (q), 157.8 (CH), 145.3 (q), 71.7 (CH), 59.4 (CH2), 58.9 (CH), 57.4 (CH2), 25.9 
(CH3), 18.2 (q), -4.5 (CH3), -4.6 (CH3); IR (thin film, NaCl plate, cm
-1) 3334, 2929, 
2250, 1712, 1464, 1259, 1080; HRMS (ESI) m/z calcd for C13H28NO4Si [M+NH4]
+, 
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2-(Benzyloxymethyl)-4-(tert-butyldimethylsilyloxy)cyclopent-2-enone 242              
and 4-(benzyloxy)-2-(benzyloxymethyl)cyclopent-2-enone 243 
 
Method A: A mixture of alcohol 240 (100 mg, 0.41 mmol, 1 equiv), 2-benzyloxy-1-
methylpyridinium triflate (303 mg, 0.87 mmol, 2.1 equiv) and MgO (34.9 mg,         
0.7 mmol, 2.1 equiv, vacuum dried) were dissolved in benzotrifluoride (0.85 mL) and 
heated to 85 °C for 22 hr. The reaction mixture was cooled to RT and excess 
saturated NH4Cl was added. The resulting mixture was extracted with EtOAc, the 
organic phase washed with brine, dried over MgSO4, filtered and the solvent 
removed in vacuo. Flash column chromatography (SiO2, hexane/EtOAc 9:1) 
afforded a separable mixture of mono-benzylated 242 as a colourless oil (20 mg, 
15% yield) and bis-benzylated 243 as a colourless oil (63 mg, 50% yield). 
Method B: A solution of alcohol 240 (50 mg, 0.21 mmol, 1 equiv), benzyl 
trichloroacetimidate (104 mg, 0.41 mmol, 2 equiv) and triflic acid (10 µL, 0.11 mmol, 
0.54 equiv) were dissolved in a solvent mixture of cyclohexane:DCM (5 mL, 2:1) and 
stirred at RT for 4 hr. The reaction mixture was diluted with EtOAc, washed with 
saturated NH4Cl, brine, dried over MgSO4, filtered and solvent evaporated under 
reduced pressure. Flash column chromatography (SiO2, hexane/EtOAc 9:1) 
furnished bis-benzylated 243  as  a colourless oil (9.9 mg, 16% yield). 
Mono-benzylated 242: 1H NMR (360 MHz, CDCl3) δ 7.39 – 7.27 (m, 6H, 6 × ArH, 1 × 
CH=C), 4.97 – 4.89 (m, 1H, CHCH=C), 4.58 (s, 2H, OCH2Ph), 4.23 – 4.18 (m, 2H, 
CH2OBn), 2.77 (dd, JAB, AX = 18.3, 5.9 Hz, 1H, CH2CO), 2.32 (dd, JBA, BX = 18.3, 2.1 
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Hz, 1H, CH2CO), 0.91 (s, 9H, SiC(CH3)3), 0.16 – 0.09 (m, 6H, 2 × SiCH3); 
13C NMR 
(91 MHz, CDCl3) δ 204.9 (q), 158.3 (CH), 144.2 (q), 137.9 (q), 128.6 (CH), 128.0 
(CH), 127.9 (CH), 73.5 (CH2), 69.3 (CH), 64.0 (CH2), 45.9 (CH2), 25.9 (CH3), 18.3 
(q), -4.6 (CH3), -4.6 (CH3); IR (thin film, NaCl plate, cm
-1) 2929, 1713, 1471, 1362, 
1254, 1089; HRMS (ESI) m/z calcd for C19H29O3Si [M+H]
+, 333.1880, found 
333.1880. 
Bis-benzylated 243: 1H NMR (800 MHz, CDCl3) δ 7.57 – 7.53 (m, 1H, CH=C), 7.43 – 
7.27 (m, 10H, ArH ), 4.75 – 4.70 (m, 1H, CHOBn), 4.67 – 4.55 (m, 4H, 2 × CH2Ph), 
4.27 – 4.19 (m, 2H, CH2O), 2.75 (dd, JAB, AX = 18.3, 5.9 Hz, 1H, CH2CO), 2.45 (dd, 
JBA, BX = 18.3, 2.0 Hz, 1H, CH2CO); 
13C NMR (201 MHz, CDCl3) δ 204.4 (q), 155.4 
(CH), 145.6 (q), 137.9 (q), 137.7 (q), 128.7 (CH), 128.6 (CH), 128.2 (CH), 128.0 
(CH), 128.0 (CH), 127.9 (CH), 75.2 (CH), 73.4 (CH2), 71.9 (CH2), 64.0 (CH2), 42.7 
(CH2); IR (thin film, NaCl plate, cm
-1) 3030, 2858, 2250, 1710, 1496, 1454, 1094; 
HRMS (ESI) m/z calcd for C20H21O3 [M+H]




A solution of alcohol 240 (6.8 g, 28.1 mmol, 1 equiv), imidazole (4.77 g, 70.1 mmol, 
2.5 equiv) and DMAP (343 mg, 2.8 mmol, 0.1 equiv) in DMF (50 mL) was stirred for 
10 mins at 0 °C before addition of TBDPSCl (9.25 g, 33.7 mmol, 1.2 equiv). The 
resulting mixture was then allowed to warm to RT and stirred for 2 hr before being 
quenched with H2O (5 mL) and poured into a separating funnel containing Et2O and 
distilled H2O. The organic layer was separated and washed twice with distilled water 
to remove any residual DMF. The organic extract was dried over MgSO4, filtered 
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and solvent removed in vacuo. Flash column chromatography (SiO2, hexane/EtOAc 
9:1) yielded cyclopentenone 244 as a pale yellow oil (9.98 g, 74% yield). 
1H NMR (600 MHz, CDCl3) δ 7.69 – 7.64 (m, 4H, ArH), 7.47 – 7.35 (m, 7H, 6 × ArH, 
1 × CHCH=C ), 4.97 – 4.91 (m, 1H, CHCH=C), 4.47 – 4.41 (m, 2H, CH2O), 2.76 (dd, 
J = 18.3, 5.9 Hz, 1H, CH2CO), 2.32 (dd, J = 18.3, 1.9 Hz, 1H, CH2CO), 1.10 (s, 9H, 
CH2OSiC(CH3)3), 0.94 (s, 9H, COSiC(CH3)3), 0.17 (s, 3H, SiCH3), 0.15 (s, 3H, 
SiCH3); 
13C NMR (151 MHz, CDCl3) δ 204.7 (q), 157.1 (CH), 146.9 (q), 135.6 (CH), 
135.6 (CH), 133.2 (q), 133.1 (q), 130.0 (CH), 130.0 (CH), 127.9 (CH), 69.2 (CH), 
58.9 (CH2), 46.3 (CH2), 27.0 (CH3), 25.9 (CH3), 19.4 (q), 18.3 (q), -4.5 (CH3), -4.5 
(CH3); IR (thin film, NaCl plate, cm
-1) 3071, 2930, 1713, 1471, 1428, 1254, 1113; 
HRMS (ESI) m/z calcd for C28H44NO3Si2 [M+Na]




Iodo-dioxolane 147 (13.2 g,  55 mmol, 4 equiv) was dissolved in dry Et2O (100 mL), 
cooled to −78 °C under an atmosphere of N2 before slow addition of 
tBuLi (67.6 mL, 
1.7 M solution in pentane, 115 mmol, 8.4 equiv). The resulting mixture was stirred at  
−78 °C for 45 mins before warming to room temperature and stirring for another 1 
hr. At which time, the mixture was cannulated into a precooled solution of enone 173 
(5 g, 13.6 mmol, 1 equiv) in dry Et2O (50 mL) at −78°C. The resulting reaction 
mixture was stirred at −78 °C for 1.5 hr before warming to room temperature and left 
for a further 30 mins. The reaction was quenched with distilled water (10 mL) and 
poured into a separating funnel containing saturated NH4Cl solution. The organic 
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layer was separated and the aqueous fraction was extracted twice with EtOAc. The 
organic extracts were combined, washed with brine, dried over MgSO4, filtered and 
solvent evaporated under reduced pressure. Purification by flash column 
chromatography (SiO2, hexane/EtOAc 8:2) furnished an inseparable 6:1 
diastereomeric mixture of tertiary alcohol 245 as an oil (4.73 g, 72% yield). 
1H NMR (500 MHz, CDCl3) major diastereomer: δ 7.74 – 7.65 (m, 4H, ArH), 7.47 – 
7.36 (m, 7H, 6 × ArH, 1 × CH=C), 5.85 – 5.82 (m, 1H), 4.57 (s, 1H, CHOH), 4.46 – 
4.28 (m, 2H, CH2O), 3.98 – 3.80 (m, 4H, OCH2CH2O), 2.96 (s, 1H, OH), 2.42 (dd, 
JAB, AX = 14.2, 6.9 Hz, 1H, CH2COH), 1.98 – 1.64 (m, 3H, CH2, CH2COH ), 1.60 – 
1.45 (m, 2H, CH2), 1.27 (s, 3H, CH3CCH2), 1.07 (s, 9H, SiC(CH3)3); The 
1H NMR 
signals of the minor diastereoisomer were too weak to be confidently assigned;          
13C NMR (126 MHz, CDCl3) major diastereomer: δ 149.6 (q), 135.7 (CH), 135.6 
(CH), 132.9 (q), 132.8 (q), 130.6 (CH), 130.0 (CH), 129.9 (CH), 127.8 (CH), 127.8 
(CH), 109.8 (q), 83.7 (q), 73.5 (CH), 64.7 (CH2), 60.8 (CH2), 48.2 (CH2), 33.7 (CH2), 
32.7 (CH2), 26.8 (CH3), 23.9 (CH3), 19.1 (q); The 
13C NMR signals of the minor 
diastereoisomer were too weak to be confidently assigned; IR (thin film, NaCl plate, 
cm-1) 3398, 2932, 2247, 1472, 1428, 1113; HRMS (ESI) m/z calcd for C28H42NO5Si 
[M+NH4]
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A solution of tertiary alcohol 245 (1 g, 2.07 mmol, 1 equiv), NaHCO3 (0.87 g, 10.36 
mmol, 5 equiv) and DMP (1.14 g, 2.69 mmol, 1.3 equiv) in DCM (30 mL) was stirred 
at RT for 1 hr. The reaction mixture was quenched with H2O (5 mL) and the organic 
layer was separated, washed with brine, dried over MgSO4 filtered and the solvent 
removed in vacuo. Purification by flash column chromatography (SiO2, 
hexane/EtOAc 4:6) furnished enone 246 as an off-white solid (0.92 g, 92 % yield).  
1H NMR (500 MHz, CDCl3) δ 7.72 – 7.63 (m, 4H, ArH), 7.49 – 7.34 (m, 6H, ArH), 
6.21 (t, J = 1.7 Hz, 1H, C=CH), 4.69 (dd, JAB, AX = 17.5, 1.8 Hz, 1H, CH2OH), 4.54 
(dd, JBA, BX = 17.5, 1.6 Hz, 1H, CH2OH), 4.01 – 3.76 (m, 4H, OCH2CH2O), 2.97 (s, 
1H, OH), 2.60 (d, J = 18.3 Hz, 1H, CH2CO), 2.48 (d, J = 18.3 Hz, 1H, CH2CO), 1.95 
– 1.84 (m, 1H, CH2), 1.80 – 1.67 (m, 1H, CH2), 1.66 – 1.49 (m, 2H, CH2), 1.26 (s, 
3H, CH3CCH2), 1.08 (s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 204.7 (q), 
179.8 (q), 135.7 (CH), 135.6 (CH), 132.5 (q), 132.5 (q), 130.3 (CH), 130.2 (CH), 
129.1 (CH), 128.1 (CH), 109.5 (q), 79.2 (q), 64.8 (CH2), 64.8 (CH2), 60.9 (CH2), 50.1 
(CH2), 34.0 (CH2), 32.9 (CH2), 26.9 (CH3), 24.0 (CH3), 19.3 (q); IR (thin film, NaCl 
plate, cm-1) 3425, 2932, 2249, 1695, 1628, 1114; HRMS (ESI) m/z calcd for 
C28H36O5SiNa [M+Na]
+, 503.2224, found 503.2229; MP 60-62 C. 
 
 Experimental Procedures 





A solution of enone 246 (750 mg, 1.56 mmol, 1 equiv) in anhydrous THF (20 mL) 
was cooled to −78 °C under N2 and stirred for 10 mins before slow addition of LDA 
(4.33 mL, 1.8 M solution in THF/heptane/ethylbenzene, 7.80 mmol, 5 equiv). The 
reaction mixture was stirred for 1 hr and then cannulated across to a precooled 
solution of Eschenmoser’s salt (808 mg, 4.68 mmol, 4 equiv) in THF (10 mL) at     
−78 °C.  The reaction was left stirring at −78 °C for 2 hr before allowing to warm to 
RT and stirred for a further 30 mins. The reaction was quenched with a saturated 
NaHCOs solution and extracted with DCM. The DCM extracts were washed with 
brine, dried over MgSO4, filtered and solvent evaporated under reduced pressure. 
The crude  orange residue was dissolved in a mixture of DCM:NaHCO3 (30 mL, 2:1) 
and under vigorous stirring, one portion of mCPBA (808 mg, 4.68 mmol, 3 equiv) 
was carefully added and left to stir for 1 hr before separating the organic layer. The 
aqueous layer was extracted with DCM and the combined organic fractions were 
dried over MgSO4, filtered and solvent removed under reduced pressure leaving an 
orange crude oil. Flash column chromatography (SiO2, hexane/EtOAc 4:6) afforded 
an inseparable 2:1 mixture of exo-methylene 247 (ca. 209 mg, 27% yield) and 
starting material 246 (ca. 113 mg, 33%) as an impure white solid (322 mg) as 
determined by 1H NMR.  
1H NMR (500 MHz, CDCl3) δ 7.74 – 7.59 (m, 4H, ArH), 7.49 – 7.34 (m, 6H, ArH), 
6.56 (s, 1H, C=CH), 6.09 (s, 1H, CH2=C), 5.56 (s, 1H, CH2=C), 4.72 (dd, J = 18.5, 
1.8 Hz, 1H, CH2O), 4.54 (dd, J = 18.5, 1.8 Hz, 1H, CH2O), 3.97 – 3.68 (m, 4H, 
OCH2CH2O ), 2.20 (s, 1H, OH), 1.97 (td, J = 12.8, 4.6 Hz, 1H, CH3CCH2CH2), 1.78 – 
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1.70 (m, 1H, CH3CCH2CH2), 1.45 – 1.36 (m, 1H, CH3CCH2CH2), 1.18 (s, 3H, 
CH3CCH2), 1.09 (s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 193.1 (q), 176.4 
(q), 149.6 (q), 135.7 (CH), 135.6 (CH), 132.7 (q), 132.6 (q), 130.6 (CH), 130.3 (CH0, 
130.2 (CH), 128.1 (CH), 128.1 (CH), 116.4 (CH2), 109.3 (q), 78.6 (q), 64.8 (CH2), 
64.8 (CH2), 60.4 (CH2), 33.8 (CH2), 32.0 (CH2), 26.9 (CH3), 23.9 (CH3), 19.4 (q); IR 
(thin film, NaCl plate, cm-1) 3415, 2932, 2249, 1700, 1114; HRMS (ESI) m/z calcd 
for C29H36O5SiNa [M+Na]




Tertiary alcohol 246 (2.1 g, 4.37 mmol, 1 equiv), 2,6-lutidine (3.2 mL, 27.53 mmol, 
6.3 equiv) was dissolved in dry DMF (40 mL) and cooled to 0 °C under an 
atmosphere of N2. The resulting mixture was stirred for 5 mins before dropwise 
addition of a TESOTf (2.96 mL, 13.11 mmol, 3 equiv). The reaction mixture was 
stirred for 20 mins before warming to RT and left for a further 1.5 hr until the reaction 
was complete as confirmed by TLC. This was then quenched with saturated NH4Cl 
solution extracted with Et2O. The Et2O extracts was washed twice with distilled 
water to remove residual DMF and the organic fractions were combined, dried over 
MgSO4, filtered and concentrated in vacuo. Flash column chromatography (SiO2, 
hexane/EtOAc 4:1) supplied TES ether 248 as a colourless oil (2.28 g, 88% yield). 
1H NMR (500 MHz, CDCl3) δ 7.69 – 7.62 (m, 4H, ArH), 7.47 – 7.36 (m, 6H, ArH), 
6.37 (t, J = 1.9 Hz, 1H, C=CH), 4.64 (dd, JAB, AX = 18.7, 1.8 Hz, 1H, CH2OH), 4.45 
(dd, J = 18.7, 2.0 Hz, 1H, CH2OH), 3.94 – 3.71 (m, 4H, OCH2CH2O), 2.56 (d, J = 1.9 
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Hz, 2H, CH2CO), 1.84 – 1.74 (m, 1H, CH2), 1.53 – 1.42 (m, 2H, CH3CCH2CH2), 1.35 
– 1.26 (m, 1H, CH2), 1.20 (s, 3H, CH3CCH2), 1.08 (s, 9H, SiC(CH3)3), 0.82 (t, J = 7.9 
Hz, 9H, , Si(CH2CH3)3), 0.51 – 0.43 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, 
CDCl3) δ 204.4 (q), 182.7 (q), 135.6 (CH), 135.6 (CH), 133.0 (q), 132.9 (q), 130.1 
(CH), 130.1 (CH), 128.3 (CH), 128.0 (CH), 128.0 (CH), 109.5 (q), 80.6 (q), 64.8 
(CH2), 64.8 (CH2), 60.4 (CH2), 50.2 (CH2), 34.7 (CH2), 34.1 (CH2), 26.9 (CH3), 24.0 
(CH3), 19.4 (q), 7.0 (CH3), 6.3 (CH2); IR (thin film, NaCl plate, cm
-1) 2956, 1719, 






A solution of enone 248 (2.5 g, 4.20 mmol, 1 equiv) in anhydrous THF (65 mL) was 
cooled to −78 °C under N2 and stirred for 10 mins before slow addition of LDA (7.01 
mL, 1.8 M solution in THF/heptane/ethylbenzene, 12.61 mmol, 3 equiv). The 
reaction mixture was stirred for 1 hr and then cannulated across to a precooled 
solution of Eschenmoser’s salt (2.33 g, 12.61 mmol, 3 equiv) in dry THF (30 mL) at 
−78 °C.  The resulting solution was left stirring at −78 °C for 2 hr before allowing to 
warm to RT and stirred for a further 30 mins. The reaction was quenched with a 
saturated NaHCO3 solution and extracted with DCM. The DCM extracts were 
washed with brine, dried over MgSO4, filtered and solvent evaporated under 
reduced pressure. The crude  orange residue was dissolved in a mixture of 
DCM:NaHCO3 (75 mL, 2:1) and under vigorous stirring, one portion of mCPBA  
(2.18 g, 12.61 mmol, 3 equiv) was carefully added and left to stir for 30 mins before 
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separating the organic layer. The aqueous layer was extracted with DCM and the 
combined organic fractions were dried over MgSO4, filtered and solvent removed 
under reduced pressure leaving an orange crude oil. Flash column chromatography 
(SiO2, hexane/EtOAc 17:3) afforded exo-methylene 249 as a white solid (2.17 g, 85 
% yield). 
1H NMR (500 MHz, CDCl3) δ 7.72 – 7.61 (m, 4H, ArH), 7.49 – 7.35 (m, 6H, ArH), 
6.65 (s, 1H, C=CH), 6.14 (s, 1H, CH2=C), 5.51 (s, 1H, CH2=C), 4.63 (dd, JAB, AX = 
19.0, 1.9 Hz, 1H, CH2O), 4.47 (dd, JBA, BX = 19.0, 2.0 Hz, 1H, CH2O), 3.88 – 3.68 (m, 
4H, OCH2CH2O), 1.92 (td, J = 13.0, 4.3 Hz, 1H, CH3CCH2CH2), 1.67 (td, J = 12.9, 
4.2 Hz, 1H, CH3CCH2CH2), 1.28 (td, J = 13.3, 4.4 Hz, 1H, CH3CCH2CH2), 1.16 (s, J 
= 7.0 Hz, 3H, CH3CCH2), 1.14 – 1.03 (m, 10H, 9 × SiC(CH3)3, 1 × CH3CCH2CH2), 
0.79 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.51 – 0.29 (m, 6H, Si(CH2CH3)3); 
13C NMR 
(126 MHz, CDCl3) δ 193.6 (q), 178.1 (q), 148.7 (q), 135.6 (CH), 135.6 (CH), 132.8 
(q), 132.8 (q), 130.1 (CH), 130.1 (CH), 130.0 (CH), 128.1 (CH), 128.0 (CH), 116.9 
(CH2), 109.4 (CH), 79.7 (q), 64.7 (CH2), 64.7 (CH2), 60.1 (CH2), 34.0 (CH2), 33.4 
(CH2), 26.9 (CH3), 23.8 (CH3), 19.4 (q), 7.0 (CH3), 6.1 (CH2); IR (thin film, NaCl 
plate, cm-1) 3072, 2955, 1740, 1709, 1618, 1240, 1114; HRMS (ESI) m/z calcd for 
C35H54NO5Si2 [M+NH4]
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2-(3-((tert-Butyldiphenylsilyloxy)methyl)-2-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)-5-
oxo-2-(triethylsilyloxy)cyclopent-3-enyl)acetonitrile 251 and 252 
 
Exo-methylene 249 (100 mg, 0.165 mmol, 1 equiv) was dissolved in anhydrous 
DCM (8 mL) and cooled to 0 °C before the dropwise addition of diethylaluminium 
cyanide (198 µL µL, 1M solution in toluene, 0.198 mmol, 1.2 equiv). The reaction 
mixture was stirred at 0 °C for 1 hr before quenching with saturated NaHCO3 
solution (2 mL). The mixture was extracted twice with EtOAc, and the combined 
organic layers were washed with brine, dried over MgSO4, filtered and the solvent 
removed under reduced pressure. Flash column chromatography (SiO2, 
hexane/EtOAc 4:1) furnished a separable 1.1:1 diastereomeric mixture of 251 (36 
mg, 35% yield) and 252 (32 mg, 31% yield), both as oils in a combined 66% overall 
yield. 
Major diastereomer 251: 1H NMR (500 MHz, CDCl3) δ 7.75 – 7.57 (m, 4H, ArH), 
7.50 – 7.36 (m, 6H, ArH), 6.48 (t, J = 1.7 Hz, 1H, C=CH ), 4.63 (dd, JAB, AX = 18.8, 
1.6 Hz, 1H, CH2O), 4.36 (dd, JBA, BX = 18.9, 1.9 Hz, 1H, CH2O), 3.99 – 3.79 (m, 4H, 
OCH2CH2O), 2.89 (dd, J = 8.0, 6.4 Hz, 1H, CHCH2), 2.80 (dd, J = 17.3, 6.3 Hz, 1H, 
CH2CN), 2.51 (dd, J = 17.3, 8.2 Hz, 1H, CH2CN), 1.92 – 1.81 (m, 1H, CH3CCH2), 
1.67 (td, J = 13.3, 5.9 Hz, 1H, CH3CCH2), 1.27 – 1.17 (m, 1H, CH3CCH2CH2), 1.15 
(s, 3H, CH3CCH2), 1.08 (s, 9H, SiC(CH3)3), 0.87 – 0.78 (m, 10H, 9 × Si(CH2CH3)3), 1 
× CH3CCH2CH2), 0.49 (q, J = 7.9 Hz, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) 
δ 200.1 (q), 180.8 (q), 135.6 (CH), 135.5 (CH), 132.6 (q), 132.5 (q), 130.2 (CH), 
128.1 (CH), 126.8 (CH), 118.6 (q), 109.0 (q), 82.2 (q) , 65.0 (CH2), 65.0 (CH2), 60.7 
(CH2), 56.7 (CH), 34.7 (CH2), 31.3 (CH2), 26.8 (CH3), 24.1 (CH3), 19.4 (q), 12.5 
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(CH2), 7.1 (CH3), 6.4 (CH2); IR (thin film, NaCl plate, cm
-1) 2957, 1715, 1629, 1428, 
1114; HRMS (ESI) m/z calcd for C36H55N2O5Si2 [M+NH4]
+, 651.3644, found 
651.3644. 
Minor diastereomer 252: 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.59 (m, 4H, ArH), 
7.51 – 7.35 (m, 6H, ArH), 6.49 (t, J = 1.8 Hz, 1H, C=CH), 4.54 (dd, JAB, AX = 18.8, 1.8 
Hz, 1H, CH2O), 4.43 (dd, JBA, BX = 18.8, 1.9 Hz, 1H, CH2O), 3.92 – 3.64 (m, 4H, 
OCH2CH2O), 2.72 – 2.61 (m, 2H, 1 × CH2CN, 1 × CHCH2), 2.48 (dd, J = 17.9, 10.3 
Hz, 1H, CH2CN), 1.96 (td, J = 13.1, 4.8 Hz, 1H, CH3CCH2), 1.69 – 1.61 (m, 1H, 
CH3CCH2), 1.53 – 1.44 (m, 1H, CH3CCH2CH2), 1.31 – 1.22 (m, 1H, CH3CCH2CH2), 
1.19 (s, 3H, CH3CCH2), 1.08 (s, 9H, SiC(CH3)3), 0.81 (t, J = 7.9 Hz, 9H, 
Si(CH2CH3)3), 0.55 – 0.40 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 
203.4 (q), 180.2 (q), 135.6 (CH), 135.5 (CH), 132.6 (q), 132.5 (q), 130.3 (CH), 130.2 
(CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 118.8 (q), 109.1 (q), 81.7 (q), 64.9 (CH2), 
64.8 (CH2), 60.7 (CH2), 51.6 (CH), 34.0 (CH2), 32.2 (CH2), 26.8 (CH3), 24.0 (CH3), 
19.4 (q), 14.5 (CH2), 7.2 (CH3), 6.7 (CH2); IR (thin film, NaCl plate, cm
-1) 2956, 1715, 











 Experimental Procedures 





Exo-methylene 205 (20 mg, 0.036 mmol, 1 equiv) was dissolved in anhydrous DCM 
(3 mL) and cooled to 0 °C before the dropwise addition of diethylaluminium cyanide 
(78.2 µL, 1M solution in toluene, 0.078 mmol, 2.2 equiv). The reaction mixture was 
stirred at 0 °C for 4 hr before quenching with excess saturated NH4Cl solution. The 
organic layer was washed with brine, dried over MgSO4, filtered and the solvent 
removed under reduced pressure. Flash column chromatography (SiO2, 
hexane/EtOAc 9:1) furnished a single diastereomer of the title compound 253 as a 
colourless oil (11.9 mg, 57% yield). 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.60 (m, 4H, ArH), 7.49 – 7.35 (m, 6H, ArH), 
6.49 (t, J = 1.7 Hz, 1H, C=CHCO), 4.62 (dd, J = 18.7, 1.6 Hz, 1H, CH2OSi), 4.37 (dd, 
J = 18.8, 1.8 Hz, 1H, CH2OSi), 3.14 – 3.07 (m, 1H, CH2), 2.95 (t, J = 6.9 Hz, 1H, 
CH2CH), 2.73 (dd, J = 17.4, 6.3 Hz, 1H, CH2), 2.39 (dd, J = 17.4, 7.6 Hz, 1H, CH2), 
2.03 (s, 3H, CH3CO), 2.00 – 1.88 (m, 1H, CH2), 1.42 (t, J = 7.3 Hz, 2H, CH2CN), 
1.09 (s, 9H, SiC(CH3)3 ), 0.73 (s, 9H, SiC(CH3)3 ), 0.07 (s, 3H, SiCH3), 0.02 (s, 3H, 
SiCH3); 
13C NMR (126 MHz, CDCl3) δ 205.4 (q), 199.5 (q), 180.8 (q), 135.5 (CH), 
135.4 (CH), 132.5 (q), 132.4 (q), 130.2 (CH), 128.0 (CH), 128.0 (CH), 126.8 (CH), 
117.8 (q), 82.2 (q) , 60.8 (CH2), 56.6 (CH), 38.5 (CH2), 30.6 (CH2), 30.1 (CH3), 26.8 
(CH3), 25.5 (CH3), 19.3 (q), 18.1 (q), 12.7 (CH2), -2.2 (CH3), -2.9 (CH3); IR (thin film, 
NaCl plate, cm-1) 2930, 2857, 2359, 1715, 1708, 1471, 1112; HRMS (ESI) m/z calcd 
for C34H48NO4Si2 [M+H]
+, 590.3116, found 590.3117. 
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2-(6-((tert-Butyldiphenylsilyloxy)methyl)-3-(2-hydroxyethoxy)-3-methyl-4-oxo-6a-
(triethylsilyloxy)-1,2,3,3a,4,6a-hexahydropentalen-3a-yl)acetonitrile 254 and 255 
 
Exo-methylene 249 (1 g, 1.65 mmol, 1 equiv) was dissolved in anhydrous toluene 
(40 mL mL) under N2, cooled to 0 °C and left to stir for 10 mins before dropwise 
addition of diethylaluminium cyanide (1.9 mL, 1 M in toluene, 1.9 mmol, 1.15 equiv). 
The reaction mixture was left stirring for 30 mins until the dropwise addition of TiCl4 
(4.94 mL, 1M solution in DCM, 4.94 mmol, 3 equiv) and the resultant mixture was 
left stirring for a further 30 mins before quenching with saturated NaHCO3 solution 
(10mL), dried over MgSO4, filtered and the solvent evaporated under reduced 
pressure. Flash column chromatography (SiO2, hexane/EtOAc 6:4) furnished a 
separable 15:1 diastereomeric mixture of 254 (751 mg, 72% yield) as a white solid 
and 255 (48.9, 5% yield) as an oil.  
Major diastereomer 254: 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.61 (m, 4H, ArH), 
7.49 – 7.35 (m, 6H, ArH), 6.42 (t, J = 1.7 Hz, 1H, C=CH), 4.59 (dd, JAB, AX = 18.4, 1.9 
Hz, 1H, CH2O), 4.40 (dd, JBA, BX = 18.4, 1.7 Hz, 1H, CH2O), 3.70 (s, 2H, 
OCH2CH2OH), 3.53 – 3.46 (m, 1H, OCH2CH2OH), 3.35 – 3.29 (m, 1H, 
OCH2CH2OH), 2.59 (d, J = 16.5 Hz, 1H, CH2CN), 2.48 (d, J = 16.5 Hz, 1H, CH2CN), 
1.98 (s, 1H, OH), 1.95 – 1.84 (m, 2H, CH3CCH2CH2), 1.73 – 1.64 (m, 1H, CH2), 1.28 
(s, 3H, CH3CCH2), 1.09 (s, 9H, SiC(CH3)3), 1.02 – 0.93 (m, 1H, CH2), 0.81 (t, J = 7.9 
Hz, 9H, Si(CH2CH3)3), 0.57 – 0.39 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, 
CDCl3) δ 204.2 (q), 180.2 (q), 135.5 (CH), 132.9 (q), 132.4 (q), 130.2 (CH), 130.2 
(CH), 128.1 (CH), 128.0 (CH), 127.9 (CH), 119.1 (q), 89.4 (q), 83.0 (q), 65.2 (q), 
62.8 (CH2), 62.1 (CH2), 61.3 (CH2), 34.0 (CH2), 32.2 (CH2), 26.9 (CH3), 19.4 (q), 
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18.5 (CH3), 17.0 (CH2), 7.1 (CH3), 6.6 (CH2); IR (thin film, NaCl plate, cm
-1) 3461, 
2955, 2251, 1709, 1634, 1112; HRMS (ESI) m/z calcd for C36H55N2O5Si2 [M+NH4]
+ 
651.3644, found 651.3650; MP 81-83 C. 
X-ray crystal structure for 254:  
 
Minor diastereomer 255: 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.60 (m, 4H, ArH), 
7.50 – 7.34 (m, 6H, ArH), 6.39 (t, J = 1.6 Hz, 1H, C=CH), 4.55 (dd, JAB, AX = 18.2, 1.8 
Hz, 1H, CH2O), 4.40 (dd, JBA, BX = 18.2, 1.7 Hz, 1H, CH2O), 3.71 – 3.56 (m, 2H, 
OCH2CH2OH), 3.56 – 3.47 (m, 1H, OCH2CH2OH), 3.39 – 3.30 (m, 1H, 
OCH2CH2OH), 2.59 (d, J = 16.2 Hz, 1H, CH2CN), 2.47 (d, J = 16.2 Hz, 1H, CH2CN), 
2.15 (s, 1H, OH), 1.99 – 1.83 (m, 2H, CH3CCH2CH2), 1.81 – 1.67 (m, 2H, 
CH3CCH2CH2), 1.35 (s, 3H, CH3CCH2), 1.09 (s, 9H, SiC(CH3)3), 0.81 (t, J = 7.9 Hz, 
9H, Si(CH2CH3)3), 0.58 – 0.39 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 
203.2 (q), 178.7 (q), 135.6 (CH), 135.6 (CH), 132.9 (q), 132.5 (q), 130.2 (CH), 130.2 
(CH), 128.1 (CH), 128.1 (CH), 127.9 (CH), 118.2 (q), 89.5 (q), 83.7 (q), 65.4 (q), 
63.5 (CH2), 62.0 (CH2), 61.1 (CH2), 35.6 (CH2), 34.9 (CH2), 26.9 (CH3), 19.4 (q), 
18.8 (CH3), 18.5 (CH2), 7.2 (CH3), 6.6 (CH2); IR (thin film, NaCl plate, cm
-1) 3451, 
2958, 2251, 1709, 1634, 1113; HRMS (ESI) m/z calcd for C36H55N2O5Si2 [M+NH4]
+ 
651.3644, found 651.3635. 
 
 Experimental Procedures 





A solution of the bicycle 254 (600 mg, 0.95 mmol, 1 equiv), imidazole (161 mg, 2.37 
mmol, 2.5 equiv) and PPh3 (621 mg, 2.37 mmol, 2.5 equiv) in anhydrous DCM (15 
mL) was stirred for 5 mins before addition in one portion of I2 (480 mg, 1.89 mmol, 2 
equiv). The resultant mixture was stirred for a further 1 hr before being quenched 
with excess NaS2O3 solution. The organic layer was separated, washed with brine, 
dried over MgSO4, filtered and solvent removed in vacuo.  Flash column 
chromatography (SiO2, hexane/EtOAc 17:3) gave the title compound 256 as an     
off-white solid (660 mg, 94% yield). 
1H NMR (500 MHz, CDCl3) δ 7.69 – 7.60 (m, 4H, ArH), 7.49 – 7.34 (m, 6H, ArH), 
6.43 (t, J = 1.7 Hz, 1H, C=CH), 4.61 (dd, JAB, AX = 18.4, 1.9 Hz, 1H, CH2O), 4.40 (dd, 
JBA, BX = 18.4, 1.7 Hz, 1H, CH2O), 3.62 (dt, JAB, AX = 10.2, 6.9 Hz, 1H, OCH2CH2I), 
3.48 (dt, JBA, BX = 10.2, 6.2 Hz, 1H, OCH2CH2I), 3.21 – 3.13 (m, 2H, OCH2CH2I), 2.66 
(d, J = 16.5 Hz, 1H, CH2CN), 2.55 (d, J = 16.5 Hz, 1H, CH2CN), 1.94 (td, J = 12.9, 
6.2 Hz, 1H, CH2), 1.85 (dd, J = 14.0, 6.1 Hz, 1H, CH2), 1.68 (dd, J = 12.4, 6.0 Hz, 
1H, CH2), 1.28 (s, 3H, CH3CCH2), 1.09 (s, 9H, SiC(CH3)3), 0.97 (td, J = 13.7, 6.2 Hz, 
1H, CH2), 0.81 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.58 – 0.38 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 204.1 (q), 180.4 (q), 135.6 (CH), 135.5 (CH), 133.0 
(q), 132.4 (q), 130.2 (CH), 130.1 (CH), 128.1 (CH), 128.0 (CH), 127.9 (CH), 118.3 
(q), 89.2 (q), 83.5 (q), 65.4 (q), 62.6 (CH2), 61.4 (CH2), 34.1(CH2), 32.5 (CH2), 26.9 
(CH3), 19.4 (q), 18.2 (CH3), 17.0 (CH2), 7.1 (CH3), 6.6 (CH2), 3.5 (CH2); IR (thin film, 
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NaCl plate, cm-1) 2956, 2251, 1709, 1634, 1462, 1111; HRMS (ESI) m/z calcd for 
C36H54IN2O4Si2 [M+NH4]




Bicycle 256 (40 mg, 0.054 mmol, 1 equiv) and activated Zn dust100 (35.2 mg,                 
53.7 mmol, 10 equiv) were dissolved in dry MeOH (2 mL) and the resulting 
suspension was heated to 50 °C for 17 hr. The reaction mixture was filtered to 
remove the zinc and the solvent evaporated under reduced pressure. The crude 
was purified by flash column chromatography (SiO2, hexane/EtOAc 9:1) to afford 
reduced 257 as a white solid (14.6 mg, 44% yield). 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.60 (m, 4H, ArH), 7.49 – 7.34 (m, 6H, ArH), 
6.42 (t, J = 1.7 Hz, 1H, C=CH), 4.62 (dd, JAB, AX = 18.4, 1.9 Hz, 1H, CH2O), 4.40 (dd, 
JBA, BX = 18.4, 1.7 Hz, 1H, CH2O), 3.37 (dt, JAB, AX = 14.0, 7.0 Hz, 1H, OCH2CH3), 
3.27 – 3.18 (m, 1H, OCH2CH3), 2.63 (d, J = 16.5 Hz, 1H, CH2CN), 2.55 (d, J = 16.5 
Hz, 1H, CH2CN), 1.94 – 1.81 (m, 2H, CH3CCH2CH2), 1.64 (dd, J = 11.8, 6.0 Hz, 1H, 
CH2), 1.24 (s, 3H, CH3CCH2), 1.12 (t, J = 7.0 Hz, 3H, OCH2CH3), 1.09 (s, 9H, 
SiC(CH3)3), 0.95 – 0.87 (m, 1H, CH2), 0.85 – 0.76 (m, 9H, Si(CH2CH3)3), 0.59 – 0.38 
(m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 204.6 (q), 180.5 (q), 135.6 
(CH), 135.5 (CH), 133.1 (q), 132.5 (q), 130.1 (CH), 130.1 (CH), 128.1 (CH), 128.0 
(CH), 127.9 (CH), 118.5 (q), 89.3 (q), 82.4 (q), 65.5 (q), 61.5 (CH2), 56.4 (CH2), 34.2 
(CH2), 32.0 (CH2), 26.9 (CH3), 19.4 (q), 17.9 (CH3), 16.8 (CH2), 15.8 (CH3), 7.1 
(CH3), 6.6 (CH2); IR (thin film, NaCl plate, cm
-1) 2957, 2251, 1709, 1635, 1428, 
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1112; HRMS (ESI) m/z calcd for C36H55N2O4Si2 [M+NH4]
+ 635.3695, found 635.3688; 




A solution of bicycle 256 (1200 mg, 1.61 mmol, 1 equiv) and activated Zn dust100 
(1055 mg, 16.1 mmol, 10 equiv) were dissolved in a solvent mixture of THF:0.1 M 
AcOH (37 mL, 9:1) and heated to reflux for 20 hr. The resultant suspension was 
filtered to remove the zinc, dried over MgSO4, filtered and solvent evaporated under 
reduced pressure. Flash column chromatography (SiO2, hexane/EtOAc 9:1) 
furnished tricycle 258 as an off-white solid (846 mg, 89% yield). 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.60 (m, 4H, ArH), 7.50 – 7.36 (m, 6H, ArH), 
6.47 (t, J = 1.6 Hz, 1H, C=CH), 4.56 (dd, JAB, AX = 18.3, 1.8 Hz, 1H, CH2O), 4.44 (dd, 
JBA, BX = 18.3, 1.7 Hz, 1H, CH2O), 3.08 (d, J = 18.4 Hz, 1H, CCH2CO), 2.69 (d, J = 
18.4 Hz, 1H, CCH2CO), 2.06 – 1.98 (m, 1H, CH2), 1.94 – 1.82 (m, 2H, CH2), 1.30 – 
1.19 (m, 4H, CH3CCH2, CH2), 1.10 (s, 9H, SiC(CH3)3), 0.80 (t, J = 7.9 Hz, 9H, 
Si(CH2CH3)3), 0.53 – 0.35 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 
202.0 (q), 178.7 (q), 174.9 (q), 135.5 (CH), 135.4 (CH), 132.6 (q), 132.3 (q), 130.2 
(CH), 129.2 (CH), 128.0 (CH), 128.0 (CH), 92.5 (q), 88.8 (q), 66.6 (q), 60.7 (CH2), 
34.4 (CH2), 32.8 (CH2), 31.9 (CH2), 26.8 (CH3), 22.8 (CH3), 19.3 (q), 6.9 (CH3), 6.4 
(CH2); IR (thin film, NaCl plate, cm
-1) 2958, 1781, 1715, 1630, 1428, 1112; HRMS 
(ESI) m/z calcd for C34H50NO5Si2 [M+NH4]
+ 608.3222, found 608.3214; MP                    
76−78 C. 
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A solution of tricycle 258 (120 mg, 0.20 mmol, 1 equiv) was dissolved in a solvent 
mixture of THF:0.05 M HCl (40 mL, 79:1) and heated to reflux for 7 hr. The reaction 
mixture was diluted with brine and extracted twice with EtOAc. The organic extracts 
were dried over MgSO4, filtered and solvent removed in vacuo. Flash column 
chromatography (SiO2, hexane/EtOAc 7:3) furnished tertiary alcohol 264 as an off-
white solid (68.3 mg, 71% yield). 
1H NMR (500 MHz, CDCl3) δ 7.71 – 7.59 (m, 4H, ArH), 7.52 – 7.35 (m, 6H, ArH), 
6.30 (t, J = 1.6 Hz, 1H, C=CH), 4.70 (dd, JAB, AX = 17.6, 1.8 Hz, 1H, CH2O), 4.61 (dd, 
JBA, BX = 17.6, 1.5 Hz, 1H, CH2O), 3.04 (d, J = 18.2 Hz, 1H, CCH2CO), 2.87 (s, 1H, 
OH), 2.79 (d, J = 18.2 Hz, 1H, CCH2CO), 2.11 – 2.02 (m, 2H, CH3CCH2, 
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CH3CCH2CH2), 1.96 (td, J = 13.6, 6.9 Hz, 1H, CH2), 1.57 (s, 1H), 1.32 – 1.20 (m, 
4H, CH3CCH2, CH2), 1.09 (s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 202.0 
(q), 177.0 (q), 175.1 (q), 135.7 (CH), 135.6 (CH), 132.2 (q), 132.1 (q), 130.5 (CH), 
130.4 (CH), 130.1 (CH), 128.2 (CH), 128.2 (CH), 93.6 (q), 87.5 (q), 65.6 (q), 61.1 
(CH2), 34.5 (CH2), 33.0 (CH2), 31.8 (CH2), 26.9 (CH3), 22.7 (CH3), 19.3 (q); IR (thin 
film, NaCl plate, cm-1) 3411, 2932, 1757, 1713, 1626, 1112; HRMS (ESI) m/z calcd 
for C28H36NO5Si [M+NH4]




A solution of tricycle 264 (100 mg, 0.21 mmol, 1 equiv), imidazole (118 mg, 0.63 
mmol, 3 equiv), DMAP (2.6 mg, 0.02 mmol, 0.1 equiv) in anhydrous DCM (6 mL) 
were stirred at RT before adding (bromomethyl)chlorodimethylsilane (85 µL, 0.63 
mmol, 3 equiv). The resultant mixture was heated to reflux for 3 hr before quenching 
with brine and extracted with DCM. The organic extracts were dried over MgSO4, 
filtered and the solvent evaporated under reduced pressure.  Flash column 
chromatography (SiO2, hexane/EtOAc 17:3) afforded the title compound 266 as a 
white solid (125 mg, 95% yield). 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.60 (m, 4H, ArH), 7.50 – 7.45 (m, 2H, ArH), 
7.44 – 7.38 (m, 4H, ArH), 4.59 (dd, JAB, AX = 18.4, 1.9 Hz, 1H, CH2O), 4.47 (dd, JBA, 
BX = 18.4, 1.9 Hz, 1H, CH2O), 3.10 (d, J = 18.4 Hz, 1H, CCH2CO), 2.65 (d, J = 18.4 
Hz, 1H, CCH2CO), 2.23 (s, 2H, CH2Br), 2.04 (dd, J = 14.2, 6.1 Hz, 1H, CH2), 2.00 – 
1.87 (m, 2H, CH2), 1.32 – 1.19 (m, 4H, CH3CCH2, CH2), 1.10 (s, 9H, SiC(CH3)3), 
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0.17 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3); 
13C NMR (126 MHz, CDCl3) δ 201.5 (q), 
178.0 (q), 174.7 (q), 135.6 (CH), 135.6 (CH), 132.6 (q), 132.3 (q), 130.4 (CH), 130.4 
(CH), 129.7 (CH), 128.2 (CH), 128.2 (CH), 92.6 (q), 89.4 (q), 66.5 (q), 60.7 (CH2), 
34.5 (CH2), 32.6 (CH2), 32.2 (CH2), 26.9 (CH3), 22.7 (CH3), 19.4 (q), 16.2 (CH2), -0.5 
(CH3), -0.5 (CH3); IR (thin film, NaCl plate, cm
-1) 2932, 2360, 1774, 1714, 1630, 
1110; HRMS (ESI) m/z calcd for C31H43BrNO5Si2 [M+NH4]
+ 644.1858, found 




A solution of tertiary alcohol 264 (110 mg, 0.23 mmol, 1 equiv) dissolved in MeCN  
(6 mL) was  stirred for 10 mins at 50 °C in a plastic container before the addition of 
HF (1.2 mL, 48% Aq HF). The resulting mixture was stirred for a further 3 hr before 
diluting with 1 M NaOH and ensuring the pH of the solution was neutralised. The 
EtOAc extracts of this mixture were washed with brine, dried over MgSO4, filtered 
and solvent evaporated under reduced pressure. Flash column chromatography 
(SiO2, hexane/EtOAc 9:1) furnished diol 268 as a white solid (846 mg, 89% yield). 
1H NMR (500 MHz, CD3OD) δ 6.26 (t, J = 1.8 Hz, 1H, C=CH), 4.58 – 4.56 (m, 2H, 
CH2OH), 3.02 (d, J = 18.1 Hz, 1H, CCH2CO), 2.73 (d, J = 18.1 Hz, 1H, CCH2CO), 
2.21 (dd, J = 13.4, 6.3 Hz, 1H, CH2), 2.08 (dd, J = 14.4, 6.7 Hz, 1H, CH2), 1.88 (td, J 
= 13.7, 6.7 Hz, 1H, CH2), 1.56 (td, J = 14.2, 6.4 Hz, 1H, CH2), 1.27 (s, 3H, 
CH3CCH2); 
13C NMR (126 MHz, CD3OD) δ 203.9 (q), 182.8 (q), 177.1 (q), 129.4 
(CH), 95.3 (q), 88.0 (q), 66.4 (q), 59.3 (q), 35.2 (CH2), 33.1 (CH2), 32.7 (CH2), 22.8 
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(CH3); IR (KBr disc, cm
-1) 3400, 2917, 2521, 1760, 1710, 1627, 1095; HRMS (ESI) 
m/z calcd for C12H18NO5 [M+NH4]
+ 256.1179, found 256.1183; MP 130-132 C. 
(5a-Hydroxy-3a-methyl-2,8-dioxo-2,3a,4,5,5a,8-hexahydro-1H-pentaleno[1-b]furan-
6-yl)methyl methyl carbonate 269 
 
Diol 268 (47 mg, 0.20 mmol, 1 equiv), triethylamine (63.9 mg, 0.63 mmol, 3.2 equiv), 
DMAP (5 mg, 0.04 mmol, 0.2 equiv) and methyl chloroformate (28 mg, 0.30 mmol, 
1.5 equiv) were dissolved in anhydrous THF (6 mL) and heated to reflux for 16 hr. 
The reaction mixture was diluted with brine and extracted with EtOAc, dried over 
MgSO4, filtered and the solvent removed in vacuo. Flash column chromatography 
(SiO2, hexane/EtOAc 1:1) furnished carbonate 269 as an oil (48 mg, 82% yield).  
1H NMR (500 MHz, CDCl3) δ 6.24 (t, J = 1.5 Hz, 1H, C=CH), 5.12 (dd, JAB, AX = 17.0, 
1.6 Hz, 1H, CH2O), 5.07 (dd, JBA, BX = 17.0, 1.6 Hz, 1H, CH2O), 3.84 (s, 3H, CH3O), 
3.75 (s, 1H, OH), 3.07 (d, J = 18.3 Hz, 1H, CCH2CO), 2.82 (d, J = 18.3 Hz, 1H, 
CCH2CO), 2.27 (dd, J = 13.3, 6.5 Hz, 1H, CH2), 2.21 – 2.06 (m, 2H, CH3CCH2CH2 ), 
1.50 (td, J = 13.6, 6.6 Hz, 1H, CH2), 1.29 (s, 3H, CH3CCH2); 
13C NMR (126 MHz, 
CDCl3) δ 201.6 (q), 175.6 (q), 172.2 (q), 155.6 (q), 130.3 (CH), 94.2 (q), 87.8 (q), 
65.2 (q), 63.4 (CH2), 55.7 (CH3), 34.3 (CH2), 32.9 (CH2), 32.2 (CH2), 22.6 (CH3); IR 
(thin film, NaCl plate, cm-1) 3416, 2931, 1755, 1631, 1446, 1264; HRMS (ESI) m/z 
calcd for C14H17O7 [M+H]
+ 297.0969, found 297.0968. 
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(5a-((Bromomethyl)dimethylsilyloxy)-3a-methyl-2,8-dioxo-2,3a,4,5,5a,8-hexahydro-
1H-pentaleno[1-b]furan-6-yl)methyl methyl carbonate 270 
 
A solution of tertiary alcohol 269 (30 mg, 0.10 mmol, 1 equiv), imidazole (37 mg, 
0.54 mmol, 5.3 equiv), DMAP (1.2 mg, 0.01 mmol, 0.1 equiv) in anhydrous DCM (4 
mL) were stirred at RT before adding (bromomethyl)chlorodimethylsilane (34 µL, 
0.25 mmol, 2.5 equiv). The resultant mixture was heated to reflux for 2 hr before 
quenching with brine and extracting with DCM. The organic extracts were dried over 
MgSO4, filtered and the solvent evaporated under reduced pressure. Flash column 
chromatography (SiO2, hexane/EtOAc 7:3) afforded tricycle 270 as a colourless oil 
(37 mg, 82% yield).  
1H NMR (500 MHz, CDCl3) δ 6.27 – 6.24 (m, 1H, C=CH), 5.05 (d, J = 1.6 Hz, 2H, 
CH2O), 3.85 (s, 3H, CH3O), 3.13 (d, J = 18.4 Hz, 1H, CCH2CO), 2.69 (d, J = 18.3 
Hz, 1H, CCH2CO), 2.46 (d, J = 1.3 Hz, 2H, CH2Br), 2.32 (dd, J = 12.9, 6.2 Hz, 1H, 
CH2), 2.21 (dd, J = 14.2, 6.7 Hz, 1H, CH2), 2.12 (td, J = 13.2, 6.7 Hz, 1H, CH2), 1.52 
(td, J = 13.8, 6.3 Hz, 1H, CH2), 1.28 (s, 3H, CH3CCH2), 0.38 (s, 3H, SiCH3), 0.36 (s, 
3H SiCH3); 
13C NMR (126 MHz, CDCl3) δ 201.0 (q), 174.5 (q), 171.1 (q), 155.4 (q), 
130.3 (CH), 92.7 (q), 90.0 (q), 66.2 (q), 63.3 (CH2), 55.7 (CH3), 34.6 (CH2), 32.8, 
(CH2), 32.3 (CH2), 22.7 (CH3), 16.3 (CH2), -0.2 (CH3), -0.2 (CH3); IR (thin film, NaCl 
plate, cm-1) 2961, 1755, 1633, 1446, 1260; HRMS (ESI) m/z calcd for C17H24BrO7Si 
[M+H]+ 447.0469, found 447.0473. 
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(5a,8-Dihydroxy-3a-methyl-2-oxo-2,3a,4,5,5a,8-hexahydro-1H-pentaleno[1-b]furan-
6-yl)methyl methyl carbonate 275 
 
A solution of carbonate 269 (28 mg, 0.095 mmol, 1 equiv), CeCl3·7H2O (106 mg, 
0.28 mmol, 3 equiv) in anhydrous MeOH (2.5 mL) was stirred and cooled to 0 °C 
before addition NaBH4 (10.7 mg, 0.28 mmol, 3 equiv) in one portion. The resultant 
reaction mixture was stirred for 4 hr before being quenched with distilled H2O         
(1 mL) and then diluted with EtOAc. The mixture was dried over MgSO4, filtered and 
solvent evaporated under reduced pressure. Flash column chromatography (SiO2, 
hexane/EtOAc 2:8) furnished a single diastereomer of diol 275 as a colourless oil 
(18 mg, 64% yield). 
1H NMR (500 MHz, CDCl3) δ 5.90 – 5.87 (m, 1H, C=CH), 4.82 – 4.78 (m, 1H, 
CHOH), 4.77 (s, 2H, CH2O), 3.80 (s, 3H, CH3O), 3.02 (s, 1H, COH), 2.88 (d, J = 
17.6 Hz, 1H, CCH2CO), 2.70 (d, J = 17.6 Hz, 1H, CCH2CO), 2.27 – 2.10 (m, 3H, 
CH2, CHOH), 1.92 – 1.74 (m, 3H, CH2, CH2), 1.62 (s, 3H, CH3CCH2); 
13C NMR (126 
MHz, CDCl3) δ 176.1 (q), 155.9 (q), 143.2 (q), 132.9 (CH), 97.5 (q), 92.4 (q), 78.6 
(CH), 63.3 (CH2), 62.8 (q), 55.3 (CH3), 37.2 (CH2), 35.5 (CH2), 34.9 (CH2), 23.0 
(CH3); IR (thin film, NaCl plate, cm
-1) 3411, 2960, 1744, 1448, 1276; HRMS (ESI) 
m/z calcd for C14H22NO7 [M+NH4]
+ 316.1391, found 316.1392. 
 
 
 Experimental Procedures 





A solution of diol 245 (100 mg, 0.21 mmol, 1 equiv) and TBAI (38 mg, 0.10 mmol, 
0.5 equiv) in anhydrous THF (6 mL) was stirred at RT before adding NaH (15 mg, 
60% mineral oil, 0.62 mmol, 3 equiv) followed by dropwise addition of BnBr (37 µL, 
0.41 mmol, 1.5 equiv). The reaction was stirred for 6 hr and the reaction was 
quenched with distilled H2O (2 mL), dried over MgSO4, filtered and evaporated to 
dryness. Flash column chromatography (SiO2, hexane/EtOAc 1:1) furnished alcohol 
278 as a brown oil (75 mg, 63% yield). 
1H NMR (500 MHz, CDCl3) δ 7.75 – 7.63 (m, 4H, ArH), 7.48 – 7.27 (m, 11H, ArH), 
5.95 (s, 1H, C=CH), ), 4.57 (d, J = 11.7 Hz, 1H, CH2O), 4.53 (d, J = 11.7 Hz, 1H, 
CH2O), 4.46 – 4.26 (m, 3H, CH2Ph, CHOH), 3.97 – 3.76 (m, 4H, OCH2CH2O), 2.56 
(d, J = 2.1 Hz, 1H, OH), 2.42 (dd, JAB, AX = 14.0, 6.8 Hz, 1H, CH2CH), 1.96 (dd,        
JBA, BX = 14.0, 3.5 Hz, 1H, CH2CH), 1.80 (d, J = 4.5 Hz, 1H, CH2), 1.66 (dd, J = 13.0, 
3.5 Hz, 1H, CH2), 1.48 (dt, J = 13.5, 6.7 Hz, 2H, CH2), 1.25 (s, 3H, CH3CCH2), 1.07 
(s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 150.8 (q), 138.7 (q), 135.8 (CH), 
135.7 (CH), 133.1 (q), 133.1 (q), 130.0 (CH), 129.9 (CH), 128.6 (CH), 127.9 (CH), 
127.9 (CH), 127.9 (CH), 127.9 (CH), 127.7 (CH), 109.9 (q), 83.4 (q), 80.0 (CH), 70.9 
(CH2), 64.8 (CH2), 60.8 (CH2), 45.7 (CH2), 33.9 (CH2), 32.7 (CH2), 26.9 (CH3), 24.0 
(CH3), 19.3 (q); IR (thin film, NaCl plate, cm
-1) 3445, 2931, 2359, 1739, 1428, 1113; 
HRMS (ESI) m/z calcd for C35H48NO5Si [M+NH4]
+ 590.3296, found 590.3301. 
 
 Experimental Procedures 





Method A: A solution of alcohol 278 (50 mg, 0.09 mmol, 1 equiv), Zn-Cu129,143 (46 
mg, 0.70 mmol, 8 equiv), CH2I2 (28 µL, 0.35 mmol, 4 equiv) in anhydrous Et2O         
(5 mL) was stirred for 5 mins before I2 (5.5 mg, 0.04 mmol, 0.5 equiv) was added in 
one portion. The reaction mixture was heated to reflux and left stirring for 17 hr 
before the reaction was quenched with distilled H2O (2 mL), dried over MgSO4, 
filtered and the solvent evaporated under reduced pressure. Flash column 
chromatography (SiO2, hexane/EtOAc 7:3) furnished bicycle 279 as a yellow oil 
(13.8 mg, 25% yield). 
Method B: A solution of alcohol 278 (80 mg, 0.14 mmol, 1 equiv) and Et2Zn (138 µL, 
1 M solution in toluene, 1.11 mmol, 8 equiv) in anhydrous Et2O (5 mL) was cooled to 
0 °C and was stirred for 5 mins before CH2I2 (181 µL, 2.23 mmol, 16 equiv)was 
added in one portion. The reaction mixture was left stirring for 24 hr at RT before 
brine and DCM was added, the organic layer was separated, dried over MgSO4, 
filtered and the solvent removed under reduced pressure. Flash column 
chromatography (SiO2, hexane/EtOAc 7:3) furnished bicycle 279 as a yellow oil (15 
mg, 18% yield). 
1H NMR (500 MHz, CDCl3) δ 7.76 – 7.59 (m, 4H, ArH), 7.50 – 7.27 (m, 11H, ArH), 
4.51 (d, J = 11.7 Hz, 1H, CH2Ph), 4.44 (d, J = 11.7 Hz, 1H, CH2Ph), 4.24 (dd,               
JAB, AX = 10.6, 1.0 Hz, 1H, CH2OSi), 4.08 – 4.00 (m, 1H, CHOH), 4.00 – 3.85 (m, 4H, 
OCH2CH2O), 3.16 (d, J = 10.6 Hz, 1H, CH2OSi), 2.66 (s, 1H, OH), 2.15 – 1.99 (m, 
2H, CH2, CCH2CH), 1.94 – 1.81 (m, 1H, CH2), 1.74 – 1.60 (m, 2H, CH3CCH2CH2), 
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1.51 – 1.38 (m, 2H, CCH2CH, CCH2CH), 1.34 (s, 3H, CH3CCH2), 1.06 (s, 9H, 
SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 138.7 (q), 135.8 (CH), 135.7 (CH), 133.1 
(q), 133.0 (q), 130.0 (CH), 130.0 (CH), 128.5 (CH), 127.9 (CH), 127.9 (CH), 127.9 
(CH), 127.7 (CH), 110.2 (q), 79.3 (CH), 71.3 (CH2), 66.4 (CH2), 64.8 (CH2), 64.8 
(CH2), 38.3 (CH2), 36.4(q), 33.5 (CH2), 33.0 (CH2), 27.0 (CH3), 24.6 (CH3), 24.1 
(CH), 19.2 (q), 11.3 (CH2); ); IR (thin film, NaCl plate, cm
-1) 3564, 2930, , 2359, 
1428, 1066; HRMS (ESI) m/z calcd for C36H46NaO5Si [M+Na]





Method A: A solution of bicycle 254 (50 mg, 0.08 mmol, 1 equiv) was dissolved in 
anhydrous DCM (80 mL) and stirred at RT before the dropwise addition of BF3·Et2O 
(161 µL, 1.26 mmol, 16 equiv). The reaction mixture was then heated to precisely    
30 °C and stirred for 9 hr at which time the reaction was diluted with brine and 
extracted twice with DCM. The organic extracts were combined, dried over MgSO4, 
filtered and the solvent removed in vacuo. Flash column chromatography (SiO2, 
hexane/EtOAc 1:1) furnished tricyclic alcohol 280 (27.9 mg, 68% yield) as an oil. 
Tricyclic alcohol 280: 1H NMR (500 MHz, CDCl3) δ 7.71 – 7.58 (m, 4H, ArH), 7.51 – 
7.34 (m, 6H, ArH), 6.29 (t, J = 1.9 Hz, 1H, C=CH), 4.70 (dd, JAB, AX = 19.1, 1.9 Hz, 
1H, CH2O), 4.52 (dd, JBA, BX = 19.1, 1.9 Hz, 1H, CH2O), 3.82 – 3.67 (m, 2H, 
OCH2CH2OH), 3.55 – 3.41 (m, 2H, OCH2CH2OH), 3.21 (d, J = 18.7 Hz, 1H, 
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CCH2CO), 2.41 – 2.26 (m, 2H, CCH2CO, OH), 2.13 (dt, J = 13.6, 6.9 Hz, 1H, 
CH3CCH2), 2.01 (dt, J = 14.4, 7.3 Hz, 1H, CH3CCH2CH2), 1.71 (dt, J = 13.8, 6.7 Hz, 
1H, CH3CCH2CH2), 1.52 (dt, J = 14.0, 7.1 Hz, 1H, CH3CCH2), 1.29 (s, 3H, 
CH3CCH2), 1.09 (s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 202.9 (q), 176.0 
(q), 175.5 (q), 135.6 (CH), 135.6 (CH), 132.6 (q), 132.4 (q), 130.4 (CH), 130.3 (CH), 
129.5 (CH), 128.2 (CH), 128.1 (CH), 97.9 (q), 82.5 (q), 66.4 (q), 63.7 (CH2), 62.3 
(CH2), 60.6 (CH2), 36.9 (CH2), 33.1 (CH2), 31.4 (CH2), 26.9 (CH3), 19.3 (q), 18.0 
(CH3);  IR (thin film, NaCl plate, cm
-1) 3457, 3072, 2930, 1789, 1712, 1627, 1114; 
HRMS (ESI) m/z calcd for C30H40NO6Si [M+NH4]




A solution of tricycle 280 (110 mg, 0.22 mmol, 1 equiv), imidazole (38 mg, 0.55 
mmol, 2.5 equiv) and PPh3 (145 mg, 0.55 mmol, 2.5 equiv) in dry DCM (6 mL) was 
stirred for 5 mins at RT before the addition of I2 (112 mg, 0.44 mmol, 2 equiv) in one 
portion. The reaction mixture was stirred for 2 hr before being diluted with saturated 
Na2S2O3 solution and extracted with EtOAc. The EtOAc extracts were washed with 
brine and dried over MgSO4, filtered and the solvent removed in vacuo. Flash 
column chromatography (SiO2, hexane/EtOAc 17:3) delivered the title compound 
285 as white solid (95 mg, 73% yield). 
1H NMR (500 MHz, CDCl3) δ 7.68 – 7.60 (m, 4H, ArH), 7.50 – 7.35 (m, 6H, ArH), 
6.29 (t, J = 1.9 Hz, 1H, C=CH), 4.71 (dd, JAB, AX = 19.1, 2.0 Hz, 1H, CH2O), 4.53 (dd, 
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JBA, BX = 19.1, 1.9 Hz, 1H, CH2O), 3.66 (dt, J = 10.2, 6.2 Hz, 1H, ICH2CH2), 3.56 (dt, 
J = 10.2, 6.3 Hz, 1H, ICH2CH2), 3.29 (d, J = 18.7 Hz, 1H, CH2CO), 3.24 – 3.16 (m, 
2H, CH2I), 2.33 (d, J = 18.7 Hz, 1H, CH2CO), 2.14 – 2.02 (m, 2H, CH3CCH2, 
CH3CCH2CH2), 1.78 – 1.68 (m, 1H, CH2), 1.51 – 1.41 (m, 1H, CH2), 1.30 (s, 3H, 
CH3CCH2), 1.09 (s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 203.1 (q), 176.2 
(q), 174.9 (q), 135.6 (CH), 135.6 (CH), 132.6 (q), 132.4 (q), 130.4 (CH), 130.3 (CH), 
129.6 (CH), 128.2 (CH), 128.1 (CH), 97.5 (q), 82.5 (q), 66.5 (q), 63.2 (CH2), 60.7 
(CH2), 36.6 (CH2), 32.9 (CH2), 31.4 (CH2), 26.9 (CH3), 19.3 (q), 18.1 (CH3), 3.2 
(CH2); IR (thin film, NaCl plate, cm
-1) 2955, 2854, 1778, 1714, 1625, 1428, 1101; 
HRMS (ESI) m/z calcd for C30H39INO5Si [M+NH4]
+ 648.1637, found 648.1634;       




A solution of tricycle 285 (76 mg, 0.12 mmol, 1 equiv) and activated Zn dust100 (79 
mg, 1.2 mmol, 10 equiv) in a solvent mixture of THF:0.1M AcOH (3 mL, 9:1) was 
heated to reflux for 3 hr. The reaction mixture was diluted in brine and extracted 
twice with EtOAc. The EtOAc extracts were combined and dried over MgSO4 and 
evaporated to dryness. Flash column chromatography (SiO2, hexane/EtOAc 17:3) 
delivered the tertiary alcohol 286 as a white solid (37 mg, 65% yield).  
1H NMR (500 MHz, CDCl3) δ 7.64 (dd, J = 6.8, 1.2 Hz, 4H, ArH), 7.50 – 7.35 (m, 6H, 
ArH), 6.30 (t, J = 1.8 Hz, 1H, C=CH), 4.71 (dd, JAB, AX = 19.1, 1.9 Hz, 1H, CH2O), 
4.55 (dd, JBA, BX = 19.1, 1.8 Hz, 1H, CH2O), 3.18 (d, J = 18.8 Hz, 1H, CH2CO), 2.34 
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(d, J = 18.8 Hz, 1H, CH2CO), 2.17 (ddd, J = 13.7, 10.1, 7.0 Hz, 1H, CH2), 1.90 (ddd, 
J = 13.3, 6.9, 4.1 Hz, 1H, CH2), 1.79 (ddd, J = 13.7, 6.7, 4.1 Hz, 1H, CH2), 1.67 (s, 
1H, OH), 1.54 (ddd, J = 13.4, 10.1, 6.8 Hz, 1H, CH2), 1.39 (s, 3H, CH3CCH2), 1.09 
(s, 9H, SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 203.6 (q), 176.1 (q), 175.0 (q), 
135.6 (CH), 135.6 (CH), 132.6 (q), 132.4 (q), 130.3 (CH), 130.3 (CH), 129.7 (CH), 
128.1 (CH), 128.1 (CH), 97.6 (q), 77.9 (q), 66.0 (q), 60.7 (CH2), 40.4 (CH2), 32.9 
(CH2), 31.8 (CH2), 26.9 (CH3), 23.9 (CH3), 19.3 (q); IR (thin film, NaCl plate, cm
-1) 
3474, 3072, 2932, 2252, 1785, 1709, 1428, 1115; HRMS (ESI) m/z calcd for 
C28H36NO5Si [M+NH4]
+ 494.2357, found 494.2353. 
8-{[(tert-Butyldiphenylsilyl)oxy]methyl}-11-methyl-2-oxatricyclo[3.3.3.01,5]undeca-
7,10-diene-3,6- dione 283 and                                                                                                 
8-{[(tert-butyldiphenylsilyl)oxy]methyl}-11- methylidene-2-
oxatricyclo[3.3.3.01,5]undec-7- ene-3,6-dione 284 
 
A solution of tertiary alcohol 286 (36 mg, 0.08 mmol, 1 equiv) and Burgess reagent 
(27 mg, 0.11 mmol, 1.5 equiv) was dissolved in anhydrous DCM (5 mL) and heated 
to reflux for 48 hr. The reaction mixture was quenched with distilled H2O (1 mL) and 
dried over MgSO4, filtered and the solvent evaporated under reduced pressure. 
Flash column chromatography (SiO2, hexane/EtOAc 8:2) furnished an inseparable 
mixture of regioisomers endo-283:exo-284 (1:1.2) (26 mg, 76% combined yield) as a 
yellow solid. 
Endo-283/Exo-284: 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.58 (m, 4H, ArH), 7.55 – 
7.32 (m, 6H, ArH), 6.38 (t, J = 1.9 Hz, 1H, exo CH2C=CH), 6.33 (t, J = 1.9 Hz, 1H, 
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endo CH2C=CH), 5.30 – 5.22 (m, 1H, exo CH2=C/endo CH=CCH3), 5.13 (t, J = 1.8 
Hz, 1H, exo CH2=C), 4.78 – 4.68 (m, 2H, endo/exo CH2O), 4.61 – 4.50 (m, 2H, 
endo/exo CH2O), 2.92 – 2.61 (m, 3H, CH2CO, endo CH2), 2.59 – 2.48 (m, 2H, endo 
CH2/exo CH2), 2.34 – 2.23 (m, 1H, exo CH2), 2.00 – 1.92 (m, 2H, exo CH2), 1.87 – 
1.78 (m, 3H, endo CH3C=CH), 1.14 – 1.01 (m, 9H, endo/exo SiC(CH3)3); 
13C NMR 
(126 MHz, CDCl3) endo/exo δ 202.1 (q), 201.8 (q), 175.5 (q), 175.0 (q), 174.6 (q), 
174.3 (q), 147.5 (q), 137.3 (q), 135.6 (CH), 135.6 (CH), 132.6 (q), 132.4 (q), 132.4 
(q), 130.3 (CH), 130.3 (CH), 130.3 (CH), 129.7 (CH), 129.2 (CH), 128.2 (CH), 128.2 
(CH), 128.1 (CH), 124.6 (CH), 110.9 (CH2), 98.1 (q), 96.7 (q), 68.2 (q), 63.2 (q), 60.8 
(CH2), 60.8 (CH2), 40.8 (CH2), 38.2 (CH2), 34.2 (CH2), 33.8 (CH2), 33.3 (CH2), 26.9 
(CH3), 19.3 (q), 13.4 (CH3); IR (thin film, NaCl plate, cm
-1) 3068, 2359, 2253, 1785, 
1709, 1628, 1428, 1106; HRMS (ESI) m/z calcd for C28H34NO4Si [M+NH4]
+ 
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8-{[(tert-Butyldiphenylsilyl)oxy]methyl}-11-(2-hydroxyethoxy)-11-methyl-2- 
oxatricyclo[3.3.3.01,5]undec-7-ene-3,6-dione 280,                                                             
2-(6-((tert-butyldiphenylsilyloxy)methyl)-3-methyl-4-oxo-6a-(triethylsilyloxy)-
1,3a,4,6a-tetrahydropentalen-3a-yl)acetonitrile 281,                                                        
2-(6-((tert-butyldiphenylsilyloxy)methyl)-3-methylene-4-oxo-6a-(triethylsilyloxy)-
1,2,3,3a,4,6a-hexahydropentalen-3a-yl)acetonitrile 282,                                                    
8-{[(tert-butyldiphenylsilyl)oxy]methyl}-11-methyl-2- oxatricyclo[3.3.3.01,5]undeca-
7,10-diene-3,6- dione 283 and                                                                                                       
8-{[(tert-butyldiphenylsilyl)oxy]methyl}-11-methylidene-2-oxatricyclo[3.3.3.01,5]undec-
7- ene-3,6-dione 284 
 
Method B: A solution of bicycle 254 (515 mg, 0.81 mmol, 1 equiv) was dissolved in 
anhydrous DCM (80 mL) and stirred at RT before the dropwise addition of BF3·Et2O 
(1.43 mL, 10.57 mmol, 13 equiv). The reaction mixture was then heated to reflux 
and stirred for 6 hr at which time the reaction was diluted with brine and extracted 
twice with DCM. The organic extracts were combined, dried over MgSO4, filtered 
and the solvent removed in vacuo. Flash column chromatography (SiO2, 
hexane/EtOAc 1:1) afforded a mixture of five products: 280 (56.6 mg, 13% yield) as 
an oil, an inseparable mixture of regioisomers endo-281:exo-282 (1:1.5) as a brown 
oil (86.1 mg, 19%), an inseparable mixture of regioisomers endo-283:exo-284 
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(1:0.6) as a white solid (24.5 mg, 7%) and unreacted starting material 254 (36 mg, 
7% yield). 
Tricyclic alcohol 280: 1H NMR (500 MHz, CDCl3) δ 7.71 – 7.58 (m, 4H, ArH), 7.51 – 
7.34 (m, 6H, ArH), 6.29 (t, J = 1.9 Hz, 1H, C=CH), 4.70 (dd, JAB, AX = 19.1, 1.9 Hz, 
1H, CH2O), 4.52 (dd, JBA, BX = 19.1, 1.9 Hz, 1H, CH2O), 3.82 – 3.67 (m, 2H, 
OCH2CH2OH), 3.55 – 3.41 (m, 2H, OCH2CH2OH), 3.21 (d, J = 18.7 Hz, 1H, 
CCH2CO), 2.41 – 2.26 (m, 2H, CCH2CO, OH), 2.13 (dt, J = 13.6, 6.9 Hz, 1H, 
CH3CCH2), 2.01 (dt, J = 14.4, 7.3 Hz, 1H, CH3CCH2CH2), 1.71 (dt, J = 13.8, 6.7 Hz, 
1H, CH3CCH2CH2), 1.52 (dt, J = 14.0, 7.1 Hz, 1H, CH3CCH2), 1.29 (s, 3H, 
CH3CCH2), 1.09 (s, 9H, SiC(CH3)3);    
13C NMR (126 MHz, CDCl3) δ 202.9 (q), 176.0 
(q), 175.5 (q), 135.6 (CH), 135.6 (CH), 132.6 (q), 132.4 (q), 130.4 (CH), 130.3 (CH), 
129.5 (CH), 128.2 (CH), 128.1 (CH), 97.9 (q), 82.5 (q), 66.4 (q), 63.7 (CH2), 62.3 
(CH2), 60.6 (CH2), 36.9 (CH2), 33.1 (CH2), 31.4 (CH2), 26.9 (CH3), 19.3 (q), 18.0 
(CH3);  IR (thin film, NaCl plate, cm
-1) 3457, 3072, 2930, 1789, 1712, 1627, 1114; 
HRMS (ESI) m/z calcd for C30H40NO6Si [M+NH4]
+ 538.2619, found 538.2615. 
Endo-281/Exo-282 1H NMR (500 MHz, CDCl3) δ 7.74 – 7.60 (m, 4H, ArH), 7.51 – 
7.35 (m, 6H, ArH), 6.45 (t, J = 1.8 Hz, 1H, exo CH2C=CH), 6.33 (t, J = 1.8 Hz, 1H, 
endo CH2C=CH), 5.36 (d, J = 1.6 Hz, 1H, endo CH=CCH3), 5.20 – 5.16 (m, 1H, exo 
CH2=C), 5.15 – 5.10 (m, 1H, exo CH2=C), 4.65 – 4.55 (m, 1H, endo/exo CH2O), 4.50 
– 4.38 (m, 2H, endo/exo CH2O), 2.82 (d, J = 16.7 Hz, 1H, exo CH2CN), 2.75 (d, J = 
16.7 Hz, 1H, endo CH2CN), 2.62 – 2.52 (m, 3H, endo/exo CH2CN, CH2), 2.52 – 2.37 
(m, 2H, endo/exo CH2), 2.05 – 1.87 (m, 3H, endo/exo CH2, CH2 ), 1.76 – 1.70 (m, 
3H,  endo CH3C=CH), 1.09 (s, 9H, endo/exo SiC(CH3)3), 0.88 – 0.76 (m, 9H, 
endo/exo Si(CH2CH3)3), 0.62 – 0.39 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, 
CDCl3) δ 203.1 (q), 202.0 (q), 179.1 (q), 178.4 (q), 146.9 (q), 137.9 (q), 135.6 (CH), 
135.6 (CH), 135.5 (CH), 135.3 (CH), 134.9 (CH), 134.6 (CH), 134.6 (CH), 132.8 (q), 
132.8 (q), 132.7 (q), 132.7 (q), 132.5 (q), 132.5 (q), 130.4 (CH), 130.3 (CH), 130.3 
(CH), 130.2 (CH), 130.2 (CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 128.1 (CH), 
 Experimental Procedures 
198 | P a g e  
 
128.0 (CH), 125.8 (CH), 125.1 (CH), 118.1 (q), 117.7 (q), 111.7 (CH2), 89.6 (q), 88.1 
(q), 68.6 (q), 63.2 (q), 61.3 (CH2), 60.7 (CH2), 42.9 (CH2), 34.6 (CH2), 30.1 (CH2), 
26.9 (CH3), 26.8 (CH3), 26.1 (CH3), 19.7 (CH2), 19.4 (q), 19.4 (q), 19.3 (q), 19.1 (q), 
17.6 (CH2), 13.4 (CH3), 7.2 (CH3), 7.1 (CH3), 6.6 (CH2), 6.5 (CH2); IR (thin film, NaCl 
plate, cm-1) 3072, 2957, 2359, 2253, 1716, 1630, 1590, 1428, 1114; HRMS (ESI) 
m/z calcd for C34H49N2O3Si2 [M+NH4]
+ 589.3276, found 589.3274. 
Endo-283/Exo-284 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.58 (m, 4H, ArH), 7.51 – 
7.32 (m, 6H, ArH), 6.38 (t, J = 1.9 Hz, 1H, exo CH2C=CH), 6.33 (t, J = 1.9 Hz, 1H, 
endo CH2C=CH), 5.29 – 5.23 (m, 2H, exo CH2=C/endo CH=CCH3), 5.13 (t, J = 1.7 
Hz, 1H, exo CH2=C), 4.77 – 4.68 (m, 2H, endo/exo CH2O), 4.60 – 4.51 (m, 2H, 
endo/exo CH2O), 2.91 – 2.61 (m, 5H, endo/exo CH2CO, endo CH2), 2.34 – 2.22 (m, 
2H, endo/exo CH2), 2.01 – 1.93 (m, 1H, exo CH2), 1.83 (d, J = 1.7 Hz, 3H, endo 
CH3C=CH), 1.14 – 1.04 (m, 9H, endo/exo SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 
202.1 (q), 201.8 (q), 175.5 (q), 175.0 (q), 174.6 (q), 174.3 (q), 147.5 (q), 137.3 (q), 
135.6 (CH), 135.6 (CH), 132.6, (q), 132.5 (q), 132.4 (q), 132.4 (q), 130.4 (CH), 130.3 
(CH), 130.3 (CH), 129.7 (CH), 129.2 (CH), 128.2 (CH), 128.1 (CH), 124.6 (CH), 
110.9 (CH2), 98.1 (q) , 96.7 (q), 68.2 (q), 63.2 (q), 60.8 (CH2), 60.8 (CH2), 40.8 
(CH2), 38.2 (CH2), 34.2 (CH2), 33.8 (CH2), 33.3 (CH2), 26.9 (CH3), 19.3 (q), 13.4 
(CH3); IR (thin film, NaCl plate, cm
-1) 3068, 2359, 2253, 1785, 1709, 1628, 1428, 
1106; HRMS (ESI) m/z calcd for C28H34NO4Si [M+NH4]
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8-{[(tert-Butyldiphenylsilyl)oxy]methyl}-11-methyl-2-oxatricyclo[3.3.3.01,5]undeca-
7,10-diene-3,6- dione 283 and                                                                                                
8-{[(tert-butyldiphenylsilyl)oxy]methyl}-11- methylidene-2-
oxatricyclo[3.3.3.01,5]undec-7- ene-3,6-dione 284 
 
An inseparable mixture endo-283:exo-284 (1:1.2) (30 mg, 0.065 mmol, 1 equiv) and 
p-TsOH (12.5 mg, 0.065 mmol, 1 equiv) in anhydrous benzene (5 mL) was stirred 
and heated to reflux for 60 hr.  The reaction mixture was diluted with brine and the 
organic layer separated. The remaining aqueous faction was extcted twice with 
EtOAc and the organic extracts combined, dried over MgSO4, filtered and the 
solvent evaporated under reduced pressure. Flash column chromatography       
(SiO2, hexane/EtOAc 8:2) furnished an inseparable mixture of regioisomers                          
endo-283:exo-284 (3:1) (7 mg, 23% combined yield) as a yellow solid. 
Endo-283/Exo-284: 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.59 (m, 4H, ArH), 7.52 – 
7.34 (m, 6H, ArH), 6.38 (t, J = 1.9 Hz, 1H, exo CH2C=CH), 6.33 (t, J = 1.8 Hz, 1H, 
endo CH2C=CH), 5.30 – 5.21 (m, 2H, endo CH=CCH3, exo CH2=C), 5.13 (t, J = 1.6 
Hz, 1H, exo CH2=C), 4.80 – 4.65 (m, 2H, endo CH2O, exo CH2O), 4.66 – 4.46 (m, 
2H, CH2O, exo CH2O), 2.95 – 2.46 (m, 8H, endo CH2CO, exo CH2CO, 2 × endo 
CH2, 2 × exo CH2), 2.36 – 2.22 (m, 1H, exo CH2), 2.02 – 1.90 (m, 1H, exo CH2), 
1.83 (d, J = 1.7 Hz, 3H, endo CH3C=CH), 1.13 – 1.05 (m, 9H, endo/exo SiC(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 202.1 (q), 201.8 (q), 175.5 (q), 175.0 (q), 174.6 (q), 
174.3 (q), 147.5 (q), 137.3 (q), 135.6 (CH), 135.6 (CH), 132.5 (q), 132.4 (q), 132.4 
(q), 130.4 (CH), 130.3 (CH), 130.3 (CH), 129.7 (CH), 129.2 (CH), 128.2 (CH), 128.1 
(CH), 124.6 (CH), 110.9 (CH), 98.1 (q), 96.7 (q), 68.2 (q), 63.2 (q), 60.8 (CH2), 60.8 
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(CH2), 40.8 (CH2), 38.2 (CH2), 34.2 (CH2), 33.8 (CH2), 33.3 (CH2), 26.9 (CH3), 19.3 
(q), 13.4 (CH3). 
3-Hydroxyheptane-2,5-dione 295 
 
Methyl propionylacetate 294 (20 g, 0.15 mol, 1 equiv) was cooled to 0 °C before 
being dissolved in a chilled solution of KOH (9.8 g, 0.18 mol, 1.1 equiv) in distilled 
H2O (63 mL) and left stirring for 30 mins. The reaction mixture was then placed in 
the refrigerator for 6 days before CO2 was bubbled into the solution at RT for 2 hr 
followed by the addition of pyruvaldehyde (28.5 mL, 40% aqueous solution,        
0.13 mol, 0.9 equiv) and left stirring at RT for 24 hr. After which time, the reaction 
was placed back in the refrigerator for 17 hr and then diluted with EtOAc. The 
organic layer was separated and the aqueous fraction was extracted an additional 
three times with EtOAc. The organic extracts were combined, dried over MgSO4, 
filtered and the solvent evaporated under reduced pressure. The crude was purified 
by vacuum distillation (6 mbar, 128 °C), furnishing 3-hydroxyheptane-2,5-dione 295 
as clear and colourless oil (12.9 g, 58% yield). 
1H NMR (500 MHz, CDCl3) δ 4.38 – 4.30 (m, 1H, CH), 3.72 (d, J = 5.4 Hz, 1H, OH), 
2.94 (dd, JAB, AX = 17.0, 3.8 Hz, 1H, CHCH2CO), 2.82 (dd, JBA, BX = 17.0, 6.4 Hz, 1H, 
CHCH2CO), 2.49 (q, J = 7.2 Hz, 2H, CH2CH3), 2.26 (s, 3H, CH3CO), 1.06 (t, J = 7.3 
Hz,3H, CH3CH2); 
13C NMR (126 MHz, CDCl3) δ 210.0 (q), 209.4 (q), 74.0 (CH), 45.0 
(CH2), 37.1 (CH2), 25.5 (CH3), 7.5 (CH3). 
The spectroscopic data were in agreement with those previously published.137 
 
 Experimental Procedures 




A solution of diketone 295 (15 g, 0.10 mmol, 1 equiv) in MeOH (75 mL) was cooled 
to 0 °C. An aqueous solution of 20% K2CO3 (470 mL) was added slowly over 1 hr 
such that the internal temperature of the reaction did not exceed 8 °C. The reaction 
mixture was stirred for 2 hr at 0 °C before being allowed to warm to RT and left for a 
further 24 hr. The solution was extracted three times with EtOAc, dried over MgSO4, 
filtered and the solvent removed in vacuo. Flash column chromatography (SiO2, 
hexane/EtOAc 2:8) delivered enone 296 as a clear orange oil (9.49 g, 72% yield). 
1H NMR (500 MHz, CDCl3) δ 4.72 (t, J = 6.0 Hz, 1H, CH), 2.77 (dd, JAB, AX = 18.4, 6.2 
Hz, 1H, CH2), 2.27 (dd, JBA, BX = 18.4, 1.9 Hz, 1H, CH2), 2.23 (d, J = 6.8 Hz, 1H, 
OH), 2.08 (s, 3H, CCCH3), 1.71 (s, 3H, CHCCH3); 
13C NMR (126 MHz, CDCl3) δ 
205.8 (q), 168.3 (q), 138.3 (q), 71.8 (CH), 44.4 (CH2), 13.8 (CH3), 8.1 (CH3). 
The spectroscopic data were in agreement with those previously published.137 
2,3-Dimethyl-4-(triethylsilyloxy)cyclopent-2-enone 297 
 
A solution of enone 296 (13.9 g, 0.11 mol, 1 equiv), triethylamine (18.7 g, 0.12 mol, 
1.1 equiv), DMAP (35.4 mL, 0.25 mol, 2.3 equiv) in anhydrous DCM (180 mL) was 
cooled to 0 °C before slow addition of TESCl (20.4 mL, 0.12 mol, 1.1 equiv). The 
reaction was stirred for 13 hr at RT before adding brine and separating the organic 
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layer. The DCM extracts were dried over MgSO4, filtered and the solvent evaporated 
under reduced pressure. Flash column chromatography (SiO2, hexane/EtOAc 9:1) 
delivered enone 297 as a clear orange oil (23.5 g, 89% yield). 
1H NMR (500 MHz, CDCl3) δ 4.69 – 4.63 (m, 1H, CH), 2.70 (dd, JAB, AX = 18.0, 6.0 
Hz, 1H, CH2CO), 2.23 (dd, JBA, BX = 18.0, 2.0 Hz, 1H, CH2CO), 2.01 (s, 3H, 
CHC=CCH3), 1.69 (s, 3H, CHCCH3), 0.98 (t, J = 8.0 Hz, 9H, Si(CH2CH3)3), 0.65 (q, J 
= 7.9 Hz, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 205.6 (q), 169.0 (q), 
137.7 (q), 71.8 (CH), 45.1 (CH2), 13.9 (CH3), 8.1 (CH3), 6.9 (CH3), 4.9 (CH2); IR (thin 
film, NaCl plate, cm-1) 2956, 1711, 1663, 1064, 1015; HRMS (ESI) m/z calcd for 
C13H25O2Si [M+H]




A solution of dioxolane 147 (12.9 g, 53.2 mmol, 1.6 equiv) in anhydrous Et2O        
(80 mL) was cooled to −78 °C and stirred for 10 mins before the slow addition of 
tBuLi (65.8 mL, 1.7 M solution in pentane, 111.9 mmol, 3.4 equiv). The reaction was 
stirred for a further 1 hr at −78 °C before being allowed to warm to RT for another      
1 hr. After which time, the mixture was cannulated into a precooled solution of 
enone 297 (8g, 33.3 mmol, 1 equiv) in Et2O (250 mL) at −78 °C ensuring the internal 
temperature of the reaction did not exceed −70 °C. The reaction was left stirring for 
a further 90 mins at −78 °C before warming to RT and quenching with distilled H2O     
(10 mL). The solution was dried over MgSO4, filtered and solvent removed under 
reduced pressure. Flash column chromatography (SiO2, hexane/EtOAc 6:4) 
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afforded a single diastereomer of tertiary alcohol 298 as a clear colourless oil      
(10.23 g, 86% yield). 
1H NMR (500 MHz, CDCl3) δ 4.38 – 4.30 (m, 1H, CH), 4.00 – 3.85 (m, 4H, 
OCH2CH2O), 2.40 (dd, JAB, AX = 13.9, 6.9 Hz, 1H, CH2CH), 1.83 – 1.37 (m, 11H, 2 × 
CH3CC, 2 × CH2, CH2CH), 1.31 (s, 3H, CH3CCH2), 0.97 (t, J = 8.0 Hz, 9H, 
Si(CH2CH3)3), 0.65 – 0.58 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3)            
δ 138.4 (q), 136.8 (q), 109.9 (q), 83.9 (q), 76.4 (CH), 64.7 (CH2), 48.1 (CH2), 33.8 
(CH2), 31.9 (CH2), 23.9 (CH3), 11.6 (CH3), 9.0 (CH3), 6.8 (CH3), 4.8 (CH2); IR (thin 
film, NaCl plate, cm-1) 3444, 2956, 1645, 1458, 1378, 1065; HRMS (ESI) m/z calcd 
for C19H36O4SiNa [M+Na]
+ 379.2275, found 379.2276. 
2,3-Dimethyl-4-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)cyclopent-2-enone 299 
 
Tertiary alcohol 298 (650 mg, 1.82 mmol, 1 equiv) and TCNQ (37 mg, 0.18 mmol, 
0.1 equiv) were dissolved in a solvent mixture of THF:H2O (10 mL, 9:1) and stirred 
at RT for 24 hr. The reaction mixture was diluted with EtOAc, dried over MgSO4, 
filtered and the solvent removed in vacuo. Flash column chromatography (SiO2, 
hexane/EtOAc 1:9) afforded enone 299 as a yellow oil (208 mg, 51% yield). 
1H NMR (500 MHz, CDCl3) δ 3.99 – 3.84 (m, 4H, OCH2CH2O), 2.67 (s, 1H, CH), 
2.49 (dd, JAB, AX = 18.6, 6.5 Hz, 1H, CH2CO), 2.04 (dd, JBA, BX = 18.6, 1.9 Hz, 1H, 
CH2CO), 2.00 (s, 3H, CHC=CCH3 ), 1.93 – 1.84 (m, 1H, CH2), 1.70 – 1.64 (m, 4H, 
CHCCH3, ), 1.61 – 1.55 (m, 2H, CH2), 1.36 – 1.26 (m, 4H, CH3CCH2, CH2); 
13C NMR 
(126 MHz, CDCl3) δ 208.8 (q), 172.6 (q), 136.9 (q), 109.8 (q), 64.9 (CH2), 64.8 
(CH2), 42.5 (CH), 40.4 (CH2), 36.4 (CH2), 27.0 (CH2), 24.0 (CH3), 15.3 (CH3), 8.1 
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(CH3); IR (thin film, NaCl plate, cm
-1) 2950, 2359, 2342, 1698, 1646, 1385, 1061; 
HRMS (ESI) m/z calcd for C13H21O3 [M+H]




A solution of tertiary alcohol 298 (10.2 g, 0.03 mol, 1 equiv) in anhydrous DCM    
(170 mL was treated with TBAF (40.1 mL, 0.04 mol, 1.4 equiv) and stirred for 1 hr at 
RT. The reaction mixture was then supplemented with TPAP (0.50 g, 14.3 mmol, 
0.05 equiv), NMO (10.1 g, 0.09 mol, 3 equiv) and stirred for a further 20 hr before 
the reaction solvent was removed under reduced pressure. The crude brown oil was 
purified by flash column chromatography (SiO2, 100% EtOAc), which afforded 
cyclopentenone 300 as a brown oil (6.43 g, 93% yield). 
1H NMR (500 MHz, CDCl3) δ 4.04 – 3.90 (m, 4H, OCH2CH2O), 2.70 – 2.65 (m, 1H, 
OH), 2.57 (d, J = 18.3 Hz, 1H, CCH2CO), 2.41 (d, J = 18.3 Hz, 1H, CCH2CO), 2.03 – 
1.93 (m, 4H, HOCC=CCH3, CH2), 1.78 – 1.67 (m, 4H, HOCCCH3, CH2), 1.67 – 1.57 
(m, 2H, CH3CCH2CH2), 1.33 (s, 3H, CH3CCH2); 
13C NMR (126 MHz, CDCl3) δ 205.5 
(q), 170.4 (q), 137.3 (q), 109.7 (q), 78.5 (q), 64.9 (CH2), 64.9 (CH2), 48.5 (CH2), 34.1 
(CH2), 32.3 (CH2), 24.0 (CH3), 11.3 (CH3), 8.1 (CH3); IR (thin film, NaCl plate, cm
-1) 
3432, 2928, 2359, 1699, 1652, 1381, 1065; HRMS (ESI) m/z calcd for C13H20NaO4 
[M+Na]+ 263.1254, found 263.1257. 
 
 
 Experimental Procedures 





Cyclopentenone 300 (3 g, 12.5 mmol, 1 equiv) and 2,6-lutidine (6.1 mL, 52.4 mmol, 
4.2 equiv) in dry DMF (35 mL) was stirred for 5 mins at RT before the dropwise 
addition of TESOTf (5.7 mL, 25.0 mmol, 2 equiv). The reaction mixture was stirred 
for 3 hr before being quenched with distilled H2O (10 mL) and extracted with Et2O. 
The ethereal extracts were washed twice with distilled H2O to remove any residual 
DMF, dried over MgSO4, filtered and the solvent removed in vacuo. Flash column 
chromatography (SiO2, hexane/EtOAc 8:2) furnished the title compound 301 as a 
pale yellow oil (4.0 g, 91% yield). 
1H NMR (500 MHz, CDCl3) δ 4.00 – 3.84 (m, 4H, OCH2CH2O), 2.52 (d, J = 18.2 Hz, 
1H, CCH2CO), 2.44 (d, J = 18.2 Hz, 1H, CCH2CO), 1.97 – 1.86 (m, 4H, 
SiOCC=CCH3, CH2), 1.68 (s, 3H, SiOCCCH3), 1.63 (td, J = 12.7, 4.0 Hz, 1H, CH2), 
1.53 (td, J = 13.0, 4.0 Hz, 1H, CH2), 1.37 – 1.25 (m, 4H, CH3CCH2, CH2), 0.90 (t, J = 
7.9 Hz, 9H, Si(CH2CH3)3), 0.57 – 0.47 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, 
CDCl3) δ 205.5 (q), 171.8 (q), 136.7 (q), 109.7 (q), 80.4 (q), 64.8 (CH2), 64.8 (CH2), 
48.2 (CH2), 34.2 (CH2), 34.1 (CH2), 24.1 (CH3), 11.6 (CH3), 8.0 (CH3), 7.1 (CH3), 6.4 
(CH2); IR (thin film, NaCl plate, cm
-1) 2956, 2359, 1709, 1657, 1379, 1071; HRMS 
(ESI) m/z calcd for C19H34NaO4Si [M+Na]




 Experimental Procedures 





A solution of dioxolane enone 301 (6 g, 16.9 mmol, 1 equiv) in anhydrous THF      
(60 mL) was cooled −78 °C and stirred for 10 mins before the addition of LDA     
(28.2 mL, 1.8 M THF/heptane/ethylbenzene, 50.8 mmol, 3 equiv). The reaction was 
stirred at −78 °C for 1 hr before being allowed to warm to RT and then transferred to 
a stirred suspension of Eschenmoser’s salt (9.4 g, 50.8 mmol, 3 equiv) in dry THF 
(150 mL) at −78 °C. The resulting solution was left stirring at −78 °C for 2 hr before 
being allowed to warm to RT and stirred for a further 30 mins. The reaction was 
quenched with a saturated NaHCO3 solution and extracted with DCM. The DCM 
extracts were washed with brine, dried over MgSO4, filtered and solvent evaporated 
under reduced pressure. The crude orange residue was dissolved in a mixture of 
DCM:NaHCO3 (120 mL, 2:1) and under vigorous stirring, one portion of mCPBA (8.8 
g, 50.8 mmol, 3 equiv) was carefully added and left to stir for 30 mins before 
separating the organic layer. The aqueous layer was extracted with DCM and the 
combined organic fractions were dried over MgSO4, filtered and solvent removed 
under reduced pressure leaving an orange crude oil. Flash column chromatography 
(SiO2, hexane/EtOAc 2:8) afforded exo-methylene 302 as a clear pale yellow oil 
(4.04 g, 65% yield). 
1H NMR (500 MHz, CDCl3) δ 6.10 (s, 1H, CH2=C), 5.50 (s, 1H, CH2=C), 3.97 – 3.79 
(m, 4H, OCH2CH2O), 2.04 – 1.94 (m, 4H, SiOCC=CCH3, CH2), 1.87 (td, J = 13.0, 4.3 
Hz, 1H, CH2), 1.78 (d, J = 0.8 Hz, 3H, SiOCCCH3), 1.31 (td, J = 13.2, 4.3 Hz, 1H, 
CH2), 1.25 (s, 3H, CH3CCH2), 1.12 (td, J = 13.3, 4.3 Hz, 1H, CH2), 0.85 (t, J = 7.9 
Hz, 9H, Si(CH2CH3)3), 0.50 – 0.35 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, 
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CDCl3) δ 194.5 (q), 167.1 (q), 147.4 (q), 139.1 (q), 116.0 (CH2), 109.7 (q), 79.8 (q), 
64.8 (CH2), 64.7 (CH2), 33.6 (CH2), 33.2 (CH2), 23.9 (CH3), 11.1 (CH3), 8.3 (CH3), 
7.0 (CH3), 6.1 (CH2); IR (thin film, NaCl plate, cm
-1) 2955, 1706, 1666, 1239, 1378, 
1072; HRMS (ESI) m/z calcd for C20H34NaO4Si [M+Na]
+ 389.2119, found 389.2126. 
2-[6a-(Triethylsilyloxy)-3-(2-hydroxyethoxy)-3,5,6-trimethyl-4-oxo-1,2,3,3a,4,6a-
hexahydropentalen-3a-yl]acetonitrile 303 and 304 
 
A solution of α-methylene 302 (2 g, 5.5 mmol, 1 equiv) in anhydrous toluene (50 mL) 
under N2, cooled to 0 °C and left to stir for 10 mins before dropwise addition of 
diethylaluminium cyanide (6 mL, 1 M solution in toluene, 6.0 mmol, 1.1 equiv). The 
reaction mixture was left stirring for 30 mins until the dropwise addition of TiCl4    
(6.0 mL, 1M solution in DCM, 6.0 mmmol, 1.1 equiv) and the resultant mixture was 
left stirring for a further 30 mins before quenching with saturated NaHCO3 solution 
(10 mL). The organic layer was separated and the aqueous layer extracted twice 
with EtOAc. The organic extracts were combined, dried over MgSO4, filtered and the 
solvent evaporated under reduced pressure. Flash column chromatography (SiO2, 
hexane/EtOAc 9:11) furnished a separable 7:1 diastereomeric mixture of major 
diastereomer 303 (1.32 g, 62% yield) as an oil and minor diastereomer 304 (181 
mg, 8% yield) as an oil. 
Major diastereomer 303: 1H NMR (500 MHz, CDCl3) δ 3.82 – 3.64 (m, 2H, CH2OH), 
3.51 (ddd, J = 10.2, 6.6, 3.8 Hz, 1H, CH2OC), 3.37 (ddd, J = 9.6, 4.8, 3.6 Hz, 1H, 
CH2OC), 2.60 (d, J = 16.5 Hz, 1H, CH2CN), 2.49 (d, J = 16.5 Hz, 1H, CH2CN), 2.13 
– 1.86 (m, 6H, SiOCC=CCH3, CH2, CH2), 1.72 (d, J = 0.8 Hz, 3H, SiOCCCH3), 1.25 
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(s, 3H, CH3CCH2), 1.03 – 0.88 (m, 10H, Si(CH2CH3)3, CH2), 0.78 – 0.66 (m, 6H, 
Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 205.1 (q), 169.1 (q), 136.7 (q), 119.4 
(q), 90.2 (q), 83.5 (q), 63.1 (q), 62.8 (CH2), 62.2 (CH2), 33.5 (CH2), 32.0 (CH2), 18.8 
(CH3), 17.2 (CH2), 12.5 (CH3), 8.3 (CH3), 7.3 (CH3), 6.9 (CH2); IR (thin film, NaCl 
plate, cm-1) 3493, 2954, 2877, 2359, 1704, 1656, 1458, 1237, 1059; HRMS (ESI) 
m/z calcd for C21H39N2O4Si [M+NH4]
+ 411.2674, found 411.2664. 
Minor diastereomer 304: 1H NMR (500 MHz, CDCl3) δ 3.64 – 3.47 (m, 3H, CH2OH, 
CH2OC,), 3.41 – 3.27 (m, 1H, CH2OC), 2.60 (d, J = 16.2 Hz, 1H, CH2CN), 2.49 (d, J 
= 16.2 Hz, 1H, CH2CN), 2.26 (s, 1H, OH), 2.07 – 1.99 (m, 4H, SiOCC=CCH3, CH2), 
1.92 – 1.80 (m, 2H, CH3CCH2CH2), 1.73 – 1.64 (m, 4H, SiOCCCH3, CH2), 1.36 (s, 
3H, CH3CCH2), 1.02 – 0.92 (m, 9H, Si(CH2CH3)3), 0.77 – 0.67 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 204.3 (q), 167.4 (q), 137.1 (q), 118.4 (q), 90.4 (q), 
83.9 (q), 63.6 (CH2), 63.2 (q), 62.0 (CH2), 35.6 (CH2), 34.4 (CH2), 19.1 (CH3), 18.7 
(CH2), 12.4 (CH3), 8.2 (CH3), 7.3 (CH3), 6.9 (CH2); IR (thin film, NaCl plate, cm
-1) 
3465, 2957, 2251, 1704, 1657, 1456, 1241, 1076; HRMS (ESI) m/z calcd for 
C21H39N2O4Si [M+NH4]










 Experimental Procedures 





Bicycle 303 (1.4 g, 3.56 mmol, 1 equiv) was dissolved in anhydrous THF (70 mL) 
and treated with TBAF (4.27 mL, 1 M solution in THF, 4.27 mmol, 1.2 equiv) and 
stirred for 1 hr at RT. The resulting solution was directly evaporated under reduced 
pressure leaving a crude mixture that was purified by flash column chromatography 
(SiO2, 100% EtOAc) affording diol 305 as a white solid (689 mg, 82% yield). 
1H NMR (500 MHz, CDCl3) δ 4.08 – 3.56 (m, 3H, CH2OH, OH), 3.56 – 3.11 (m, 3H, 
CH2OH, OH), 2.80 (d, J = 16.8 Hz, 1H, CH2CN), 2.56 (d, J = 16.8 Hz, 1H, CH2CN), 
2.09 (s, 3H, SiOCC=CCH3), 2.03 – 1.92 (m, 3H, CH2, CH2), 1.73 (s, 3H, 
SiOCCCH3), 1.28 (s, 3H, CH3CCH2), 0.98 – 0.80 (m, 1H, CH2); 
13C NMR (126 MHz, 
CDCl3) δ 204.7 (q), 169.6 (q), 136.7 (q), 120.1 (q), 88.1 (q), 83.9 (q), 62.7 (q), 62.4 
(CH2), 62.2 (CH2), 34.5 (CH2), 31.0 (CH2), 17.6 (CH3), 16.8 (CH2), 12.0 (CH3), 8.2 
(CH3); IR (thin film, NaCl plate, cm
-1) 3311, 2937, 2873, 2260, 1699, 1657, 1385, 
1049; HRMS (ESI) m/z calcd for C15H25N2O4 [M+NH4]
+ 297.1809 , found 297.1813; 
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A solution of alcohol 303 (1.2 g, 3.05 mmol, 1 equiv), imidazole (519 mg, 7.62 mmol, 
2.5 equiv), PPh3 (2 g, 7.62 mmol, 2.5 equiv) in dry DCM (60 mL) was stirred at RT. 
The resulting solution was treated in one portion with I2 (1548 mg, 6.1 mmol,            
2 equiv), stirred for 2 hr before being diluted with saturated Na2S2O3 solution and 
extracted with EtOAc. The EtOAc extracts were washed with brine and dried over 
MgSO4, filtered and the solvent removed in vacuo. Flash column chromatography 
(SiO2, hexane/EtOAc 9:1) delivered the title compound 306 as a clear yellow oil 
(1.44 g, 94% yield). 
1H NMR (500 MHz, CDCl3) δ 3.64 (dt, J = 10.1, 6.9 Hz, 1H, CH2I), 3.52 (dt, J = 10.2, 
6.3 Hz, 1H, CH2I), 3.26 – 3.16 (m, 2H, CH2O), 2.68 (d, J = 16.5 Hz, 1H, CH2CN), 
2.57 (d, J = 16.5 Hz, 1H, CH2CN), 2.09 – 1.98 (m, 4H, SiOCC=CCH3, CH2), 1.95 – 
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1.84 (m, 2H, CH3CCH2CH2), 1.72 (d, J = 0.7 Hz, 3H, SiOCCCH3), 1.26 (s, 3H, 
CH3CCH2), 1.03 – 0.97 (m, 9H, Si(CH2CH3)3), 0.93 (td, J = 13.7, 6.1 Hz, 1H, CH2), 
0.77 – 0.69 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, CDCl3) δ 205.0 (q), 169.4 (q), 
136.6 (q), 118.6 (q), 90.0 (q), 83.9 (q), 63.3 (q), 62.6 (CH2), 33.8 (CH2), 32.4 (CH2), 
18.4 (CH3), 17.3 (CH2), 12.5 (CH3), 8.3 (CH3), 7.3 (CH3), 7.0 (CH2), 3.6 (CH2); IR 
(thin film, NaCl plate, cm-1) 2954, 2876, 2251, 1704, 1656, 1457, 1237, 1071; HRMS 
(ESI) m/z calcd for C21H38I N2O3Si [M+NH4]
+ 521.1691, found 521.1690. 
5,9,10-Trimethyl-8-[(triethylsilyl)oxy]-4- oxatricyclo[6.3.0.01,5]undec-9-ene-3,                              
11-dione 307 
 
A solution of bicycle 306 (600 mg, 1.19 mmol, 1 equiv) and activated Zn dust100 (779 
mg, 11.92 mmol, 10 equiv) were dissolved in a solvent mixture of THF:0.1 M AcOH 
(60 mL, 79:1) and heated to reflux for 19 hr. The resultant suspension was dried 
over MgSO4, filtered, and the solvent evaporated under reduced pressure. Flash 
column chromatography (SiO2, hexane/EtOAc 8:2) furnished tricycle 307 as a white 
solid (362 mg, 87% yield). 
1H NMR (500 MHz, CDCl3) δ 3.10 (d, J = 18.3 Hz, 1H, CCH2CO), 2.72 (d, J = 18.3 
Hz, 1H, CCH2CO), 2.15 (dd, J = 13.0, 6.3 Hz, 1H, CH2), 2.08 (dd, J = 14.2, 6.7 Hz, 
1H, CH2), 2.03 (s, 3H, SiOCC=CCH3), 1.96 (td, J = 13.3, 6.7 Hz, 1H, CH2, 1.74 (s, 
3H, SiOCCCH3), 1.30 (td, J = 13.9, 6.3 Hz, 1H, CH2), 1.21 (s, 3H, CH3CCH2), 0.92 
(t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.62 (q, J = 7.9 Hz, 6H, Si(CH2CH3)3); 
13C NMR 
(126 MHz, CDCl3) δ 203.2 (q), 175.4 (q), 167.7 (q), 138.3 (q), 93.1 (q), 89.9 (q), 64.8 
(q), 34.5 (CH2), 32.6 (CH2), 32.3 (CH2), 23.0 (CH3), 12.4 (CH3), 8.6 (CH3), 7.2 (CH3), 
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6.7 (CH2); IR (thin film, NaCl plate, cm
-1) 2958, 2877, 1775, 1709, 1652, 1456, 1255, 
1136; HRMS (ESI) m/z calcd for C19H34NO4Si [M+NH4]
+ 368.2252, found 368.2253; 
MP 52-54 C. 
8-hydroxy-5,9,10-trimethyl-4- oxatricyclo[6.3.0.01,5]undec-9-ene-3,11-dione 308 
 
Tricycle 307 (200 mg, 0.57 mmol, 1 equiv) was dissolved in dry THF (8 mL) and was 
treated with TBAF (0.86 mL, 1 M solution in THF, 0.86 mmol, 1.5 equiv). The 
resulting solution was stirred at RT for 1 hr before the solvent was removed. The 
brown crude oil was purified by flash column chromatography (SiO2, hexane/EtOAc 
4:6) furnishing tertiary alcohol 308 as an off-white solid (130 mg, 97% yield). 
1H NMR (500 MHz, CDCl3) δ 3.08 (d, J = 18.2 Hz, 1H, CCH2CO), 3.04 (s. br, 1H, 
OH) 2.78 (d, J = 18.2 Hz, 1H, CCH2CO), 2.22 (dd, J = 13.3, 6.5 Hz, 1H, CH2), 2.14 – 
2.05 (m, 4H, HOCC=CCH3, CH2), 2.04 – 1.95 (m, 1H, CH2), 1.74 (d, J = 0.9 Hz, 3H, 
HOCCCH3), 1.40 – 1.30 (m, 1H, CH2), 1.25 (s, 3H, CH3CCH2); 
13C NMR (126 MHz, 
CDCl3) δ 203.0 (q), 175.9 (q), 168.0 (q), 138.6 (q), 94.5 (q), 87.9 (q), 63.4 (q), 34.3 
(CH2), 32.4 (CH2), 32.3 (CH2), 22.7 (CH3), 11.8 (CH3), 8.6 (CH3); IR (thin film, NaCl 
plate, cm-1) 3430, 2980, 2253, 1765, 1707, 1648, 1387, 1210, 907; HRMS (ESI) m/z 
calcd for C13H20NO4 [M+NH4]
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10,11-Dichloro-5,9,12-trimethyl-8-[(triethylsilyl)oxy]-4-
oxatetracyclo[6.5.0.01,5.09,12]tridecane- 3,13-dione 309 
 
Tricycle 307 (250 mg, 0.71 mmol, 1 equiv) was dissolved in neat trans-1,2-
dichloroethylene (12 mL) under Argon and in a quartz tube, and was irradiated with 
a Rayonet photochemical reactor equipped with 254 nm tubes (6 × 10W) for 4 hr at 
RT. The reaction mixture was evaporated under reduced pressure and the crude 
residue was purified by flash column chromatography (SiO2, hexane/EtOAc 3:1) 
affording as a single diastereomer, tetracycle 309 as a white solid (141 mg, 44% 
yield). A small single crystal was formed on slow evaporation from a solution of 
tetracycle 309 in a solvent mixture of hexane and DCM that was suitable for X-ray 
crystallography. 
1H NMR (500 MHz, CDCl3) δ 4.10 (d, J = 8.9 Hz, 1H, CHCl), 4.01 (d, J = 8.9 Hz, 1H, 
CHCl), 2.99 (d, J = 2.2 Hz, 2H, CCH2CO), 2.23 (dt, J = 13.6, 6.7 Hz, 1H, CH2), 2.16 
– 2.08 (m, 1H, CH2), 1.99 (dt, J = 13.7, 6.7 Hz, 1H, CH2), 1.72 – 1.63 (m, 1H, CH2), 
1.30 (s, 3H, CH3CCH2), 1.27 (s, 3H, CH3CCH), 1.18 (s, 3H, CH3CCH), 0.99 (t, J = 
7.9 Hz, 9H, Si(CH2CH3)3), 0.75 – 0.67 (m, 6H, Si(CH2CH3)3); 
13C NMR (126 MHz, 
CDCl3) δ 212.2 (q), 173.9 (q), 95.2 (q), 90.2 (q), 70.3 (q), 63.9 (CH), 62.1 (CH), 57.6 
(q), 55.0 (q), 37.3 (CH2), 35.3 (CH2), 34.9 (CH2), 23.4 (CH3), 16.5 (CH3), 12.2 (CH3), 
7.3 (CH3), 6.9 (CH2); IR (thin film, NaCl plate, cm
-1) 2957, 1767, 1740, 1454, 1204, 
1072, 1241, 1204, 1076; HRMS (ESI) m/z calcd for C21H36Cl2NO4Si [M+NH4]
+ 
464.1785, found 464.1785; MP 139-141 C. 
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A solution of bicycle 304 (320 mg, 0.81 mmol, 1 equiv) in dry THF (4 mL) was 
treated with TBAF (0.97 mL, 1 M solution in THF, 0.97 mmol, 1.2 equiv) and stirred 
at RT for 30 mins. The resulting solution was evaporated under reduced pressure 
and purified by flash column chromatography (SiO2, 100% EtOAc) furnishing diol 
311 as an amber coloured oil (187 mg, 82% yield). 
1H NMR (500 MHz, CDCl3) δ 3.64 – 3.51 (m, 2H, CH2O), 3.47 (ddd, J = 9.0, 5.8, 3.2 
Hz, 1H, CH2OC), 3.31 (ddd, J = 9.1, 6.0, 3.1 Hz, 1H, CH2OC), 2.70 – 2.58 (m, 2H, 
CH2CN), 2.37 (s. br, 1H. OH), 2.19 (s. br, 1H, OH), 2.12 – 2.02 (m, 4H, 
HOCC=CCH3, CH2), 2.01 – 1.91 (m, 1H, CH2), 1.90 – 1.76 (m, 2H, CH2), 1.72 (d, J = 
0.9 Hz, 3H, HOCCCH3), 1.38 (s, 3H, CH3CCH2); 
13C NMR (126 MHz, CDCl3) δ 204.1 
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(q), 167.4 (q), 137.1 (q), 119.0 (q), 88.6 (q), 84.8 (q), 63.3 (CH2), 62.2 (q), 62.0 
(CH2), 35.1 (CH2), 34.6 (CH2), 18.8 (CH3), 18.3 (CH2), 11.5 (CH3), 8.1 (CH3); IR (thin 
film, NaCl plate, cm-1) 3446, 2956, 2360, 2341, 2251, 1699, 1653, 1385; HRMS 
(ASA) m/z calcd for C15H22NO4 [M+H]
+ 280.1543, found 280.1548. 
7,8,11-Trimethyl-2- oxatricyclo[3.3.3.01,5]undeca-7,10-diene-3,6-dione 288 
 
Method A: A solution of alcohol 303 (200 mg, 0.51 mmol, 1 equiv) in anhydrous 
toluene (13 mL) was treated with BF3·Et2O (1.3 mL, 10.2 mmol, 20 equiv) and 
heated to 75 °C for 7 hr before the addition of distilled H2O (1 mL). The resulting 
biphasic solution was left for a further 1 hr before diluting with brine. EtOAc 
extractions were combined, dried over MgSO4, filtered and the solvent removed 
under reduced pressure. Flash column chromatography (SiO2, hexane/EtOAc 8:2) 
furnished lactone 288 as an off-white solid (39.2 mg, 35% yield). 
Method B: A solution of diol 305 (240 mg, 0.86 mmol, 1 equiv) in anhydrous toluene 
(15 mL) was treated with BF3·Et2O (2.2 mL, 17.2 mmol, 20 equiv) and heated to   
100 °C for 3 hr before the addition of distilled H2O (2.5 mL). The resulting biphasic 
solution was left for a further 1 hr before diluting with brine. EtOAc extractions were 
combined, dried over MgSO4, filtered and the solvent removed in vacuo. Flash 
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column chromatography (SiO2, hexane/EtOAc 8:2) delivered lactone 288 as an     
off-white solid (162 mg, 86% yield). 
Method C: A solution of diol 311 (95 mg, 0.34 mmol, 1 equiv) in anhydrous toluene 
(4 mL) was treated with BF3.Et2O (0.85 mL, 6.8 mmol, 20 equiv) and heated to 100 
°C for 2 hr before the addition of distilled H2O (1 mL). The resulting biphasic solution 
was left for a further 1 hr before diluting with brine. EtOAc extractions were 
combined, dried over MgSO4, filtered and the solvent removed in vacuo. Flash 
column chromatography (SiO2, hexane/EtOAc 8:2) delivered lactone 288 as an     
off-white solid (61 mg, 82% yield). 
1H NMR (500 MHz, CDCl3) δ 5.31 – 5.25 (m, 1H, CH=C), 2.86 – 2.61 (m, 4H, 
CH2CH=C, CCH2CO), 2.12 (d, J = 0.9 Hz, 3H, COCC=CCH3), 1.87 – 1.79 (m, 3H, 
CH3C=CH), 1.73 (d, J = 0.9 Hz, 3H, COCCCH3); 
13C NMR (126 MHz, CDCl3) δ 
203.2 (q), 175.2 (q), 164.0 (q), 138.1 (q), 137.8 (q), 124.2 (CH), 98.3 (q), 66.2 9 (q), 
40.4 (CH2), 34.7 (CH2), 13.5 (CH3), 12.6 (CH3), 8.3 (CH3); IR (thin film, NaCl plate, 
cm-1) 1773, 1697, 1643, 1196, 1148, 943; HRMS (ESI) m/z calcd for C13H18NO3 
[M+NH4]
+ 236.1281, found 236.1280; MP 132-134 C. 
X-ray crystal structure for 288:  
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3,4-Dichloro-2,5,13-trimethyl-10-oxatetracyclo[5.3.3.01,7.02,5]tridec-12-ene- 6,9-dione 
312 and 313 
 
A solution of tricycle 288 (250 mg, 1.14 mmol, 1 equiv) in neat trans-1,2-
dichloroethylene (20 mL) under Argon and in a quartz tube was irradiated with a 
Rayonet photochemical reactor equipped with 254 nm tubes (6 × 10W) for 48 hr at 
RT. The reaction mixture was evaporated under reduced pressure and the crude 
residue was purified by flash column chromatography (SiO2, hexane/EtOAc 8:2) 
affording a separable mixture of photoadducts 312, 313 and unreacted starting 
material 288 (234 mg). The recovered starting material was recycled furnishing a 
final separable mixture of diastereomers 312:313 (2:1), 312 as a white solid (148 
mg, 41% yield) and 313 as a white solid (70 mg, 19% yield).  
Major diastereomer 312: 1H NMR (500 MHz, CDCl3) δ 5.55 (d, J = 1.6 Hz, 1H, 
CH=C), 4.28 (d, J = 8.4 Hz, 1H, CHCl), 3.96 (d, J = 8.4 Hz, 1H, CHCl), 2.92 – 2.83 
(m, 2H, CCH2CO, CH2), 2.73 – 2.58 (m, 3H, CCH2CO, CH2), 1.86 – 1.82 (m, 3H, 
CH3C=CH), 1.38 (s, 3H, CH3CCH), 1.20 (s, 3H, CH3CCH); 
13C NMR (126 MHz, 
CDCl3) δ 214.4 9 (q), 173.7 (q), 141.7 (q), 127.9 (CH), 99.2 (q), 72.3 (q), 61.9 (CH), 
61.2 (CH), 57.9 (q), 54.7 (q), 39.4 (CH2), 38.8 (CH2), 17.2 (CH3), 14.1 (CH3), 11.0 
(CH3); IR (thin film, NaCl plate, cm
-1) 2974, 2931, 2866, 2256, 1788, 1739, 1448, 
1194, 978, 733; HRMS (ESI) m/z calcd for C15H20Cl2NO3 [M+NH4]
+ 332.0815, found 
332.0818. 
Minor diastereomer 313: 1H NMR (500 MHz, CDCl3) δ 5.44 – 5.37 (m, 1H, CH=C), 
4.07 (d, J = 8.7 Hz, 1H, CHCl), 3.84 (d, J = 8.7 Hz, 1H, CHCl), 2.99 – 2.66 (m, 4H, 
CCH2CO, CH2), 1.79 – 1.74 (m, 3H, CH3C=CH), 1.40 (s, 3H, CH3CCH), 1.18 (s, 3H, 
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CH3CCH); 
13C NMR (126 MHz, CDCl3) δ 209.9 (q), 173.9 (q), 137.3 (q), 125.7 (CH), 
98.8 (q), 70.6 (q), 63.2 (CH), 61.5 (CH), 59.9 (q), 53.7 (q), 40.7 (CH2), 35.0 (CH2), 
16.7 (CH3), 13.1 (CH3), 12.4 (CH3); IR (thin film, NaCl plate, cm
-1) 2983, 2360, 1788, 
1651, 1450, 1373, 1242, 1034, 858; HRMS (ESI) m/z calcd for C15H20Cl2NO3 
[M+NH4]
+ 332.0815, found 332.0820; MP 133-135 C. 
2,5,13-Trimethyl-10- oxatetracyclo[5.3.3.01,7.02,5]trideca-3,12- diene-6,9-dione 287 
 
Photoadduct 312 (100 mg, 0.32 mmol, 1 equiv), acetic anhydride (747 µL,            
7.95 mmol, 25 equiv), activated zinc dust100 (16.6 g, 154 mmol, 800 equiv) and 
TMSCl (101 µL, 0.795 mmol, 2.5 equiv) in anhydrous toluene (15 mL). The resulting 
solution was stirred and heated to 100 °C for 17 hr. After this time, the zinc was 
removed by filtration and evaporation of the solvent, left a crude residue that was 
purified by flash column chromatography (SiO2, hexane/EtOAc 17:3) affording 
cyclobutene 287 as a yellow solid (57 mg, 73% yield). 
1H NMR (500 MHz, CDCl3) δ 6.25 (d, J = 2.8 Hz, 1H, CH=CH), 6.08 (d, J = 2.8 Hz, 
1H, CH=CH), 5.23 – 5.18 (m, 1H, CH=C), 2.93 – 2.84 (m, 2H, CCH2CO, CH2), 2.66 
– 2.59 (m, 1H, CH2), 2.52 (d, J = 18.6 Hz, 1H, CCH2CO), 1.73 – 1.68 (m, 3H, 
CH3C=CH), 1.37 (s, 3H, CH3CCH), 1.15 (s, 3H, CH3CCH); 
13C NMR (126 MHz, 
CDCl3) δ 215.0 (q), 175.0 (q), 145.2 (CH), 145.0 (q), 140.5 (CH), 124.3 (CH), 97.1 
(q), 71.9 (q), 63.3 (q), 57.5 (q), 40.0 (CH2), 38.9 (CH2), 14.1 (CH3), 14.0 (CH3), 13.4 
(CH3); IR (thin film, NaCl plate, cm
-1) 2978, 1775, 1721, 1240, 1215, 1069, 963, 766; 
HRMS (ESI) m/z calcd for C15H20NO3 [M+NH4]
+ 262.1438, found 262.1441. 
 Experimental Procedures 
219 | P a g e  
 
2,5,13-Trimethyl-10- oxatetracyclo[5.3.3.01,7.02,5]trideca-3,12- diene-6,9-dione 314 
 
Photoadduct 313 (42 mg, 0.13 mmol, 1 equiv), acetic anhydride (314 µL, 3.3 mmol, 
25 equiv), activated zinc dust100 (7.0 g, 107 mmol, 800 equiv) and TMSCl (42 µL, 
0.33 mmol, 2.5 equiv) in anhydrous toluene (6 mL). The resulting solution was 
stirred and heated to 100 °C for 17 hr. After which time, the zinc was removed by 
filtration and evaporation of the solvent, left a crude residue that was purified by 
flash column chromatography (SiO2, hexane/EtOAc 17:3) affording cyclobutene 314 
as yellow solid (24 mg, 74% yield). 
1H NMR (500 MHz, CDCl3) δ 6.56 (d, J = 2.7 Hz, 1H, CH=CH), 6.11 (d, J = 2.7 Hz, 
1H, CH=CH), 5.39 – 5.34 (m, 1H, CH=C), 2.82 – 2.76 (m, 3H, CCH2CO, CH2), 2.70 
– 2.63 (m, 1H, CH2), 1.84 – 1.80 (m, 3H, CH3C=CH), 1.35 (s, 3H, CH3CCH), 1.18 (s, 
3H, CH3CCH); 
13C NMR (126 MHz, CDCl3) δ 210.8 (q), 175.2 (q), 145.4 (CH), 140.7 
(CH), 137.4 (q), 125.3 (CH), 98.1 (q), 69.2 (q), 66.4 (q), 56.2 (q), 40.2 (CH2), 38.8 
(CH2), 16.1 (CH3), 12.9 (CH3), 12.7 (CH3); IR (thin film, NaCl plate, cm
-1) 2979, 
1771, 1719, 1443, 1234, 1200, 1165, 1030, 941, 770; HRMS (ESI) m/z calcd for 
C15H20NO3 [M+NH4]
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6-Hydroxy-2,5,13-trimethyl-10- oxatetracyclo[5.3.3.01,7.02,5]trideca-3,                      
12- dien-9-one 322 
 
A solution of tetracycle 287 (30 mg, 0.12 mmol, 1 equiv) in anhydrous MeOH (3 mL) 
was treated in one portion with sodium borohydride (9.3 mg, 0.25 mmol, 2 equiv). 
The reaction mixture was left stirring for 2 hr before being quenched with 0.5 mL 
distilled water, dried over MgSO4, filtered and solvent evaporated under reduced 
pressure. Flash column chromatography (SiO2, hexane/EtOAc 7:3) furnished 322 as 
a clear colourless oil (24.4 mg, 81% yield). 
1H NMR (500 MHz, CDCl3) δ 6.10 – 6.07 (m, 2H, CH=CH, CH=CH), 5.25 (d, J = 1.6 
Hz, 1H, CH=C), 3.70 (d, J = 7.5 Hz, 1H, CHOH), 2.75 (d, J = 17.8 Hz, 1H, 
CCH2CO), 2.63 – 2.54 (m, 2H, CCH2CO, CH2), 2.51 – 2.43 (m, 1H, CH2), 1.82 – 
1.76 (m, 3H, CH3C=CH), 1.50 (d, J = 7.7 Hz, 1H, OH), 1.18 (s, 3H, CH3CCH), 1.17 
(s, 3H, CH3CCH); 
13C NMR (126 MHz, CDCl3) δ 176.3 (q), 143.0 (q), 141.5 (CH), 
138.0 (CH), 125.4 (CH), 100.0 (q), 83.1 (CH), 68.4 (q), 61.9 (q), 58.6 (q), 42.6 (CH2), 
40.5 (CH2), 19.3 (CH3), 15.8 (CH3), 14.6 (CH3) IR (thin film, NaCl plate, cm
-1) 3435, 
3037, 2925, 1770, 1446, 1379, 945, 768; HRMS (ESI) m/z calcd for C15H18O3 
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6-[(tert-Butyldimethylsilyl)oxy]-2,5,13-trimethyl-10-
oxatetracyclo[5.3.3.01,7.02,5]trideca- 3,12-dien-9-one 320 
 
Tertiary alcohol 322 (20 mg, 0.08 mmol, 1 equiv) and triethylamine (69 mg, 1.70 
mmol, 21 equiv) were dissolved in anhydrous DCM (3 mL) followed by the addition 
in one portion of TBSOTf (186 µL, 0.81 mmol, 10 equiv). The reaction mixture was 
carefully heated to 30 °C and left stirring for 5 days until most of the starting material 
had been consumed. The reaction mixture was diluted with brine, extracted twice 
with DCM and the organic layers combined, dried over MgSO4, filtered and the 
solvent removed in vacuo. Flash column chromatography (SiO2, hexane/EtOAc 
1:19) furnished 320 as a clear colourless viscous oil (23.6 mg, 81% yield) and 
unreacted starting material 322 (2 mg). 
1H NMR (500 MHz, CDCl3) δ 6.05 (d, J = 2.9 Hz, 1H, CH=CH), 5.88 (d, J = 2.9 Hz, 
1H, CH=CH), 5.12 (d, J = 1.5 Hz, 1H, CH=C), 3.64 (s, 1H, CHOSi), 2.77 (d, J = 17.6 
Hz, 1H, CCH2CO), 2.57 – 2.50 (m, 1H, CH2), 2.45 (d, J = 17.7 Hz, 1H, CCH2CO), 
2.41 – 2.34 (m, 1H, CH2), 1.82 – 1.75 (m, 3H, CH3C=CH), 1.16 (s, 3H, OCCCH3), 
1.08 (s, 3H, SiOCHCCH3), 0.91 (s, 9H, SiC(CH3)3), 0.12 – 0.09 (m, 6H, Si(CH3)3); 
13C NMR (126 MHz, CDCl3) δ 176.7 (q), 145.6 (q), 139.7 (CH), 138.9 (CH), 124.1 
(CH), 100.4 (q), 83.6 (CH), 65.3 (q), 59.7 (q), 57.9 (q), 44.6 (CH2), 39.8 (CH2), 26.1 
(CH3), 19.1 (CH3), 18.2 (q), 17.4 (CH3), 13.7 (CH3), -2.9 (CH3), -4.7 (CH3); IR (thin 
film, NaCl plate, cm-1) 3039, 2929, 2856, 2360, 2254, 1780, 1732, 1257; HRMS 
(ESI) m/z calcd for C21H32O3Si [M+H]
+ 361.2204, found 361.2202 
The spectroscopic data were in agreement with those previously published.22
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Appendix: Spectroscopic Data 
Iodo-aldol product 199 
1H-NMR (600 MHz, CDCl3), 
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Iodo-aldol product 200 
1H-NMR (600 MHz, CDCl3), 




 Appendix: Spectroscopic Data 
230 | P a g e  
 
Iodol-aldol product 206 
1H-NMR (600 MHz, CDCl3), 
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Iodol-aldol product 207 
1H-NMR (700 MHz, CDCl3), 
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Isopropyl 219 
1H-NMR (600 MHz, CDCl3), 
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Cyano-aldol product 254 
1H-NMR (500 MHz, CDCl3), 




 Appendix: Spectroscopic Data 
234 | P a g e  
 
Cyano-aldol product 255 
1H-NMR (500 MHz, CDCl3), 
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Tricycle product 264 
1H-NMR (500 MHz, CDCl3), 
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Carbonate 269 
1H-NMR (500 MHz, CDCl3), 
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Tricycles 283 and 284 
1H-NMR (500 MHz, CDCl3), 
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Cyano-aldol product 303  
1H-NMR (500 MHz, CDCl3), 





 Appendix: Spectroscopic Data 
239 | P a g e  
 
Cyano-aldol product 304  
1H-NMR (500 MHz, CDCl3), 
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Tricycle 288  
1H-NMR (500 MHz, CDCl3), 
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Cyclobutene 287 
1H-NMR (500 MHz, CDCl3), 
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Cyclobutene 314 
1H-NMR (500 MHz, CDCl3), 
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Tetracycle 322 
1H-NMR (500 MHz, CDCl3), 
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Tetracycle 320 
1H-NMR (500 MHz, CDCl3), 
13C-NMR (126 MHz, CDCl3) 
 
 
 
